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Innate immunity and host defence are rapidly evoked by structurally invariant molecular 
motifs common to microbial world, called pathogen associated molecular patterns 
(PAMPs). In addition to PAMPs, endogenous molecules released in response to 
inflammation and tissue damage, danger associated molecular patterns (DAMPs), are 
required for eliciting the response. The most important PAMPs of viruses are viral nucleic 
acids, their genome or its replication intermediates, whereas the identity and 
characteristics of virus infection-induced DAMPs are poorly defined. 
PAMPs and DAMPs engage a limited set of germ-line encoded pattern recognition 
receptors (PRRs) in immune and non-immune cells. Membrane-bound Toll-like receptors 
(TLRs), cytoplasmic retinoic acid inducible gene-I (RIG-I)-like receptors (RLRs) and 
nucleotide-binding oligomerization domain-like receptor (NLRs) are important PRRs 
involved in the recognition of the molecular signatures of viral infection, such as double-
stranded ribonucleic acids (dsRNAs). Engagement of PRRs results in local and systemic 
innate immune responses which, when activated against viruses, evoke secretion of 
antiviral and pro-inflammatory cytokines, and programmed cell death i.e., apoptosis of the 
virus-infected cell. 
Macrophages are the central effector cells of innate immunity. They produce 
significant amounts of antiviral cytokines, called interferons (IFNs), and pro-inflammatory 
cytokines, such as interleukin (IL)-1 and IL-18. IL-1 and IL-18 are synthesized as 
inactive precursors, pro-IL-1 and pro-IL-18, that are processed by caspase-1 in a 
cytoplasmic multiprotein complex, called the inflammasome, before they are biologically 
active and secreted. The signals and secretory routes that activate inflammasomes and the 
secretion of IL-1 and IL-18 during virus infections are poorly characterized. The main 
goal of this thesis was to characterize influenza A virus-induced innate immune responses 
and host-virus interactions in human primary macrophages during an infection. 
It was found that extracellular dsRNA and cytoplasmic dsRNA differed strikingly in 
their capacity to elicit IFNs, IL-1, IL-18, and apoptosis in human primary macrophages. 
Recognition of extracellular dsRNA via TLR3 induced only modest production of IFNs, 
whereas pro-IL-1 was robustly synthesized. However, extracellular dsRNA was 
insufficient alone to trigger caspase-1 activation or IL-1 and IL-18 secretion. In contrast, 
cytoplasmic dsRNA elicited marked expression of IFNs, caspase-1 activation, and 
subsequent processing of constitutively produced pro-IL-18, and IL-18 secretion. 
Nonetheless, TLRs were needed to augment the weak cytoplasmic RNA-induced 
expression of pro-IL-1 in order to achieve significant secretion of IL-1. Interestingly, 
cytoplasmic dsRNA stimulus and influenza A virus infection, but not TLRs, were able to 
activate caspase-3, the ultimate executioner of apoptosis. This apoptotic response was 
intimately associated with the activities of RIG-I/mitochondrial antiviral signalling protein 
(MAVS). The results indicate that the cytoplasmic RNA recognition pathway elicited a 
strong antiviral cytokine response, secretion of IL-18, and apoptosis, but IL-1 could only 
be released from cytoplasmic dsRNA-stimulated or influenza A virus-infected human 
primary macrophages if TLRs were simultaneously activated. Overall, the results 






To elucidate virus-infection-induced inflammasome activation further, secreted 
proteins, secretomes, from cytoplasmic dsRNA-stimulated human primary macrophages 
were analysed with high-throughput mass spectrometric (MS)-based methods. 
Cytoplasmic dsRNA induced subtle secretion of lysosomal proteases cathepsins which 
have been postulated to promote inflammasome activation and apoptosis. Further 
characterization revealed that inflammasome activation preceded apoptosis, and that 
cathepsin D was simultaneously secreted with inflammasome components before 
cathepsin B was secreted. Pharmacological inhibition of cathepsin B abolished IL-18 
secretion and apoptosis in response to cytoplasmic dsRNA stimulus and 
encephalomyocarditis virus (EMCV) and vesicular stomatitis virus (VSV) infections. 
Moreover, gene silencing experiments targeted against cathepsin D suggested role for 
cathepsin D in cytoplasmic dsRNA-induced inflammasome activation. These results 
highlighted the importance of cathepsins in mediating the innate immune responses 
against RNA-viruses. 
Two-dimensional electrophoresis (2DE) coupled with MS was performed to better 
elucidate influenza A virus-induced innate immune responses in human primary 
macrophages. Compared to controls, subcellular proteomes of influenza A virus infected 
cells displayed significant changes in mitochondria and cytoplasm. In particular, the 
cytoskeleton was significantly reorganized, including caspase-3-mediated fragmentation 
of the actin network, and translocation of intact and fragmented actins into mitochondria. 
In addition to proteins of influenza A virus, RLR signalling components, RIG-I, TRIM25, 
and TRADD translocated sequentially to mitochondria during infection. Disruption of 
actin network with actin depolymerizing agent, cytochalasin D, prevented e.g., 
transcription of IFNs, but not caspase-3 activation or viral protein expression. The results 
pointed to a requirement of intact actin for IFN-signalling, and emphasized the importance 
of interactions between actin and mitochondria in the regulation of innate immune 
responses during influenza A virus infection. 
In order to obtain a more global view on host-virus interactions in response to 
influenza A virus infection, quantitative high-throughput subcellular proteomic and 
secretome profiling were performed. Dramatic alterations were observed. Influenza A 
virus infection altered the abundance and location of more than 1000 proteins in nuclear, 
mitochondrial, and cytoplasmic proteomes at early time points of infection. Furthermore, 
several nuclear, mitochondrial, and lysosomal proteins were detected in cytoplasmic 
proteomes and secretomes, and among the secreted proteins, several potential DAMPs 
were detected. In an attempt to uncover host-virus-responses and possible regulatory 
proteins important for inflammasome activation, a protein-protein interaction network 
from intracellular and inflammation-associated proteins of influenza A virus-infected 
human primary macrophages was constructed via bioinformatics. Based on results from 
the network analysis and functional studies, cathepsin B, P2X7-receptor, and Src tyrosine 
kinases appeared to be involved in the influenza A virus-induced pro-inflammatory 
cytokine response of IL-1 and IL-18. 
In summary, this thesis provides interesting insights into innate immune responses 
against RNA-viruses and has characterized host-virus interactions during influenza A 







Immuunivaste on luokiteltu toiminnallisesti luontaiseen ja hankittuun immuniteettiin. 
Luontainen immuniteetti on nopea ensivaste taudinaiheuttajaa vastaan, ja se edeltää 
lymfosyytteihin ja vasta-aineisiin perustuvaa pitkäkestoista hankittua immuniteettia. 
Luontaisen immuniteetin toiminta perustuu liukoisiin ja solukalvoissa oleviin 
tunnistereseptoreihin. Tärkeitä tunnistereseptoriperheitä ovat solukalvojen Toll-kaltaiset 
reseptorit (TLRs), sekä liukoiset soluliman RIG-I:n kaltaiset reseptorit (RLRs) ja 
Nukleotidi-sitoutumis- ja oligomerisaatioalueen -kaltaiset reseptorit (NLRs). 
Tunnistereseptorien sitoutuminen patogeenien rakenteisiin tai infektion ja kudosvaurion 
yhteydessä soluista vapautuviin vaarasignaaleihin aktivoi luontaisen immuniteetin. 
Tärkein tunnistereseptoreita aktivoiva viraalinen rakenne on viruksen nukleiinihapot, 
perimäaines tai sen replikaatiotuotteet. Virusinfektion aikana solusta vapautuvat 
vaarasignaalit ovat huonosti tunnettuja. Tunnistereseptorien aktivoituminen johtaa usein 
systeemiseen ja paikalliseen antiviraalisten sytokiinien ja tulehdusvälittäjäaineiden 
erittymiseen ja infektoituneen solun ohjelmoituun solukuolemaan, apoptoosiin. Ilman 
luontaista immuniteettiä hankittu immuniteetti ei voi muodostua kohdattua 
taudinaiheuttajaa vastaan. 
Makrofagit ovat keskeisiä luontaisen immuniteetin soluja, jotka tuottavat antiviraalisia 
sytokiinejä ja tulehdusvälittäjäaineita, kuten interferoneja (IFN) ja interleukiineja (IL). IL-
1 ja IL-18 ovat elimistön tärkeimpiä tulehdusvälittäjäaineita. Ne tuotetaan biologisesti 
toimimattomina esiasteina, jotka kaspaasi-1 prosessoi soluliman inflammasomi-
rakenteessa biologisesti aktiivisiksi. Signaalit, jotka johtavat inflammasomin aktivaatioon 
ja sitä seuraavaan IL-1 ja IL-18 erittymiseen virusinfektiossa, ovat huonosti 
karakterisoituja. Väitöskirjatyön päätavoitteena oli tutkia luontaisen immuniteetin 
aktivoitumismekanismeja ja isäntä-virus vuorovaikutusta influenssa A virus -
infektoiduissa ihmisen primääri makrofageissa. 
Virusinfektio tuottaa soluun ribonukleiinihappoja (RNAs). Solun ulkopuolinen RNA 
usein fagosytoidaan ja tunnistetaan TLR-välitteisesti, kun taas solulimassa oleva 
viraalinen RNA aktivoi soluliman RLR- ja NLR-tunnistereseptoreja. Makrofageissa solun 
ulkopuolinen ja soluliman viraalinen RNA aiheuttivat huomattavan erilaiset antiviraali 
sytokiini- ja tulehdusvälittäjäainevasteet. Solun ulkopuolisen viraalisen RNA:n 
tunnistaminen TLR-reitin kautta aikaansai merkittävän pro-IL-1:n tuotannon, muttei 
huomattavaa IL-1 eritystä tai IFN:n ilmentämistä. Soluliman viraalisen RNA:n ja 
influenssa A-viruksen tunnistaminen soluliman tunnistereseptorien välityksellä puolestaan 
indusoivat voimaakkaan IFN:n ilmentämisen, kaspaasi-1 aktivaation ja IL-18 erityksen. 
Virusinfektion aikainen IL-1:n tuotto ja eritys vaati kuitenkin TLR- ja soluliman 
tunnistereseptorien yhteistoiminnan. Soluliman viraalinen RNA ja influenssa A-virus, 
muttei solun ulkopuolinen RNA, aktivoivat myös kaspaasi-3:a ja sen välittämää 
ohjelmoitua solukuolemaa, apoptoosia. Kaspaasi-3:n aktivaatio ja apoptoosi kytkeytyi 
vahvasti soluliman RLR-tunnistereseptorien toimintaan. Tulokset osoittavat soluliman 
tunnistereseptorien olevan avainasemassa puolustautumisessa viruksia vastaan. 
Soluliman viraalisen RNA:n tunnistaminen aiheutti makrofageissa huomattavaa 






proteiinien joukossa oli lysosomaalisia proteaaseja, katepsiineja, joiden tiedetään 
osallistuvan sekä inflammasomin aktivaatioon että apoptoosiin. Tarkempi karakterisointi 
osoitti soluliman viraalisen RNA:n aktivoivan inflammasomin ennen apoptoosia ja 
katepsiini-D:n erittyvän stimuloiduista soluista yhdessä inflammasomi-komponenttien 
kanssa ennen katepsiini-B:tä. Katepsiini-D:n ilmentämisen hiljentäminen vähensi 
soluliman viraalisen RNA:n aikaansaamaa IL-18 eritystä. Lisäksi katepsiini-B proteiinin 
toiminnan farmakologinen estäminen rajoitti huomattavasti inflammasomin aktivaatiota ja 
apoptoosia, myös Encephalomyocarditisvirus (EMCV)- ja Vesicular stomatitis-virus 
(VSV) -infektiossa. Tulokset korostavat katepsiinien tärkeyttä luontaisen immuniteetin 
vasteissa virusinfektion aikana. 
Kaksiulotteista proteiinien elektroforeettista erottelua yhdistettynä proteiinien 
massaspektometri (MS)-pohjaiseen tunnistukseen hyödynnettiin solunsisäisten 
proteiinimuutoksien havainnollistamiseksi influenssa A-virus -infektoiduissa 
makrofageissa. Infektoituneiden solujen mitokondrioiden ja solulimojen proteomit 
erosivat huomattavasti kontrolli solujen vastaavista. Etenkin solutukirangassa havaittiin 
suuria muutoksia: aktiinitukiranka pilkkoutui kaspaasi-3-välitteisesti ja aktiinisäikeet 
siirtyivät solulimasta mitokondrioihin. Influenssa A-viruksen proteiinien lisäksi myös 
RLR-reitin signalointimolekyylit, RIG-I, TRIM25 ja TRADD, siirtyivät solulimasta 
kyseisiin organelleihin infektion edetessä. Aktiinitukiverkon polymerisaation estäminen 
sytokalasiini-D:llä vähensi antiviraalisten sytokiinien ilmentymistä. Yhdiste ei kuitenkaan 
vaikuttanut kaspaasi-3:n aktivaatioon tai virusproteiinien tuotantoon influenssa A-virus -
infektoiduissa soluissa. Tulokset viittaavat yhtenäisen aktiinitukiverkoston olevan tärkeä 
IFN:ien ilmentymiseen, mutta ei apoptoosin tai virusreplikaation etenemiseen. 
Mitokondrioiden ja aktiinien välinen vuorovaikutus ilmentänee niiden osallistumista 
luontaisen immuniteetin vasteiden säätelyyn influenssa A-virus -infektoiduissa soluissa. 
Viimeisessä osatyössä influenssa A-virus-makrofagi-vuorovaikutusta profiloitiin 
kokonaisvaltaisella, kvantitatiivisella MS-pohjaisella proteomiikalla aikapisteittäin. 
Soluista analysoitiin soluliman, tuman ja mitokondrioiden proteiinifraktiot sekä 
sekretomit. Kvantitatiivinen proteomiikka-analyysi paljasti yli tuhannen proteiinin määrän 
ja paikan muutoksen jo varhaisessa vaiheessa influenssa A-virus -infektiota. Useita tuman, 
lysosomien ja mitokondrioiden proteiineja havaittiin solulimasta, mikä viittaa vilkkaaseen 
soluorganellien väliseen proteiiniliikenteeseen ja näiden organellien mahdolliseen 
solukalvojen lisääntyneeseen läpäisevyyteen tai vaurioon. Myös huomattava määrä 
vaarasignaaleja erittyi infektoituneista soluista. Tunnistetuista ja tulehdukseen liittyvistä 
solunsisäisistä proteiineista luotiin bioinformatiikan keinoin proteiini-proteiini 
vuorovaikutusverkosto, jonka avulla selvitettiin isäntä -virus -vuorovaikutusta ja 
mahdollisia inflammasomin säätelyproteiineja. Vuorovaikutusverkoston ja 
funktionaalisten kokeiden tulokset osoittivat katepsiinien, P2X7-reseptorin ja Src-
tyrosiinikinaasien osallistuvan inflammasomin aktivaatioon influenssa A-virus-infektiossa 
ihmisen primääri makrofageissa. 
Väitöskirjan tulokset antavat kattavan kuvan luontaisen immuniteetin 
aktivaatiomekanismeista RNA-virusinfektion aikana ja isäntä-virus -vuorovaikutuksesta 
influenssa A-virus -infektoiduissa ihmisen primääri makrofageissa. 
Abbreviations and a mini-glossary 
For convenience and in contrast to the customary form, in certain case 
the abbreviated name will be presented first in the text. 
 
2'-5'OAS, 2'-5'-oligoadenylate synthetase: 
an enzyme that converts adenosine triphosphate (ATP) into 
2'-5'-oligoadenylates in response to interferon (IFN) signal. 
 
5'-ppp, 5'-triphosphate: 
three phosphate molecules at the 5' end of ribonucleic acid (RNA) or 
deoxyribonucleic acid (DNA) molecules. 
 
AIM2, absent in melanoma-2: 
a cytoplasmic pattern recognition receptor (PRR) belonging to 
AIM-like receptors (ALRs). 
 
ASC, apoptosis-associated speck-like protein containing CARD: 
an essential component in all inflammasomes. 
 
ATP, adenosine triphosphate: 
the main energy-transfer molecule in the cell used by enzymes and 
structural proteins in many cellular processes. Cellular respiration in mitochondria 
is the largest source of ATP in eukaryotic cells. 
 
BAX, B-cell CLL/lymphoma 2 (Bcl-2)-associated X protein: 
a pro-apoptotic protein involved in dissipation of mitochondrial membrane potential. 
 
Bcl-2, B-cell CLL/ lymphoma-2: 
an anti-apoptotic protein which binds and inhibits pro-apoptotic functions of Bax. 
 
Bid, BH3 interacting domain death agonist: 
Proteolysis of Bid into its truncated variant (t-Bid) promotes apoptosis. 
 
CARD, caspase recruitment domain: 
an important protein domain found e.g., in retinoic acid -inducible gene-I 
(RIG-I), melanoma differentiation-associated gene-5 (MDA-5), mitochondrial 
antiviral signalling protein (MAVS), and in caspases. 
 
Caspase, cysteine-dependent aspartate-directed proteases: 
a family of cysteine proteases that play essential roles in apoptosis, 






Cyt c, cytochrome c: 
a small heme-containing protein which is an essential component of 
electron transport chain. It loosely associates with the inner membrane of 
the mitochondrion, and its release into cytoplasm triggers apoptosis. 
 
DAMP, danger associated molecular pattern: 
endogenous molecules that signals for danger. 
 
DNA, deoxyribonucleic acids: 
the genetic code of flora and fauna, with the exception of RNA viruses. 
Information coded in DNA is passed onto the next generation during 
cell division or replication. 
 
ds, double-strand: 
complementary pairing of single-stranded (ss) nucleotides into ds-variants. 
 
EMCV, encephalomyocarditis virus: 
a positive sense ssRNA virus of Picornavirus family that causes 
encephalitis and myocarditis, mainly in its natural host, rodents. 
 
FADD, Fas-Associated protein via death domain: 
an adapter molecule which is part of death-inducing signaling complex (DISC). 
FADD also interacts with MAVS. 
 
HA, hemagglutinin: 
an important structural capsid protein of influenza viruses. 
HA mediates binding of virus to a permissive host cell. 
 
HSP, heat shock protein: 
a protein that assists in correct folding, function, and stability of other proteins. 
 
HCV, hepatitis C virus: 
a positive-sense ssRNA virus of Flaviviridae family. 
Hepatitis C virus causes hepatitis C in humans. 
 
HMGB1, high mobility group box-1 protein: 
a chromatin-binding nuclear protein with versatile functions. 
Extracellularly HMGB1 is a DAMP. 
 
IFNs, interferons: 
antiviral cytokines which have been subcategorized 







a group of important cytokines. The term interleukin derives from (inter-), 
meaning communication, and (-leukin) indicating that these proteins are 
mainly produced and targeted by leukocytes. 
 
IL-1Ra, IL-1 receptor (IL-1R) antagonist: 
IL-1Ra blocks access of IL-1 to its receptor IL-1R. 
 
IRF, IFN regulatory factor: 
a family of transcription factors that, upon phosphorylation, translocate into nucleus 
and activate expression of genes containing IFN-stimulated response elements (ISREs). 
 
LGP2, Laboratory of genetics and pathology-2: 
a member of RIG-I-like receptors (RLRs). LGP2 is a RNA helicase which 
regulates functions of RIG-I and MDA-5. 
 
LPS, lipopolysaccharide: 
a cell wall component of gram-negative bacteria. 
 
LRR, leucine rich-repeat: 
Structural motif of proteins composed of 20-30 tandem copies of amino acid 
sequences rich of leucines. LRRs are the ligand-binding part of several PRRs. 
 
M2, Matrix protein-2: 
an essential ion channel protein of influenza A virus particle. 
 
MAVS, mitochondrial antiviral signalling protein 
(or alternatively IPS-I/VISA/CARDIF): a downstream signalling protein of RLRs. 
 
MDA-5, melanoma differentiation-associated gene-5: 
a member of RLR group of cytoplasmic PRRs. 
MDA-5 detects dsRNA derived from viruses. 
 
mRNA, messenger RNA: 
carries coding information derived from DNA (or from negative sense 
ssRNAs of viruses) for synthesis of proteins. 
 
MyD88, Myeloid differentiation primary response gene 88: 
an adapter signaling protein for all Toll-like receptors (TLRs), except for TLR3. 
 
MS, mass spectrometry:  
an analytical technique that measures mass-to-charge ratio of charged 







an enzyme found on the surface of influenza virus particles, and 
essential for virus propagation. 
 
NADPH-oxidase, nicotinamide adenine dinucleotide phosphate-oxidase: 
a membrane-bound enzyme complex which generates superoxide. Superoxides 
may spontaneously form hydrogen peroxides, i.e., reactive oxygen species (ROS). 
 
NF-κB, nuclear factor kB: 
transcription factor needed for expression of many inflammation-associated genes. 
 
NLR, nucleotide-binding oligomerization domain (NOD)-like receptor: 
a large group of proteins that function as cytoplasmic PRRs. 
 
NLRP3, NOD-like receptor protein-3: 
an important member of NLR group of cytoplasmic PPRs. 
 
PAMP, pathogen associated molecular pattern: 
invariant structural motifs common to pathogens but not to mammalian cells. 
 
PKR, dsRNA-activated protein kinase: 
detects foreign cytoplasmic dsRNA in cells. 
 
Poly(I:C), polyinosinic-polycytidylic acid: 
a synthetic mimetic of dsRNA. 
 
RNA, ribonucleic acid: 
A chain of nucleotide units, comprising of a nitrogenous base (generally adenine, 
cytosine, guanine, or uracil), a ribose sugar, and a phosphate, covalently joined to each 
other by ester bonds. Different types of RNAs are required for synthesis of proteins. 
 
RNAseL, ribonuclease-L: 
2'-5'OAS and 2'-5'-oligoadenylate-dependent ribonuclease, 
a component of IFN-regulated system which mediates the antiviral and 
antiproliferative roles of IFNs. 
 
RIG-I, retinoic acid-inducible gene-I: 
a member of RLRs of cytoplasmic PRRs. RIG-I detects cytoplasmic RNA 
mainly of viral origin. 
 
RLR, RIG-I-like receptor: 
a group of cytoplasmic PRRs (i.e., RIG-I, MDA-5, and LGP2) 






ROS, reactive oxygen species: 
chemically-reactive molecules containing oxygen. Oxygen ions and 
peroxides are produced in large amounts from different parts of cell 
during stress responses. 
 
SLE, systemic lupus erythematosus: 
severe systemic autoimmune disease affecting multiple parts of the body. 
 
STAT, signal transducer and activator of transcription: 
Family of transcription factors which are necessary for expression of IFNs. 
 
siRNA, small interfering RNA: 
effector molecules of RNA interference (RNAi), a post-transcriptional mechanism for 
inhibition of gene expression of specific genes. siRNA binds to complementary 
nucleotides found in mRNA molecules and interferes or blocks their translation. 
 
ss, single-stranded: 
RNA or DNA molecules that contain only one strand of nucleotides. 
 
TIR-domain, Toll/IL-1R-domain: 
A protein domain found in flora and fauna. 
In mammals, TIR-domains are found from e.g., TLRs and IL-1R. 
 
TLR, toll-like receptor: 
a membrane-bound PRR group mediating recognition of several types of PAMPs. 
 
TRADD, Tumor necrosis factor receptor type 1-associated via death domain: 
an adapter protein essential for RIG-I-mediated signalling and induction of apoptosis. 
 
TRAF3, tumor necrosis factor receptor-associated factor-3: 
an important signal transduction molecule for TLRs and RLRs. 
 
TRIF, TIR-domain-containing adapter-inducing IFN-β: 
a signalling adapter protein downstream from TLR3 and -4. 
 
TRIM25, tripartite motif protein-25: 
an E3 ubiquitine ligase which ubiquitinates RIG-I and enables 
RIG-I's downstream signalling. 
 
vRNP, viral ribonucleoprotein: 
a complex containing viral genomic RNA and associated nucleoproteins. 
 
VSV, vesicular stomatitis virus: 
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Review of the literature 
1. Innate immunity: the primary sensor of "self" and "non-self" 
Immunity is conceptually categorized into the innate and acquired immune systems. Innate 
immunity is the first line of defence against pathogenic insults found in all classes of plant 
and animal life (Nurnberger et al., 2004). It functions continuously, supervises the well-
being of organisms, and launches innate immune reactions within minutes to hours after 
the first pathogenic insult. 
Innate immunity consists of physical, chemical, humoral, and cellular defence 
mechanisms. The first physical obstacle that an invading microbe has to confront is often 
the intact epithelial cell lining which covers external surfaces and lines the internal 
cavities of vertebrates, such as respiratory, genital, and gastrointestinal tracts. In the lungs, 
an organ targeted by respiratory viruses, physiological and chemical protection is provided 
by cilia and the mucous lining: cilia move inhaled foreign particles trapped in the mucus 
present in the trachea toward the oral cavities to be swallowed and digested in the acidic 
pH of stomach. Furthermore, lung epithelial cells produce substances that aid in the 
protection of respiratory tract from inhaled microbes, like mucus, antimicrobial peptides, 
and surfactants (Sadler and Williams, 2008). In the blood, an important part of humoral 
innate immunity is formed by certain plasma proteins produced mainly by hepatocytes, 
such as complement proteins. They cooperate with cellular part of the innate immunity in 
the identification, destruction, and clearance of pathogens, as well as in the removal of 
infected and damaged cells at the site of infection and tissue damage (Medzhitov, 2007; 
Meri, 2003). 
While innate immunity operates immediately after first encounter with pathogens, 
long-term acquired immune responses, mediated by B- and T-lymphocytes in vertebrates, 
are effective only after several days. During these early days, innate immunity guides the 
development of proper type of acquired immune responses and provides an often life-long 
immunological memory. The immunological memory ensures that more efficient and 
faster acquired immune responses are evoked if the same pathogen is re-encountered in 
later life. Needless to say, defects in innate immunity often result in severe inflammatory 
conditions, autoinflammatory diseases, or high susceptibilities to pathogens, and at worst, 
the premature death of the infected individual (Castellino and Germain, 2006; Hoffman et 
al., 2001; Medzhitov, 2007; Picard et al., 2003). 
1.1. Cells of the innate immunity 
The most important part of the innate immunity is its cellular arm consisting of white 
blood cells i.e., leukocytes, mainly of myeloid origin. These include monocytes and 
monocyte-derived macrophages and dendritic cells (DCs); mast cells, and granulocytes, 
such as neutrophils, eosinophils, and basophils. In addition, cytolytic NKs and subset of 
γδT-cells of lymphoid origin can be functionally classified as part of the innate immunity 
(Medzhitov, 2007; Matzinger, 2002) (Figure 1). 
 
 
Figure 1 Cells of the immune System. Myeloid and B-cell progenitors develop in the bone 
marrow, whereas naïve T-cells differentiate mainly in the thymys. Monocytes 
represent 10% of leukocytes in human blood and serve as precursors for 
macrophages and DCs. A healthy human has approximately 450 monocytes/μl which 
represents a total of 2.25 billion monocytes in 5 litre of blood (Robbins and Swirski, 
2010). For simplicity, only some of the distinct monocyte-, macrophage-, DC-, and T-
cell types are depicted. 
The interaction of the humoral and cellular parts of the innate immunity with pathogens, 
pathogenic material, infected host cells, cell remnants, or other immunostimulatory 
molecules results in host cell activation. This includes e.g., 1) secretion of soluble 
mediators, such as chemokines, antiviral- and pro- inflammatory cytokines, and 
endogenous danger signalling molecules, called danger-associated molecular patterns 
(DAMPs); 2) increased expression of different kinds of receptors and costimulatory 
molecules; and 3) elevated phagocytic or cytotoxic activities of certain host cell 
populations. Activated resident cells attract circulating leukocytes to the site of infection 
or tissue injury for the elimination of the infectious agents and for the initiation of tissue 







Figure 2 Orchestration of cellular innate immune responses against viruses. Initial contact of 
PRRs with PAMPs and/or DAMPs trigger humoral and cellular part of immune 
responses resulting in programmed cell death, i.e., apoptosis, lysis, or recovery of the 
infected host cell. Nonpermissive cells do not support viral replication, thus they are 
not prone to infection. 
1.1.1 Professional phagocytes and antigen presenting cells (APCs) 
Monocytes, macrophages, DCs, and neutrophils are professional phagocytes (Savina and 
Amigorena, 2007). After recognition of pathogen, they phagocytose; i.e., engulf and 
enclose foreign material into phagosomes; and trigger oxidative burst i.e., the increased 
production of reactive oxygen species (ROS) to destroy the intruders. ROS can be either 
released into the local extracellular environment, or utilized intracellularly in phagosomes 
to break down the engulfed matter. A low pH and actions of lysosomal proteases are also 
important for phagocytic destruction inside phagosomes. The impressive phagocytic 
activity of macrophages can clear approximately 2x1011 erythrocytes each day. This 











Edwards, 2008)! Thus, in addition to host defence, phagocytes play an essentially part in 
the overall maintenance of homeostasis. 
The primary effector cells of the innate immunity, DCs, and macrophages, are also 
professional antigen presenting cells (APCs). In other words, they present antigens to T-
cells of the immune system in order to evoke acquired immunity. APCs establish proper 
T-cell responses during infection: they process and present antigens in complex with 
major histocompatibility complex (MHC) class I and II molecules to T-cells possessing 
cognate receptors specific for the antigen-MHC complex on the APC (Iwasaki and 
Medzhitov, 2010; Le Bon et al., 2003; Sporri and Reis e Sousa, 2005). This is in contrast 
to the majority of cells in the body that present virus infection-associated peptides in MHC 
class I molecules to CD8+T-cells only after they have been infected themselves. However, 
uninfected APCs may capture antigens through phagocytosis and present these exogenous 
peptides to effector T-cells. Therefore, APCs' function is essential for the host defence 
also against viruses that do not infect APCs. The presentation of viral antigens, especially 
by DCs, involves maturation of naїve CD8+T-cells into cytotoxic CD8+T-cells and the 
differentiation of naїve CD4+T-cells to helper T-(Th)-cells of which there are various 
kinds (e.g., Th1, Th2, Th17). These DC-T-cell-interactions in conjunction with cytokines, 
are key for full effector activities of T-cells, since other APCs trigger mainly previously 
activated effector T-cells of acquired immunity (Castellino and Germain, 2006; Rock and 
Shen, 2005). If DCs present "self-antigens", the result is normally self-tolerance, for 
example through deletion of autoreactive T-cells. Thus, in addition to the fact that 
functions of APCs are highly important for proper development of T-cell responses 
against infectious agents, they also prevent the development of autoimmune reactions 
against self-derived material, as well as maintain tolerance to harmless environmental 
stimuli and commensal micro-organisms (Flint et al., 2004h). 
1.2. Activation of innate immunity by pathogenic microbes: pathogen 
associated molecular patterns (PAMPs) 
PAMPs are conserved and invariant structural components or metabolic products of 
pathogenic protozoa, fungi, bacteria, and viruses that are not commonly expressed or 
found in the animal kingdom (Janeway, 1989; Medzhitov, 2007). Since PAMPs are 
essential for microbes, they are not prone to structural modifications, and conversely, are 
competently distinguished as "non-self" and danger. PAMPs are proteins, 
oligosaccharides, lipids, and nucleic acids in varying compositions. A classical PAMP is 
lipopolysaccharide (LPS), a component of outer membrane of gram-negative bacteria. It is 
composed of several oligosaccharides and a lipid molecule, designated lipid A, which is 






1.2.1. Viral PAMPs 
Viruses are obligatory parasites that cannot produce infectious progeny virus particles, i.e., 
virions, independently of their host. In fact, the whole virion is created of components 
derived from metabolic processes of the host cell, and thus it poses a major challenge to 
the immune system. As a consequence, protein, lipid, or carbohydrate modifications 
restricted only to viruses are in scarce or do not exist. Instead, part of the innate immunity 
has specialized to detect viral nucleic acids, which are thought to serve as the primary 
PAMPs of viruses at present. Indeed, in order to replicate and produce de novo virion 
components, viruses must first undress their virion-coding sequences, deoxyribonucleic 
acids (DNA) and/or ribonucleic acids (RNAs), from their viral capsids and present them to 
the host's transcriptional and protein synthetic machineries (The general protein synthesis 
scheme is presented in figure 3). Furthermore, viral nucleic acids, especially if present in 
the cytoplasm, are a relatively early sign of active viral replication in a cell, and this is one 
further reason why viruses are primarily recognized by virtue of their nucleic acids. 
The immunostimulatory nature of viral nucleic acids is due to their divergent structure, 
unusual location, or abundance in the host cell. In terms of viral and bacterial DNA, they 
contain often unmethylated cytidine-guanoside-rich, so called CpG, motifs that are rarely 
present in mammalian DNA (Hemmi et al., 2000; Krug et al., 2004). Moreover, the 
nucleic acid products polymerized by viral polymerases do not necessarily resemble those 
polymerized by the host polymerases. In additon, eukaryotic host DNA is highly coiled 
and tightly packed into chromosomes and is only occasionally located in the cytoplasm: it 
is normally sequestered in nuclei and mitochondria (except during the prometaphase stage 
of cell division when the nuclear membranes disappear and chromosomes are released into 
the cytoplasm). Furthermore, if endogenous DNA is found in the extracellular space, 
cytoplasm, or endolysosomal compartment, then the host's nucleases can degrade these 
unwanted self-nucleic acids which means that the host is mainly devoid of free intra- and 
extracellular DNA (Vilaysane and Muruve, 2009). This is in clear contrast to the situation 
with certain DNA-containing pathogens which replicate in the cytoplasm e.g., to Listeria 
monocytegenes- and vaccinia virus-infections, in which foreign DNA molecules enter the 
cytoplasm, and this facilitates distinction between DNA of "self" and "non-self" 
(Rathinam et al., 2010). 
Recognition of viral RNA seems to be more complex than that of microbial DNA: 
vertebrate cells contain many different species of RNA molecules, such as messenger 
RNA (mRNA), transfer RNA (tRNA), small nuclear RNAs (snRNAs), ribosomal RNAs 
(rRNAs), and several regulatory RNAs, such as microRNAs (miRNAs) and Piwi-
interacting RNAs (piRNAs) (Brosnan and Voinnet, 2009). In addition to specialized 
functions, these RNAs have unique structures since both their bases and sugars can be 
modified in numerous ways as they mature. Processes that affect the molecular make-up 
of RNAs include splicing (for certain mRNAs and tRNAs), capping (a special 5'-end 
methylguanosine structure, 5'-cap, in mRNAs and snRNAs), polyadenylation (3'-polyA-
tail in mRNAs), phosphorylation (5'-monophosphate in tRNAs and rRNAs), and editing 
with unusual bases, such as pseudouridine (all RNAs except mRNAs) (Perry, 1981; 






not confined to the nuclei or mitochondria, but shuttle between different cellular 
compartments like nuclei, endoplasmic reticulum (ER), and cytoplasm. Nonetheless, the 
innate immune system is able to discriminate between "self-" and "non-self-RNAs". 
Several important molecular features of viral RNA are not commonly found in 
eukaryotic RNAs e.g., 1) three phosphates in the 5'-end of RNA molecules (abbreviated as 
5'-ppp) (albeit the abundantly expressed polymerase III transcript of the host, namely 7SL 
RNA, also contains 5'-ppp (Zieve et al., 1977)); 2) covalently linked proteins at the end of 
RNA molecules, such as the V-proteins of paramyxoviruses; 3) lack of 2'-Ο-methylation 
in 5'-ends of viral RNAs; 4) nucleoside modifications, such as N6-methyladenosine; and 
in some cases, 5) extensive secondary structures (e.g., polioviruses) (Andrejeva et al., 
2004; Flint et al., 2004a; Hornung et al., 2006; Karikó et al., 2005; Pichlmair et al., 2006; 
Weber et al., 2006; Zust et al., 2011). The localized increase in the amount of RNAs 
produced during viral infection is also critical for lowering the threshold for activation of 
innate immunity (Lecture of Taniguchi T. in the 4th International HMGB1 Symposium 
2010 in Helsinki, June 20-23). 
However, although the immunostimulatory activity of RNA was recognized already in 
the 1960's (Field et al., 1967a; Field et al., 1967b; Tytell et al., 1967), it was only recently 
that the mechanism for its detection and subsequent immunoactivation was identified 
(Alexopoulou et al., 2001; Andrejeva et al., 2004; Yoneyama et al., 2004) (see 1.4.). 
1.2.1.1. Double-stranded RNA (dsRNA) 
Double-stranded RNAs play crucial roles in cells. They are structures found from key 
metabolic and catalytic RNAs of protein synthesis pathways (e.g., different tRNA and 
ribozymes, respectively). In addition, dsRNAs function in the regulation of gene 
expression (e.g., splicing and in translational repression and gene silencing). For viruses, 
dsRNAs are also essential: they are obligatory replication intermediates for many RNA-
viruses and have to be exponentially produced for productive infection. Furthermore, 
replication of several different DNA viruses produces dsRNAs as a result of converging 
bidirectional transcription. Moreover, parts of the synthesized ssRNAs can unintentionally 
anneal and form dsRNA motifs (Jacobs and Langland, 1996; Kumar and Carmichael, 
1998). The amount of dsRNAs produced during an infection cycle depend on the virus 
strain (Marcus and Sekellick, 1977; Pichlmair et al., 2006; Weber et al., 2006). The 
classification of viruses and more information about production of viral dsRNAs and 
mRNAs during virus replication is presented in figure. 4. 
 
 
Figure 3 General flow of events from genes to proteins. 1) DNA is duplicated for the daughter 
cells in synthesis-phase of cell division. 2) During interphase, cell growth requires 
unwinding of dsDNA into its ss-form so that transcription factors can gain access to 
the specific gene, and de novo protein synthesis from the subsequently formed mRNA 
may begin. Messenger RNA is transcripted in the nucleus, 3) transported to the 
cytoplasm where ribosomes translate it into protein. Splicing and miRNA-mediated 
gene silencing in the nucleus and cytoplasm, respectively, are post-transcriptional 
mechanisms that affect quality and stability of mRNAs, respectively. 
 
 
Figure 4 The Baltimore classification of viruses and production of dsRNAs and mRNAs 
during viral replication. Viruses are classified according to the nature (ss- or ds-
DNA/RNA) and polarity (+/-/±) of their genome. All viruses must produce mRNAs 
(+sense RNAs) and exponentially multiply their genetic code in order to synthesize 
viral proteins and attain productive infection. The dsRNAs are obligatory replication 
intermediates for most types of viruses. Double-stranded DNA-viruses produce 
dsRNAs by convergent transcription whereas dsRNA viruses copy both of their RNA 
strands through dsRNAs intermediates. The genome of positive sense (+) ssRNA 
viruses are directly used as mRNA, but exponential replication occurs via dsRNAs. 
The genomes of negative sense (-) ssRNA viruses are in a complementary orientation 
to that of mRNA, and for that reason, their replication also generates dsRNA. 
Moreover, parts of the ssRNA genomes can anneal and form dsRNA motifs. The 
viruses used in this study are shown in parenthesis next to the virus family in which 











1.3. Activation of innate immunity by endogenous host molecules: 
danger associated molecular patterns (DAMPs) 
Productive virus infection often significantly alters cellular metabolism and cause tissue 
damage e.g., via cell lysis and cell death. Stressed cells produce, modify, and release 
endogenous molecules which are recognized as danger signals that activate host immune 
responses and induce inflammation (Shi et al., 2003). These kinds of molecules are called 
DAMPs. As with PAMPs, DAMPs are antigenic because of their deviant structure, 
location and/or abundance. According to the danger hypothesis proposed by Polly 
Matzinger in 1994, the immune system is more concerned with danger and damage than 
with foreignness, and therefore it is also activated by danger signals of endogenous origin 
(Matzinger, 1994; Matzinger, 2002). This concept reconciled the paradox of immune 
activation during infection and sterile injury. Thus, innate immune responses can be 
initiated not only by recognizing PAMPs but also by detecting DAMPs. Indeed, infected 
cells can stimulate NK cells or the complement system with subsequent antiviral innate 
immune responses without directly interacting with viral PAMPs. Furthermore, the 
complement- and NK-cell-mediated lysis of infected cells and the subsequent spillage of 
cell contents into cell surroundings produce more DAMPs, further amplifying the immune 
responses. However in general, it is thought that both PAMPs and DAMPs are required 
for mounting effective innate immune responses. 
One of the best defined DAMPs are monosodium urate crystals. They are 
spontaneously formed from urid acid, a product of purine catabolism, which is abundantly 
released from cells at sites of tissue injury. Monosodium urate crystals accumulates in 
excess in joints during pathogenesis of gout (Martinon et al., 2006; Shi et al., 2003). At 
present, virus-infection-associated DAMPs are poorly characterized. 
1.4. Pattern recognition receptors (PRRs) 
Unlike the acquired immunity, which is based on somatic gene arrangements and somatic 
hypermutations of antigen receptors that generates a diverse set of receptor specificities 
for detecting immunostimulatory molecules, the innate immunity rely only on a small 
number of germ-line encoded receptors, called pattern recognition receptors (PRRs) 
(Janeway, 1989; Medzhitov, 2007). PRRs can be secreted, membrane-bound, or 
cytoplasmic. They are expressed in especially high numbers on monocytes, macrophages, 
and DCs, and they coordinate innate immune reactions. Binding of PAMPs to structural 
motives of signalling-adapted PRRs activate intracellular signalling cascades that lead to 
changes in gene expression and metabolism of the cell. This prompts the host to mount the 
appropriate defence against the pathogen. 
The most extensively studied signalling-capable PRRs are membrane-bound Toll-like 
receptors (TLRs) and C-type lectin receptors (CLRs), and cytoplasmic retinoic acid 
inducible gene-I (RIG)-like receptors (RLRs) and nucleotide oligomerization domain 
(NOD)-like receptors (NLRs) (Creagh and O'Neill, 2006; Geijtenbeek and Gringhuis, 
2009). Recently, a new cytoplasmic PRR group involved in recognition of foreign 
cytoplasmic DNA was proposed to be included among the above four and was named 
absent in melanoma (AIM) -like receptors (ALRs) (Unterholzner et al., 2010). In addition 
to these, there exist numerous scavenger receptors which act as PRRs. They primarily 
assist in phagocytosis of PAMPs or costimulation of TLRs, such as dsRNA-binding 
protein SR-A (Scavenger receptor class-A) and CD36, respectively (Areschoug and 
Gordon, 2009). Importantly, the simultaneous activation of different PRR class members 
is often necessary for the initiation of effective innate immune responses. 
 
Figure 5 Important pattern recognition receptors during virus infection. Upon recognition of 
PAMPs and/or DAMPs, membrane-bound TLRs, and cytoplasmic RLRs and NLRs 
trigger signaling cascades that culminate in the induction of innate immune 
responses. TLR8 and the inflammasome component called cardinal are expressed 
only in humans. 
1.4.1. Toll-like receptors (TLRs) 
A fruit fly, Drospohila melanogaster, paved the way for the initial identification of 
receptors that elicit immune responses (Lemaitre, 2004; Valanne et al., 2011). In 1996, 
Drosophila carrying mutations in a receptor called 'Toll', were found to be highly 
susceptible to fungal infections (Lemaitre et al., 1996). Furthermore, the intracellular 
domain of Drosophila 'Toll' had structural similarities and functional parallels in the 
activation of immune responses with the mammalian type I interleukin (IL)-1 receptor (IL-
1R). For these reasons, this protein domain, having essential roles in immune signalling, 
was named the Toll/IL-1R (TIR)-domain (Gay and Keith, 1991; Lemaitre, 2004). 











repetitive leucine rich repeats (LRRs), a feature they share with several PRRs from 
animals to plant species, and thus, these have been suggested to be important for 
recognition of pathogens (Creagh and O'Neill, 2006; Medzhitov et al., 1997; Nurnberger 
et al., 2004). 
The first human 'Toll' was characterized one year later in 1997 (Medzhitov et al., 
1997), and soon nine other 'Tolls', named as Toll-like receptors (TLRs), had been 
identified in humans (Chaudhary et al., 1998; Chuang and Ulevitch, 2001; Chuang and 
Ulevitch, 2000; Du et al., 2000; Heil et al., 2004; Hemmi et al., 2000; Rock et al., 1998; 
Takeuchi et al., 1999). Importantly, it was found that mammalian TLRs and Drosophila 
'Toll' signalled through conserved signalling cascade culminating in the expression of 
inflammatory genes and antimicrobial peptides (the NF-κB-pathway; see 2.2.3.1 and Fig. 
8). This suggested that the pathway operated in organisms from insects to humans in 
immune signalling (Lemaitre et al., 1996; Medzhitov et al., 1997; Rosetto et al., 1995). 
Indeed, a loss-of-function mutation in the mouse homologue of certain "human Toll" gene, 
namely tlr4, was found to result in an unresponsiveness to bacterial LPS (Poltorak et al., 
1998). This finding led also to characterization of the receptor involved in the recognition 
of this endotoxin of gram negative bacteria (namely, TLR4), which had puzzled 
researchers for a long time (Beutler and Rietschel, 2003). The knocking-out of other TLRs 
in mice revealed that TLRs serve as PRRs for the detection of a diverse variety of PAMPs. 
Membrane-bound TLRs survey in different sites of cell and recognize a vast number of 
microbial components via their LRR-protein domains that point toward the extracellular 
milieu of plasma membrane or to the topologically equivalent lumen of membrane-
enclosed intracellular compartment, such as the lumen of endolysosomes (Kawai and 
Akira, 2010) (See Fig. 5). Recognition of PAMPs by TLRs results in immune signalling 
via receptor homo- or heterodimerization. In addition in some cases, the activation of 
accessory cell surface- or soluble proteins is required. For example, heterodimerization of 
TLR2 with TLR1 and TLR6 potentiate the recognition and discrimination between tri- and 
diacetylated lipopeptides, respectively, of gram-negative and -positive bacteria, protozoa, 
mycobacteria, yeast, mycoplasma, and certain viruses (like herpes simplex virus and 
vaccinia virus (Barbalat et al., 2009; Farhat et al., 2008; Kurt-Jones et al., 2004), whereas 
binding of TLR2 to cell surface receptors, such as CD36 and Dectin-1, further extends its 
ligand range to different PAMPs (Goodridge and Underhill, 2008; Hoebe et al., 2005). 
TLR4, in turn, uses accessory proteins, such as LPS-binding protein (LBP), and LRR-
containing MD2 and CD14, for efficient responsiveness to LPS (Shimazu et al., 1999; 
Tobias et al., 1986; Wright et al., 1990). Importantly, TLR4 can recognize also structural 
features of some viruses like vesicular stomatitis virus (VSV) and DAMPs (Georgel et al., 
2007; Miller et al., 2005). At present, it is the only TLR reported to become activated by 
inorganic molecules, nickel cations, which are the causative factor in nickel allergy 







1.4.1.1. Nucleic acid-sensing TLRs in viral recognition 
TLR3, -7/8, and -9 are the most important TLRs for the detection of viruses: they are 
dedicated to recognizing nucleic acids (and their chemical mimetics) originating from the 
extracellular environment: dsRNAs (polyinosinic-polycytidylic acid (poly(I:C)), uridine- 
or uridine/guanosine-rich ssRNAs (imidazoquinone R848), and unmethylated CpG-
nucleotides of linear DNA strands (synthetic CpG-DNAs) (Alexopoulou et al., 2001; 
Diebold et al., 2004; Heil et al., 2004; Hemmi et al., 2002; Hemmi et al., 2000; Lee et al., 
2003; Lund et al., 2003; Lund et al., 2004). With some exceptions, nucleic acid-sensing 
TLRs reside primarily in endolysosomal compartments (endosomes, lysosomes, and in 
endolysosomes) where phagocytosed and endocytosed material is gathered. In addition, 
viral components sequestered from cytoplasm to endolysosomes via a process called 
autophagy, may trigger endosomal TLRs (Orvedahl and Levine, 2008). Thus, positioning 
TLRs into endolysosomes is related to their function: nucleic acid-sensing TLRs sample 
material entering cells mainly from outside the cells. In addition that the acidic 
environment of endolysosomes releases nucleic acids from the interior of viral capsids, 
this site concentrates extracellular nucleic acids in order to achieve more efficient 
recognition of them by TLRs. The compartmentalization may also help in the 
determination of the source of nucleic acids (Barton et al., 2006; Nishiya et al., 2005; 
Johnsen et al., 2006): under normal conditions, several nucleases degrade nucleic acids in 
the extra- and intracellular spaces which means that endosomes are mainly devoid of 
endogenous RNA or DNA molecules, as described in 1.2.1 (Vilaysane and Muruve, 
2009). 
Interestingly, the altered gene number of nucleic acid-sensing TLRs may predispose to 
the development of autoimmune diseases, as suggested by studies conducted in murine 
models of systemic lupus erythematosus, implying that the functions of TLRs have to be 
tightly controlled in order to maintain immune homeostasis (Deane et al., 2007; 
Subramanian et al., 2006). 
1.4.2. Retinoic acid-inducible gene-I (RIG-I) -like receptors (RLRs) 
In most cell types, detection of cytoplasmic RNA molecules is carried out by DExD/H-
(Asp-Glu-X-His/Asp)-box RNA helicases called RLRs: RIG-I, melanoma differentiation-
associated gene 5 (MDA-5) and LGP2 (Laboratory of Genetics and Physiology 2) 
(Andrejeva et al., 2004; Kato et al., 2005; Yoneyama et al., 2005; Yoneyama et al., 2004). 
In general, DExD/H-box helicases have various functions in transcription, mRNA 
splicing, translation, ribosome biosynthesis, and RNA decay (Schwer, 2001). Initially, 
RIG-I, MDA-5, and LGP2 were independently cloned by separate groups, but it was not 
before functional screenings and assays made by Yoneyama et al., that these DExD/H-box 
RNA helicases were linked to antiviral defence and innate immunity (Yoneyama et al., 
2005; Yoneyama et al., 2004). 
RIG-I was cloned as all-trans retinoic acid-inducible gene in 1997 (Sun, 1997). 






helicase in a nematode (roundworm) (Tabara et al., 2002). This helicase was part of a 
RNA-induced silencing complex functioning in dsRNA-mediated post-transcriptional 
gene silencing. Soon, it was found that LPS and interferon (IFN)- upregulated RIG-I 
pointing to its involvement in inflammation and innate immunity (Imaizumi et al., 2002; 
Imaizumi et al., 2004). MDA-5, in turn, was characterized as a new caspase recruitment 
domain (CARD)-containing protein with pro-apoptotic functions (Kovacsovics et al., 
2002). The expression of MDA-5 was induced by IFNs and the helicase had dsRNA-
dependent ATPase activities and melanoma growth suppressive properties (Kang et al., 
2002). The gene encoding for LGP2 was found from the same gene locus which encoded 
important transcription factors, signal transducers and activators of transcription (STAT) -
3 and -5 (Stat3/Stat5), for proliferation and differentiation of mammary glands (Cui et al., 
2001). By the year 2005, all these DExD/H-box RNA helicases had been demonstrated to 
detect cytoplasmic dsRNA and share unique antiviral functions in innate immunity 
(Andrejeva et al., 2004; Yoneyama et al., 2005; Yoneyama et al., 2004). 
RIG-I and MDA-5 induce primarily antiviral cytokines, IFNs, in response to the 
presence of viral RNAs in cytoplasm. They are the actual effector molecules of RLRs 
because LGP2 lacks two N-terminal CARDs necessary for downstream signalling. 
Instead, LGP2 presumably modulates the functions of RIG-I and MDA-5 (Murali et al., 
2008; Rothenfusser et al., 2005; Satoh et al., 2010; Venkataraman et al., 2007; Yoneyama 
et al., 2005). Furthermore, the fully efficient IFN response to various RIG-I dependent 
viruses requires LGP2, with the notable exception of influenza A virus and an artificial 
mimetic of viral cytoplasmic dsRNA, poly(I:C) (Satoh et al., 2010). RIG-I and MDA-5 
interact with a shared signalling molecule found mainly at the mitochondrial membrane 
via homotypic CARD-CARD-interactions. Four distinct research groups independently 
and simultaneously characterized and named this signalling partner as mitochondrial 
antiviral signalling protein (MAVS), CARD adapter-inducing IFN- (Cardif), virus-
induced signalling adapter (VISA), and IFN- promoter stimulator-1 (IPS-1) (Loo et al., 
2006; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005). (Here, the name MAVS is 
utilized). Although, the original reports indicated that RIG-I and MDA-5 have structural 
similarities and respond equally well to viral dsRNA (Yoneyama et al., 2005; Yoneyama 
et al., 2004), later knock-out studies in mice revealed differences in their specificities 
against different viruses (Kato et al., 2006; Loo et al., 2008). Thus, RIG-I and MDA-5 are 
not completely functionally equivalent. 
1.4.2.1 RNA recognition of RIG-I and MDA-5 
RIG-I has the ability to detect several negative-strand ssRNA viruses, such as influenza A 
virus, VSV, and Sendai virus; and positive-strand ssRNA viruses like Japanese 
encephalitis virus. Subsequently, RIG-I triggers IFN-signalling (Kato et al., 2006). 
Remarkably, even less than 20 molecules of viral RNA can be sensed by RIG-I (Zeng et 
al., 2010). RIG-I detects primarily RNAs carrying 5'-ppp (Hornung et al., 2006; Pichlmair 
et al., 2006). This structure is absent in host RNAs (except the 7SL RNA, depicted earlier) 






otherwise modified in the nucleus (e.g., 5'-ppp is removed from mRNAs, rRNAs, and 
tRNAs or the last base in RNA containing the free 5'-ppp is modified) (Perry, 1981). In 
contrast, several viral polymerases and T7-bacteriophage, also used for in vitro 
transcription in molecular biology, can polymerize 5'-ppp. Interestingly however, 5'-ppps 
are not solely sufficient to activate the antiviral actions of RIG-I: chemically synthetized 
5-ppp ssRNAs do not activate RIG-I, suggesting that the enzymatic synthesis of RNAs 
produces also some dsRNA by-products or structures that are required for activation of 
RIG-I (Schlee et al., 2009; Schmidt et al., 2009). Indeed, chemically synthesized dsRNA 
with or without 5'-ppp or 5'-monophosphate, and short siRNAs lacking two nucleotide 3'-
overhangs engage RIG-I (Kato et al., 2008; Lu et al., 2010; Marques et al., 2006; Takahasi 
et al., 2008). Thus, full responsiveness of RIG-I towards the viral RNAs seems to depend 
on 5'-ppp in conjunction with short blunt-end dsRNA regions (Lu et al., 2010; Pichlmair et 
al., 2006). Recently Rehwinkel et al., demonstrated that the natural agonist of RIG-I was 
RNAs containing short blunt-end, short dsRNA, and at least one 5'-ppp (Rehwinkel et al., 
2010). These kinds of partially complementary panhandle regions at the 5'- and 3'-ends of 
RNAs are found in the genomes of negative sense ssRNA viruses, like influenza A virus 
(Hsu et al., 1987). 
Interestingly, RIG-I is also capable of recognizing indirectly RNA virus infections by 
detecting short cleavage products of endogenous ssRNAs made by host ribonuclease-L 
(RNaseL) (Malathi et al., 2007) (See 1.5.2.). Moreover, RIG-I is unexpectedly involved in 
the cellular DNA-sensing machinery, which is poorly characterized at present: RIG-I is 
engaged when host polymerase III detects cytoplasmic adenosine and thymidine-rich 
DNAs and uses them as a template to synthesize dsRNA molecules with 5'-ppp (Ablasser 
et al., 2009a). This kind of RNA recognition appears to be relevant for the detection of 
small non-protein coding DNA molecules of a DNA-virus Epstein-Barr virus (termed as 
EBER1 and -2 RNA), as well as for the recognition of other DNA-viruses, such as 
adenovirus and herpes simplex virus (Ablasser et al., 2009a; Chiu et al., 2009). 
 
MDA-5 is the primary sensor for coronaviruses, such as severe acute respiratory syndrome 
coronavirus and picornaviruses, like poliovirus and encephalomyocarditis virus (EMCV) 
(Gitlin et al., 2006; Kato et al., 2006; Zust et al., 2011). These viruses subvert RIG-I-
mediated recognition by having either covalently bound protein attached to their 5'-RNA-
end or by mimicking functions homologous to and associated with the formation of 5'-cap 
structure. However, even these measures are insufficient to evade recognition by MDA-5. 
Importantly, MDA-5 recognizes viral mRNAs that lack 2'-Ο-methylation in their 5'-end 
(Zust et al., 2011). In contrast to viral RNAs, this molecular structure is present in the 5'-
cap-elements of mammalian mRNAs. MDA-5 is also the primary sensor of viruses with 
long dsRNA stretches (over 1 kb in length) and of long cytoplasmic dsRNA polymers, like 
poly(I:C), which has been used for decades as an artificial mimic of viral infection (Kato 
et al., 2008). 
 
Importantly, RIG-I and MDA-5 may cooperate in the detection of viruses. For example, 
cytoplasmic poly(I:C) is length-dependently sensed also by RIG-I: while long (˜ 4000-






bp) engage RIG-I (Kato et al., 2008). The recognition of cytoplasmic poly(I:C) by RIG-I 
is due to activities of a dsRNA specific endonuclease, Dicer, which partially digests 
poly(I:C) and subsequently converts it into a substrate of RIG-I. This finding also suggests 
that long viral RNAs primarily detected by MDA-5 may also be sensed by RIG-I. In 
addition to RIG-I, RNAseL cleavage products also engage MDA-5 after duplex formation 
(Malathi et al., 2007). Furthermore, certain viruses contain RNA structures or sequences 
that activate both RIG-I and MDA-5 (Broquet et al., 2010). These kinds of viruses include 
segmented dsRNA virus reovirus and positive-strand RNA viruses like West Nile virus 
and dengue virus (Broquet et al., 2010; Fredericksen and Gale, 2006; Loo et al., 2008). 
Furthermore, RIG-I has crucial role in the initial detection of West Nile virus infection, 
whereas MDA-5 amplifies and maintains the response. Taken together, RLRs-mediated 
recognition and distinction of cytoplasmic RNAs between host and virus, and between 
different virus families, seem to be very complex, but very accurate processes. 
1.4.3. Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and 
inflammasomes 
NLRs are cytoplasmic receptors involved in the detection of PAMPs and DAMPs and 
their activities are often licensed by other NLRs within the family or by other PRRs 
(Davis et al., 2010; Martinon et al., 2009). At present, a total of 22 NLR proteins have 
been characterized in mammals and classified into four distinct groups based on their 
structure: 1) NODs; 2) NOD, LRR, and pyrin domain-containing proteins (NLRPs); 3) 
NLRC4 (NLR family, CARD domain containing-4), formerly known as IPAF and NAIPs 
(NLR family, apoptosis inhibitory protein); and 4) CIITA (Class II Transactivator). 
Interestingly, NLR orthologues are present in plant disease resistance genes, and these 
gene products are intended to sense activities or cellular processes that are commonly 
associated with microbial infections, rather than in the direct detection of PAMPs 
(Nurnberger et al., 2004). (This indirect recognition of pathogens is also found in 
Drosophila: proteases activated by the microbial insult cleave the cytokine Spätzle, which 
then binds to Drosophila Toll triggering the antimicrobial response (Lemaitre, 2004; 
Lemaitre et al., 1996).) The importance of NLRs in antiviral responses is underlined e.g., 
by the recent discovery of viral homologue of NLRP1, encoded by Kaposi's sarcoma-
associated herpesvirus, namely Orf63 (open reading frame 63) (Gregory et al., 2011). This 
viral protein can antagonize the functions of NLRP1. Furthermore, NLR proteins, such as 
NLRX1 (NLR family, X1) and NLRC5 (NLR family, CARD containing-5), may interact 
with RLRs and negatively regulate their functions (Moore et al., 2008; Cui et al., 2010). 
NLRs are expressed in autorepressed forms. After direct or indirect binding of their 
LRR-domains with ligands (with the exception of NLRP10 which lacks LRRs (Ting et al., 
2008)), LRRs oligomerisize in an ATP-dependent manner, and large multiprotein 
molecular platforms, approximately 700 kDa in mass are formed (Agostini et al., 2004; 
Martinon et al., 2002; Martinon et al., 2009). The name "inflammasome" is used to 
describe the protein complexes that confer precursor processing of IL-1-family of pro-






"inflammasome". Although various inflammasomes exist (e.g., NOD2/NLRP1-, 
IPAF/NLRC4-, RIG-I/ASC-, and AIM2-inflammasomes), they all comprise at least 
effector protein cysteine-dependent aspartate-directed protease (caspase)-1 and adapter 
protein apoptosis-associated speck-like protein containing CARD (ASC). In humans, the 
structure is also completed by another adapter molecule called cardinal (Agostini et al., 
2004). The importance of inflammasomes is related to the function of activated caspase-1. 
It processes precursors of IL-1 family of pro-inflammatory cytokines, namely pro-IL-1 
and pro-IL-18, into their biologically active forms that are then secreted (Cerretti et al., 
1992; Thornberry et al., 1992). The name for each inflammasome is given according to the 
"sensor"-molecule which likely recognizes PAMPs and/or DAMPs. In inflammasome 
research, attention has focused on NOD-like receptor protein-3 (NLRP3), formerly called 
NALP3, cryopyrin, or PYPAF1 (Ting et al., 2008). Its function is associated with the 
development of inflammation in many non-infectious and infectious diseases. 
1.4.3.1. NLRP3-inflammasome  
NLRP3 is predominantly expressed in immune and epithelial cells, and in bone degrading 
cells, osteoblasts, thus, in strategically important cell types for health and disease (Dowds 
et al., 2004; Feldmeyer et al., 2007; Guarda et al., 2011; Martinon et al., 2009; McCall et 
al., 2008; Watanabe et al., 2007). The functional importance of NLRP3 in innate 
immunity is emphasized in patients who carry a single point mutation in the NLRP3-
encoding gene, CIAS. These individuals suffer from rare hereditary autoinflammatory 
illnesses in which an array of tissues and organs (lungs, gastrointestinal tract, skin, and 
central nervous system) are affected due to the overactivation of NLRP3-inflammasome 
(Agostini et al., 2004; Hoffman et al., 2001; Manji et al., 2001; Martinon et al., 2009). 
Many potential PAMPs and DAMPs activate NLRP3 oligomerization. Whole 
pathogens which have been demonstrated to activate the NLRP3-inflammasome include 
Neisseria gonorrhoeae and Staphylococcus aureus (Duncan et al., 2009; Kankkunen et al., 
2009; Mariathasan et al., 2006). In addition, hyphaes i.e., the long and branching 
filamentous structures of Candida albicans; bacterial pore-forming toxins; and hemozoins 
i.e., crystallized waste products of heme formed by parasite Plasmodium falciparum, 
activate NLRP3 (Dostert et al., 2009; Joly et al., 2009; Mariathasan et al., 2006). 
Importantly, acute infection with RNA and DNA viruses, such as influenza A virus and 
Sendai Virus, as well as modified vaccinia virus Ankara, results in NLRP3-inflammasome 
activation (Allen et al., 2009; Delaloye et al., 2009; Ichinohe et al., 2009; Kanneganti et 
al., 2006; Thomas et al., 2009). The exogenous particulates or chemicals that trigger 
NLRP3-inflammasome indicate that the action of NLRP3 is important in the development 
of certain work-related diseases (silica, asbestos), contact hypersensivity reactions (certain 
skin irritants), actions of vaccines (vaccine adjuvant alum), and certain pharmaceuticals 
(e.g., antibiotics) (Allam et al., 2011; Cassel et al., 2008; Dostert et al., 2008; Eisenbarth et 
al., 2008; Hornung et al., 2008; Kool et al., 2008; Sharp et al., 2009; Watanabe et al., 
2007). Interestingly, also electromagnetic radiation e.g., ultraviolet B-light, activates 






2007). Furthermore, also the host-derived molecules, DAMPs, activate NLRP3. These 
include crystals of cholesterol and monosodium urate, aggregates of fibrilliar peptide 
amyloid-, and oligomers of islet amyloid polypeptide (Duewell et al., 2010; Halle et al., 
2008; Martinon et al., 2006; Masters et al., 2010). These molecules have been linked with 
the development of atherosclerosis and arthritis, gout, Alzheimer's disease, and type II 
diabetes, in this same order. The vast structural divergence of these NLRP3 activating 
PAMPs and DAMPs and their close association to cellular stress responses suggest that 
they induce the common changes required for NLRP3-inflammasome assembly and 
subsequent caspase-1 activation. The molecular mechanisms that orchestrate 
inflammasome activation during virus infections are poorly understood. 
1.4.3.2. Inflammasomes in virus recognition  
Currently, at least three distinct inflammasomes have been characterized to function in 
antiviral defence: AIM2-, NLRP3-, and RIG-I/ASC-inflammasomes (Poeck et al., 2009; 
Rajan et al., 2011). In addition, there is preliminary evidence for existence of MDA-
5/ASC-inflammasome, but this awaits further elucidation (Poeck et al., 2009; Rajan et al., 
2011). DNA-viruses, such as vaccinia virus and mouse cytomegalovirus are detected by 
the AIM2-inflammasome (Burckstummer et al., 2009; Fernandes-Alnemri et al., 2009; 
Hornung et al., 2009; Rathinam et al., 2010), whereas the recognition of RNA viruses 
seems to be more complex. For example, the pro-inflammatory cytokine response against 
EMCV, has been reported to be MDA-5 and NLRP3-dependent or governed by NLRP3 
alone (Poeck et al., 2009; Rajan et al., 2011). Similarly, VSV has been shown to activate 
either RIG-I/ASC- or NLRP3-inflammasome (Poeck et al., 2009; Rajan et al., 2011). The 
reasons for discrepant results are unclear at present. Furthermore, in regards of influenza 
A virus infection, the host response to the virus is NLRP3-independent during first week 
post-infection, while in later stages it is NLRP3-dependent (Allen et al., 2009; Ichinohe et 
al., 2009; Thomas et al., 2009). At the moment, the requirement of RIG-I for 
inflammasome activation during these phases is not known. Moreover, also cytoplasmic 
poly(I:C)-induced inflammasome activation has been reported to be NLRP3-dependent 
with or without concomitant requirement of MDA-5 (Poeck et al., 2009; Rajan et al., 
2010). Collectively, these results highlight the variabililty in the requirement of 
cytoplasmic PRRs to activate caspase-1 and to elicit inflammation in response to RNA-
viruses. Furthermore, they point to the existence of multiple pathways of activating 
inflammasomes, partly depending on the virus family and the genus. It is not known, why 
different inflammasome structures are utilized to elicit pro-inflammatory responses against 
distinct virus families and within a virus family. Presumably, they serve to safeguard 







1.5. Other dsRNA-activated effector proteins of the innate immunity 
In addition to nucleic acid-sensing TLRs and cytoplasmic PRRs recognizing RNAs, also 
other effector molecules detect viral RNAs. However, their expression levels are low in 
uninfected cells, and need to be boosted before their full effectiveness can be attained. The 
initial recognition of viral RNA results in type I IFNs production by RLRs in most cell 
types and by TLR7/8 (but not via TLR3) in plasmacytoid DCs (pDCs) (Diebold et al., 
2004; Kato et al., 2005; Kato et al., 2006; Lund et al., 2004). Type I IFNs trigger 
expression of hundreds of IFN-inducible genes which constitute an important antiviral part 
of innate immunity. Three of these IFN-inducible antiviral effectors have been extensively 
studied. 
1.5.1. Double-stranded RNA-activated Protein kinase (PKR) 
PKR was one of the first antiviral dsRNA-binding proteins characterized (Kerr et al., 
1977). It is activated by most viruses, and consequently, viruses counteract its antiviral 
actions through a variety of mechanisms (Langland et al., 2006). The importance of PKR 
during viral infections is vital since PKR phosphorylates and subsequently inactivates 
elF2, an initiator of translation (Meurs et al., 1992). Thus, activity of PKR suppresses the 
translation not only of viral, but also of host mRNAs. If translational block continues for a 
long time, the infected cell will ultimately die, but in so doing, it will slow down the 
spread of viral infection, and the organism itself may be spared. Phosphorylation of elF2 
triggers also autophagy, one form of cellular intrinsic defence mechanism in which 
constituents of cytoplasm and mal-functioning components and organelles are digested by 
lysosomal enzymes in autophagolysosomes. Subsequently, the resulting building blocks 
are recycled in anabolic reactions within the cell (Talloczy et al., 2002). Programmed cell 
death can also be considered as another form of the cell's intrinsic defence mechanisms, 
and it is also partly mediated by PKR (Balachandran et al., 1998). 
1.5.2. 2'-5'-oligoadenylate synthetase (2'-5'OAS) and ribonuclease-L (RNAseL) 
system 
Activation of 2'-5'OAS by dsRNA results in conversion of ATP to free phosphate 
molecules and formation of 2'-5'-linked oligoadenylates of various lengths (Hartmann et 
al., 2003). These trigger activity in the RNA-degrading enzyme RNaseL. Cytoplasmic 
RNaseL catalyses degradation of self- and non-self ssRNAs resulting in a halt of protein 
synthesis and engagement of RIG-I and MDA-5 by the 3'-phosphorylated RNA 
degradation products (Malathi et al., 2007). Not only does the RNaseL system amplify the 
activation of RLR pathway, but RNAseL has also been implicated in the induction of 






1.5.3. Mx protein A (MxA) 
In contrast to PKR, 2'-5'OAS, and RNAseL that function broadly against several viruses, 
small IFN-inducible GTPases, MxA and MxB proteins in humans, defend against 
negative-strand RNA viruses like influenza A virus and VSV (Pavlovic et al., 1990). 
Human MxA interacts with proteins of influenza A virus in the nucleus where MxA 
inhibits the early transcription of the viral genome (Turan et al., 2004). 
2. Innate immune responses against viruses 
Innate immune responses against viruses are initiated when virus attaches to the surface of 
a permissive cell and invades the cell. If the viral infection outpaces the cell's intrinsic 
innate defences, more global host responses will be experienced. Often inflammation 
appears when infected cells die or lyse, and innate and acquired immune responses 
develop. If the infection is spread from the initial inoculation site, second and third rounds 
of replication may occur in other parts of the body. If the infection is cleared, the host will 
return to its normal, pre-infection state (Fig. 2). However, dramatic differences exist in 
patterns of infection, ranging from acute to lifelong persistent infections. The extent of 
activation of innate and acquired immune responses determines the host's immunity to 
subsequent infections by the same virus. The most important innate immune responses of 
cells against viruses include antiviral and pro-inflammatory cytokine responses, and 
apoptosis of the virus-infected cell. Only the acute phase of infection will be considered 
here. 
2.1. Antiviral cytokine response: Interferons (IFNs) 
Mammals, birds, reptiles, and fish synthesize IFNs, which have high antiviral, anti-
proliferative, and immunomodulatory properties. IFNs were discovered first by Isaacs and 
Lindenmann in 1957, who observed that chicken cells exposed to influenza A virus 
contained a substance that "interfered" with infection of other chicken cells by a live 
influenza A virus, hence the name "interferon" (Isaacs and Lindenmann, 1957). 
Nowadays, more than 20 IFN genes are known, and they are classified into three groups. 
In humans, type I IFNs (often abbreviated as IFN-/) contain multiple IFN- genes (at 
least 13) and single copies of IFN-, IFN-ω, -κ, and -ε genes (Génin et al., 2009). Type II 
IFNs comprises solely of IFN-. It is secreted by activated cells of the innate and acquired 
immunity: NK cells and T-cells, respectively (Renauld, 2003). In animal models of virus 
infection, the outcome of viral pathogenicity can be more severe upon disruption of IFN-
/ response than when IFN- signalling is abrogated (Muller et al., 1994), implying that 
type I IFNs play the major role in defence against viruses, as well as against some other 
microbes (Freudenberg et al., 2002). The Type III IFNs represent for IL-28A (or IFN-λ2), 
IL-28B (or IFN-λ3), and IL-29 (or IFN-λ1) (Kotenko et al., 2003). These antiviral 
cytokines have same biological effects than type I IFNs since, apart from their receptors 
(IFNAR1 and -2, and IL-28R and IL-10R, respectively), they share the same signal 
transduction pathways (i.e., IFN-stimulated gene factor-3 (ISGF3); see 2.1.2.) (Hengel et 
al., 2005; Renauld, 2003; Sheppard et al., 2003). 
2.1.1. Systemic and context-specific effects of IFN-/ 
Plasmacytoid DCs account for only 0.5% of peripheral blood mononuclear cells in 
humans, but they are still the principal cell type responsible for producing systemic 
concentrations of IFN-/ (Colonna et al., 2004; Kumagai et al., 2007; Siegal et al., 
1999). In contrast, the RLR pathway, predominating in all other cells types, contributes to 
local IFN-/ production (Kato et al., 2005; Kato et al., 2006). Indeed in mice, the 
primary IFN--producing cell type in response to pulmonary RNA viruses is the alveolar 
macrophage (Kumagai et al., 2007). The importance of type I IFNs is highlighted by the 
fact that almost all nucleated cells produce these agents and also are able to respond to 
them. 
 
Figure 6 Immunomodulating effects of IFN-α/β. In order to restrict microbial infection, both 
non-immune cells (such as resident cells at the site of infection) and cells of the 
innate- and acquired immunity respond by versatile manner to IFNs. Adapted from 
Solis et al., (2006). 
The systemic IFNs have context- and cell-specific effects. Cells that encounter type I IFNs 
without any other cues of the infection induce the expression of more than 300 IFN-
inducible genes which are involved in the detection and elimination of incoming microbes 
(de Veer et al., 2001). However, when the IFN-signalling is associated with other signs of 
infection, cells may also become sensitive to apoptotic signals (Tanaka et al., 1998; Kaiser 
et al., 2004). IFNs induce macrophages and DCs to express surface receptors for 
costimulation and antigen-presentation, such as CD80/86 and MHCI/II, respectively (Luft 
et al., 1998). Noticeably, IFN-/ permit DCs to present antigens directly without the help 











cytotoxic- CD8+T-cells; enhance the cytolytic activity of NK cells; and directly improve 
clonal expansion of CD4+T-cells (Havenar-Daughton et al., 2006; Kolumam et al., 2005; 
Le Bon et al., 2003; Nguyen et al., 2002). Furthermore, IFN-/ and DCs enable B cells 
to undergo antibody isotype switching and differentiation into antibody-producing plasma 
cells (Le Bon et al., 2001). In summary, IFNs-/ represent a crucial link between 
myeloid and lymphocytic cell populations, as well as between innate and acquired 
immune reactions (Fig. 6). The ultimate goal of secreted IFNs' is to achieve the 
elimination of infected cells. 
2.1.2. Induction of IFN-/: two phases 
The primary antiviral IFN response is initiated by the activation of certain TLRs and 
RLRs resulting in the expression of IFN-/. This early antiviral response is relatively 
weak, and is followed by a more potent, secondary phase of IFN induction in a positive 
feedback manner. The secondary IFN-response begins when the de novo synthetized IFN-
α/β bind to their cognate receptors via auto- or paracrine manner resulting in transcription 
of IFN-stimulated genes (Honda et al., 2005; Marie et al., 1998; Sato et al., 2000). 
Both IFN-/ phases are predominantly induced through sequential activation of 
transcriptional activators, called interferon regulatory factors (IRFs)-3 and -7 (Sato et al., 
2000). The first wave induces primary production of IFN- and IFN-1 (IFN-4 in mice) 
through the transcriptional activator IRF3 which is constitutively produced in many cell 
types (Marie et al., 1998; Solis et al., 2006). When a critical threshold is exceeded, i.e., 
when enough de novo IRF7, IFN-s, and IFN-1s have been synthesized and freshly 
produced IFN-/ have bound to their cognate receptors (IFNAR1 and IFNAR2) and 
signalled, the second state of IFN-/ synthesis takes place. The receptor engagement 
activates Janus kinases (JAK, or "Just another kinase") (namely, Jak1 and Tyk2) which 
phosphorylate STAT1 and -2 transcription factors. Subsequently, STAT1 and -2 
heterodimerize and interact with IRF9. Next, the formed cytoplasmic complex, called 
ISGF3, translocates into the nucleus, binds to genes containing IFN-stimulated response 
elements (ISREs), and induces their expression (Renauld, 2003). ISRE-containing genes 
include other IFNs, IRF7, RLRs, PKR, 2'-5'OAS, RNAseL, and MxA, to name but a few 
(Fig. 7). 
The initial IRF3 activation and resulting IFN- and IFN-1s production are vital for 
antiviral responses because IRF3 and IRF7 cannot efficiently form homo- or heterodimers 
and activate robust production of antiviral cytokines and IFN-inducible genes unless the 
originally low expression level of IRF7 (due to its short-half life) is augmented (Sato et 
al., 2000). 
 
Figure 7 Simplified view of RNA-virus-induced (A) primary and (B) secondary signal 
transduction pathways for expression of IFN-α/β and IFN-stimulated genes, 
respectively. (A) Engagement of TLR3, -4, -7/8, and of RIG-I and MDA-5 induce IFN-
/ expression through TRIF-, MyD88/TRIF-, MyD88-, or MAVS-dependent 
pathways, respectively, all culminating ultimately in the activation and translocation 
of IRF3/IRF7 into the nucleus. (B) The secreted and de novo produced IFN-/ 
signal via IFNRA1/2s and Jak-Stat pathways to initiate expression of IFN-responsive 
genes and subsequently to pave the way for more powerful IFN-responses. Molecules 
marked in bold have been addressed in the original publications I-IV. 
2.1.3.1 IFN-/ production mediated through TLRs 
In general, the induction of IFN-signalling through TLRs does not require that the cell 
itself is infected: phagocytic cells take in material from the extracellular environment that 
may engage TLRs in the endolysosomal compartment, as described earlier in 1.1.1 and 
1.4.1.1. Upon ligand binding to TLRs, the TIR (Toll/IL-1R)-domain of TLRs recruits 











The most important of these are MyD88 (myeloid differentiation primary response gene-
88) and TRIF (TIR-domain containing adapter inducing IFN) (Kawai et al., 1999; Kawai 
and Akira, 2010; Medzhitov et al., 1998; Yamamoto et al., 2003), both of which have their 
own specific accessory proteins which link them to IRF3 and/or IRF7 activation. Apart 
from TLR3, which signals solely through TRIF, the other IFN-induction capable-TLRs 
use adapter protein MyD88 for IFN induction. However, TLR4 utilizes sequentially both 
MyD88 and TRIF for IFN-signal transduction (Kagan et al., 2008) (Fig. 7). 
It has been noted that only PRRs signalling from the interior of the cell are potent for 
IFN-/ production for some unclear reason. This compartmentalization probably aids in 
the discrimination between self and non-self (Barton et al., 2006; Nishiya et al., 2005; 
Johnsen et al., 2006). Interestingly, TLR2 and -4 located on the plasma membrane, are 
also capable of IFN induction but only after they have been internalized into the 
endosomal compartment (Barbalat et al., 2009; Kagan et al., 2008). The mechanistic 
explanation lies probably in TRAF3 (tumor necrosis factor (TNF) receptor-associated 
factor-3), a cytoplasmic signal transduction molecule downstream of TRIF and MyD88 
(Oganesyan et al., 2006). TRAF3 is unable to recruit itself in the close vicinity of PRRs on 
the cell surface, thus, the receptors upstream of TRAF3 must be internalized first (Kagan 
et al., 2008). Why cell surface TLRs initiate IFN-signalling in the first place is not 
understood, though it may harness IFN production for the enhancement of T- and NK-cell 
functions when there is some infection. 
The IFN-signal transduction pathway downstream of MyD88 and TRAF3 continues 
through several IRAKs (IL-1R associated kinases) and ubiquitin protein ligases TRAFs 
(Kawai et al., 1999; Kawai and Akira, 2010; Medzhitov et al., 1998), whereas the 
components downstream of TRIF seem to involve TBK1 (TANK-binding kinase-1) and 
IKKε (inducible IκB kinase ε) (Fitzgerald et al., 2003; Kawai and Akira, 2010). The full 
activation of the IRF3 in response to TLR3 engagement requires yet additional kinases: 
PI3K (phosphatidylinositol-3-kinase), NAP1 (Nak-associated protein-1), and proto-
oncogene tyrosine kinase c-Src (Johnsen et al., 2006; Sarkar et al., 2004; Sasai et al., 
2005). Both MyD88 and TRIF-dependent pathways are subjected to strict regulation by 
highly conserved proteins called ubiquitines (Keating and Bowie, 2009). Ubiquitines are 
post-transcriptionally attached to specific signalling proteins by ubiquitin protein ligases 
in order to regulate the stability, function, and intracellular localization of signalling 
proteins. In addition to ubiquitines, sphingolipids have been shown to be able to modulate 
signalling via TLRs recently, highlighting the complexity of the regulation of the TLR 
signalling pathway (Napolitano and Karin, 2010) (Fig. 7). 
2.1.3.2 IFN-/ production mediated through RLRs 
The cytoplasmic RLR pathway leading to IFN- production is dependent on interactions 
of CARDs between RIG-I/MDA-5 and MAVS, as described in 1.4.2 (Meylan et al., 2005; 
Seth et al., 2005; Xu et al., 2005). The efficient IFN production in response to RIG-I and 
MDA-5 agonists is dependent primarily on mitochondrial localization of MAVS and on 






requirement was elucidated in cells infected with hepatitic C virus: NS3/4 protein of the 
virus was found to block IFN-/ production by cleaving MAVS from the mitochondrial 
membrane, which subsequently prevented the association of several essential proteins in 
close proximity to MAVS (Loo et al., 2006). Important signalling molecules of RIG-
I/MDA-5/MAVS-pathway include TBK1, IKKε, TRAF3, TRADD (TNF- receptor-1-
associated death domain protein), and c-Src (Hemmi et al., 2004; Johnsen et al., 2009; 
Michallet et al., 2008b; Saha et al., 2006). Thus, the signal transduction pathways of TLR 
and RLR for IFN-/ expression seem to converge at the level of TRAF3 and 
TBK1/IKKε (Hemmi et al., 2004; Oganesyan et al., 2006; Saha et al., 2006)(Fig. 7). 
As with TLR-induced IFN-/ production, RLR signalling is also full of interesting 
details to achieve efficient antiviral response. For example, cells that have low initial 
expression level of RIG-I, a DEAD box polypeptide-3 helicase DDX3X may serve as the 
initial sensor for RNA-mediated IFN production (Oshiumi et al., 2010). Furthermore, 
peroxisomal MAVS may establish an early and transient antiviral defence response to 
delay viral replication, before more robust and prolonged IFN-signalling from 
mitochondrial MAVS is evoked (Dixit et al., 2010). Moreover, regulators of autophagy 
Atg (autophagy related)-5-Atg12 conjugate, complement receptor gC1qR (receptor for 
globular head domain of complement component C1q), NLRC5, and NLRX1 negatively 
regulate RIG-I and MDA-5 (Cui et al., 2010; Jounai et al., 2007; Xu et al., 2009, Moore et 
al., 2008), suggesting that distinct cell's intrinsic defence processes and effectors of innate 
immunity are being coregulated to mount the appropriate intensity of antiviral responses. 
Ubiquitination plays an important part also in RIG-I-mediated IFN-/ production. 
The tripartite motif protein-25 (TRIM25) and RNF135 (Ring finger protein-135) 
ubiquitine ligases attach polyubiquitins to RIG-I to enable RIG-I's downstream signalling, 
whereas ubiquitin ligase RNF125 negatively regulates the RLR-pathway (Arimoto et al., 
2007; Gack et al., 2007; Oshiumi et al., 2009; Zeng et al., 2010). In addition to these 
ubiquitin ligases, the aforementioned proteins, and the RLR family member LGP2 
(presented in 1.4.1), there are numerous other proteins which regulate and determine the 
strength and duration of RLR signalling, implying that IFN-signalling is sophisticatedly 
fine-tuned in infected cells (Zhong et al., 2008). 
2.2. Virus-induced pro-inflammatory cytokine response 
In addition to antiviral cytokines, recognition of viruses promotes the secretion of pro-
inflammatory cytokines and elicits subsequent inflammatory responses. The latin word for 
inflammation, inflammare, means "set on fire". An acute inflammation is a vigorous 
response to injurious stimuli and an attempt to remove the cause. The four classical signs 
of inflammation; redness, heat, swelling, and pain, were already described in the 1st 
century Anno Domini by the Roman Doctor Cornelius Celsus and published in the book of 
De Medicina (Libby, 2007). The inflammatory symptoms can be attributed to increased 
blood flow, capillary permeability, influx of phagocytic cells, and tissue damage. The 
extent and nature of virus-induced inflammation depends on the primary site of infection 






privileged inflammatory sites, as in brain and testicles; 2) noncytopathic viruses do not 
necessarily induce strong inflammatory responses; and 3) some viruses encode proteins 
that bypass or reduce activation of inflammatory responses. 
Chronic inflammation ensues if innate immunity is dysfunctional or inefficient in 
clearing the inflammatory agent. The continuous inflammation of tissues is often 
destructive and leads to serious inflammatory diseases. In addition, virus infection may 
predispose host with certain genetic background to autoimmune diseases. For example, 
certain polymorphisms in the MAVS-encoding gene are linked to susceptibility to systemic 
lupus erythematosus, and MDA-5 alleles present in the general populations are associated 
with type I diabetes, whereas rare loss of function mutations in MDA-5 correlate with 
resistance to the autoimmune disease (Liu et al., 2010; Nejentsev et al., 2009; Shigemoto 
et al., 2009). 
2.2.1. IL-1 family of pro-inflammatory cytokines 
Interleukin-family of pro-inflammatory cytokines is central to inflammatory responses and 
innate immunity. The principal member of the family is IL-1. Initially, IL-1 was 
characterized as the major fever-inducing agent, but today a plethora of other biological 
properties have been associated to this cytokine (Dinarello, 2010; Dinarello et al., 1977; 
Goshen and Yirmiya, 2009; Wolf et al., 2003). The linkage between innate immunity, IL-
1, and inflammation became obvious when the cytoplasmic domains of both IL-1R type I 
and TLRs (the TIR-domain), were found to be homologous, as described previously in 
1.4.1. (Lemaitre, 2004; Martinon et al., 2009; Medzhitov et al., 1997, Valanne et al., 
2011). 
The IL-1 pro-inflammatory cytokine family consists of 11 members, both activators 
and inhibitors of inflammation and innate immunity. The original members of the IL-1 
superfamily included IL-1, IL-1α, and IL-1 receptor antagonist (IL-1Ra), the latter 
competes for receptor binding with IL-1 and IL-1, and subsequently can block their 
immunobiological functions (Dinarello, 2009; Dinarello et al., 1981). In addition to these, 
IL-18, formerly known as IFN--inducing factor, and IL-33 are part of the family and have 
been studied relatively well (Dinarello, 1999; Liew et al., 2010). The last six members of 
the superfamily; IL1F5, IL1F6, IL1F7, IL1F8, IL1F9, and IL1F10, share structural 
similarities to IL-1 and IL-1, but their actions have not been so fully elucidated. Of 
these, IL-1F5 and IL-1F7 are believed to promote anti-inflammatory responses (Costelloe 
et al., 2008; Sharma et al., 2008). 
The biology of IL-1 family cytokines is complex: the control over IL-1- and IL-18-
binding to their respective receptors and subsequent downstream signaling is exerted at 
both the extracellular and at the intracellular levels (see 2.2.3). Extracellularly, the 
functions of de novo secreted IL-1 and IL-18 can be coordinated by transmembrane and 
soluble receptors: binding of IL-1 to IL-1 receptor type II (IL-1RII) blocks IL-1-
signaling; a transmembrane protein SIGIRR (single immunoglobulin IL-1-related 
receptor) can suppress IL-1R- and TLR-mediated inflammatory responses in general, and 






neutralize IL-1 and IL-18, respectively (Colotta et al., 1993; Eisenberg et al., 1990; 
Novick et al., 1999; Wald et al., 2003). The binding of the IL-1 family of cytokines to 
their respective receptors; IL-1R1 and IL-1R accessory protein (IL-1AcP) for IL-1, and 
IL-18R and IL-18R for IL-18, results in increased gene expression in the nucleus (Born 
et al., 1998; Greenfeder et al., 1995). This can be mediated via several signal transduction 
molecules, like mitogen activated protein kinases (MAPKs), and transcription factors, 
such as nuclear factor κB (NF-κB) and activator protein-1 (AP-1) (Fig. 8C and D) 
(Dinarello, 1996; Serkkola and Hurme, 1993). 
2.2.2. Systemic effects of IL-1 and IL-18 
IL-1 and IL-18 are structurally and functionally most related and important cytokines 
within the IL-1 family. They impact on cells in central nervous system and periphery, and 
participate in the regulation of homeostasis and behavior (Besedovsky and Del Rey, 2010; 
Goshen and Yirmiya, 2009, Alboni et al. 2010). Blood monocytes, tissue macrophages, 
and DCs are the primary producers of IL-1 and IL-18 (Eder, 2009; Pirhonen et al., 1999). 
Interleukin-1 indirectly affects (via prostaglandin E2 synthesis) the thermoregulatory 
center of hypothalamus in the brain and induces fever (Dinarello, 2005). This can be 
achieved at systemic concentrations of IL-1 as low as 1-10 ng per kg of body weight 
(Dinarello, 1996; Ogilvie et al., 1996). In the periphery, endothelial cells respond to IL-1 
by producing IL-6 which contributes to vascular permeability and redness. IL-6, in turn, 
stimulates the synthesis of hepatic acute-phase proteins, and increases platelet production, 
and together with IL-1 augments number and mobilization of bone marrow cells, such as 
granulocyte progenitors and mature neutrophils. Increased vascular permeability results in 
a high protein content of plasma and subsequent swelling, as well as in infiltration of 
inflammatory cells to the site of infection via IL-1-induced expression of adhesion 
molecules. IL-1 is also involved in increased pain perception, loss of weight, and fatigue 
(Dinarello, 1996; Dinarello, 2010; Wolf et al., 2003). 
The biological functions of IL-18 are related to, but can also be opposite to that of IL-
1 (Andoh et al., 2008; Dinarello, 1999). In addition, a commonly accepted and broad 
functional division is made by their ability to polarize naїve CD4+T-cells: IL-1 drives 
predominantly inflammation-associated Th1-type and autoimmune disease-affiliated Th17-
type acquired immune responses, while IL-18, formerly known as IFN--inducing factor, 
promotes Th1-type responses only in the presence of IL-12 and IFN- (Chung et al., 2009; 
Okamura et al., 1995; Sareneva et al., 1998). However, in the absence of IL-12, IL-18 may 
also enhance allergy-coupled Th2-type reactions (Dinarello, 2009; Xu et al., 2000). In 
general, the common "flu-like" symptoms associated with microbial infections are due to 
the actions of both of these pro-inflammatory cytokines. Indeed, mice defective in IL-1 
or IL-18 signalling are more susceptible to severe influenza A virus infection than their 
wild type counterparts, showing that both of these pro-inflammatory cytokines are 






2.2.3. Production of IL-1 and IL-18: two phases 
The production of IL-1 family of pro-inflammatory cytokines differs from other cytokines, 
ultimately because of their gene structure. 1) IL-1β and IL-18 are synthesized as immature 
pro-forms, pro-IL-1 and pro-IL-18, and 2) they lack N-terminal leader signal-peptides 
which would direct them to the classical ER-Golgi-secretory pathway. In contrast, the 
precursor-forms remain in the cytoplasm in inactive states after their synthesis. In order to 
become biologically active and secreted, two signals are most often needed, depending on 
the type of IL-1 cytokine family member and of cell in question. In macrophages, the first 
signal is required for transcription and translation of pro-IL-1, but not that of pro-IL-18 
which is continuously produced (Dinarello, 1999; Netea et al., 2009). The second 
stimulus, in turn, is neccessary for activation of caspase-1-mediated processing of these 
pro-forms to their biologically active equivalents and for their secretion. However, in 
contrast to macrophages, monocytes do not need the second signal for processing or 
secretion: they possess constitutively active caspase-1 (Netea et al., 2009). The reason 
most probably is that monocytes circulate in the pathogen-free environment of the blood 
rather than residing in areas where they would be exposed to exogenous stimuli, such as 
the alveolar space or mucosal lining. Thus, in macrophages, the vigorous inflammatory 
reactions are tightly controlled by the requirement for two distinct signals. Several 
proposed mechanisms exist for secretion of IL-1β and IL-18, but the process is still not 
completely understood (Eder, 2009). 
The stability and translational efficiency of mRNAs, precursor processing, and binding 
of the mature IL-1 and IL-18 to their respective receptors determine the intensity of their 
biological responses. As with any gene to be transcripted and subsequently translated, the 
half-lives of its mRNAs and peptides will greatly influence on the final amount of protein 
produced. For example, the presence of bacterial endotoxins will elevate IL-1 mRNA 
within 15 minutes with a subsequent decline after 4 h of mRNA accumulation, whereas 
cells encountering IL-1 itself maintain half of their IL-1 mRNAs for over 24 h (Fenton 
et al., 1988; Schindler et al., 1990; Serkkola and Hurme, 1993). Furthermore, not all of the 
produced pro-forms are matured and secreted in healthy individuals: less than 10% of the 
pool of pro-IL-1 present in monocytes of blood is actually processed, and less than 5% of 
the total IL-1 produced is released from human monocytes (Dinarello, 2004; Hogquist et 
al., 1991). Furthermore, the secreted IL-1 can be captured up by type II decoy receptor 
(IL-1RII), SIGGRR, or soluble decoy receptors, such as IL-1Ra (Colotta et al., 1993; 
Dinarello, 2009; Eisenberg et al., 1990; Wald et al., 2003). Notwithstanding, the biologic 
responses to IL-1 can be evident when only 2% of IL-1Rs are occupied by IL-1 and IL-
1AcP (Ye et al., 1992). Importantly, IL-1AcP binding to IL-1 and IL-1R is rarely rate 
limiting if IL-1AcP is expressed: it binds to the cytokine-receptor complex with high 






2.2.3.1. Transcription of pro-IL-1 and pro-IL-18 
Similar to the situation during IFN-production, transcriptional activation of the IL-1B-gene 
by TLRs is mediated by TIR-TIR-domain contacts between the receptors and their adapter 
proteins. Depending on the TLR in question, MyD88 and/or TRIF can associate with 
different combinations of downstream signalling components like TRAM, IRAK1/2, -4, 
TRAF3 or -6 (Kawai and Akira, 2010). The subsequent activation of MAPK- and NF-κB-
pathways is mediated by a complex containing TAK1 (tumor necrosis growth factor--
activated kinase-), TAB (TAK-1-binding protein)-1, -2, and -3 (Ishitani et al., 2003). Most 
of these aforementioned proteins are also regulated by the levels of unconjugated free 
K63-linked polyubiquitin chains (Keating and Bowie, 2009). The TAK1/TAB-complex 
phosphorylates either MAPK kinase-6 or IκB kinase- (IKK), the latter being part of 
IKK-complex containing IKK, and IKK/NEMO (NF-κB essential modulator) (Wang et 
al., 2001). The activated MAPK-pathway triggers binding of the heterodimeric 
transcription factor AP-1 to promoter areas of pro-inflammatory cytokine genes in the 
nucleus, whereas the IKK-complex phosphorylates NF-κB inhibitory protein IκB and 
marks it for degradation (Ninomiya-Tsuji et al., 1999). Subsequently, NK-κB is 
translocated into the nucleus with a similar enhancing outcome on gene expression than 
AP-1 (Fig. 8A). 
RLRs also activate the NF-κB pathway for expression of genes important for initiation 
and maintenance of the pro-inflammatory response. This occurs in a MAVS-dependent 
manner via TRADD, TRAF6, RIP1 (receptor interacting protein-1), and/or via adapters 
CARD9 and Bcl-10 (B-cell lymphoma/leukemia 10) resulting in the engagement of the 
IKK-complex (Kawai et al., 2005; Michallet et al., 2008a; Poeck et al., 2009; Xu et al., 
2005). After recognition of dsRNA, an additional step for NF-κB-activation FADD (Fas-
associated protein with the death domain)-mediated activation of caspase-8 and -10 
(Takahashi et al., 2006). However, the precise molecular details are not completely 
understood. 
2.2.3.2. Processing of pro-IL-1 and pro-IL-18  
The early observations that cell lysis in a hypotonic buffer could promote conversion of 
pro-IL-1 to the mature cytokine, led to the identification of caspase-1 (Kostura et al., 
1989; Thornberry et al., 1992; Martinon et al., 2002). However, it took several years to 
obtain the first biochemical evidence from the existence of the inflammasome complex, a 
platform for caspase-1-mediated pro-inflammatory events, in cytoplasm (Martinon et al., 
2002). 
As briefly mentioned, in macrophages, caspase-1, formerly known as IL-1 converting 
enzyme, proteolyses the precursors of IL-1 and IL-18, as well as IL-33, and possibly that 
of IL-1F7 (Cayrol and Girard, 2009; Dinarello, 2009; Kumar et al., 2002). However, only 
the cleavage of pro-IL-1 and pro-IL-18 into their mature forms, results in the induction 
of inflammatory responses: IL-33 is already biologically active as a precursor and it is 
inactivated by caspase-1, while IL-1F7 has anti-inflammatory effects. Caspase-1 itself is 
synthesized as an inactive enzyme precursor, but if there are inflammatory stimuli, then it 
becomes recruited into inflammasomes which serve as scaffolds for the self-processing of 
pro-caspase-1 to its mature form, and for subsequent caspase-1-mediated processing of 
precursors of IL-1 and IL-18 (Agostini et al., 2004; Martinon et al., 2002). 
 
 
Figure 8 Simplification of IL-1 production, secretion, and signalling. IL-1β synthesis is 
initiated by signal 1 that induces (A) transcriptional activation of pro-IL-1β gene 
which is followed by signal 2 resulting in (B) caspase-1-mediated processing of pro-
IL-1β to biologically active equivalent in cytoplasmic multiprotein complex, called 
inflammasome. (C) Auto- or paracrine binding of secreted IL-1 to IL-1R-complex 
activates signalling cascades resulting in expression of important inflammation-
associated genes. It is noteworthy that IL-1R1 and TLRs share TIR-domains and also 
partially the same signal transduction components. (D) Decoy receptors may block 
IL-1 signalling. 
In addition to intracellular processing of IL-1 and IL-18, also extracellular maturation of 
these pro-inflammatory cytokines may occur. Neutrophils and macrophages possess serine 
proteases proteinase-3, elastase, and cathepsin-G; mast cells have chymase; and cytotoxic 











(Coeshott et al., 1999; Dinarello, 1996; Sugawara et al., 2001). In addition, a role for 
matrix metalloprotease-9 has been proposed (Amantea et al., 2007). Furthermore, certain 
pathogens like Candida albicans release enzymes that promote the processing of pro-IL-
1 into its active form (Beausejour et al., 1998). 
2.2.3.3. Secretion of biologically active IL-1 and IL-18 
As mentioned above, IL-1 and IL-18 do not contain leader-signal-peptides in their 
mRNA structures that would guide them to the classical secretory pathway consisting of 
ER- and Golgi-compartments (Eder, 2009; Rubartelli et al., 1990). In contrast, the 
secretion of these pro-inflammatory cytokines follows unconventional protein secretion 
pathways which are regulated by caspase-1 (Keller et al., 2008). 
At present, five models for IL-1 and IL-18 release exist, all of which have arisen from 
studies with LPS-primed and ATP-stimulated monocytes, macrophages, and DCs. These 
models include 1) cytolysis, 2) fusion of multivesicular bodies with plasma membrane and 
subsequent release of IL-1-containing exosomes, 3) release of microvesicles in a process 
called membrane blebbing, 4) export of these cytokines via large and specific membrane 
transporters, like pannexin-1, and 5) exocytosis through K+-dependent mechanisms 
(Andrei et al., 2004; Brough and Rothwell, 2007; Hogquist et al., 1991; MacKenzie et al., 
2001; Pelegrin and Surprenant, 2006; Pelegrin and Surprenant, 2007; Perregaux and 
Gabel, 1994; Petrilli et al., 2007; Qu et al., 2007; Qu et al., 2009). 
According to Andrei et al., pro-IL-1 is transported from cytoplasm in some still 
poorly known way to LAMP-1 (lysosomal-associated membrane protein-1) positive pre-
terminal endocytic vesicles, where it co-localizes with caspase-1 and the aspartate-specific 
protease cathepsin D (Andrei et al., 2004). Thus, this observation indicates that IL-1 and 
caspase-1 are synchronously secreted after inflammasome activation. Furthermore, in 
addition to the fact that low intracellular K+- and often high cytoplasmic Ca2+-
concentrations trigger inflammasomes (Andrei et al., 2004; Petrilli et al., 2007, Qu et al., 
2007; Qu at al., 2009), these conditions also elicit the cation-dependent phospholipase 
cascade and exocytosis: phosphotidylcholine phospholipase C augments Ca2+-levels 
resulting in increase in cytoplasmic Ca2+, which in turn, activates Ca2+-dependent 
phospholipase A2, and exocytosis. In addition, a member of the Rab GTPase, a protein 
which has important roles in protein trafficking and secretion, namely Rab39a, is 
important for caspase-1-mediated IL-1 secretion (Becker et al., 2009). It is noteworthy 
that in addition to caspase-1, also other inflammasome components and unconventionally 
secreted proteins are simultaneously exocytosed upon inflammasome and caspase-1 
activation (Feldmeyer et al., 2007; Keller et al., 2008; Martinon et al., 2002). Interestingly, 
also RIG-I is among these proteins (Kim and Yoo, 2008). While secretion of 
inflammasome components and RIG-I may possibly limit inflammasome activation 
(and/or cell death) in infected cells, the secretion of other unconventionally secreted 
proteins may further regulate the host response to an infective agent. Simultaneous 
transport of pro-IL-1 and caspase-1 and/or their abrupt secretion upon inflammasome 






inflammatory cell death, which has the characteristics of both necrosis and apoptosis 
(Brough and Rothwell, 2007; Fernandes-Alnemri et al., 2007). Furthermore, intracellular 
bacteria can be cleared from infected cells via caspase-1-mediated manner (Miao et al., 
2010). 
2.3. Death of virus infected cell 
Multiple potential cell death mechanisms may become activated during viral infection i.e., 
necrosis, apoptosis, caspase-1-mediated pyroptosis, and regulated necrosis, called 
necroptosis. However, in many cases, it is hard and sometimes impossible to make a clear 
distinction between different cell death mechanisms in a given cell population during 
infection. Since apoptosis is an important regulator of viral replication and recovery of 
host from infection, it will be mainly considered here. 
The principle of programmed cell death was described already in 1840s (Clarke and 
Clarke, 1996), but it was not until the early 1970s that the term 'apoptosis', derived from a 
Greek word describing falling leaves, was introduced to depict a special form of death of 
mammalian cells (Kerr et al., 1972). During homeostasis, apoptosis can be considered as 
an immunologically silent and non-inflammatory mode of cell death that preserves overall 
tissue and developmental homeostasis. It has been estimated that 50-70 billion cells die 
each day via apoptosis in the average human adult under normal conditions. Usually, 
apoptosis progresses quickly, and apoptotic cells are rapidly engulfed by professional 
phagocytes. Needless to say, deregulation of apoptosis and impaired clearance of 
apoptotic cells result in disease pathogenesis. In addition, the onset of apoptosis and 
removal of improperly functioning cells is also cost-effective during virus infection: 
elimination of infected cells often prevents the spread of virus since without the actions of 
the host cell, virus replication comes to an end. Furthermore, phagocytosis of virus-
infected apoptotic cells elicits innate immune responses and may also well destroy the 
virus: TLRs are engaged by virus-derived materials and hydrolases degrade engulfed virus 
particles in the endolysosomal compartments of the professional phagocytes. Thus, 
apoptosis during viral infection can be regarded as a host's in-built, intrinsic, defence 
mechanism. This is also supported by the concept that many viruses encode anti-apoptotic 
proteins (Hay and Kannourakis, 2002).  
However, viruses may also utilize apoptosis for their own benefit: the functions of 
anti-apoptotic proteins of viruses or activation of the host's anti-apoptotic proteins by 
viruses may provide more time for virus propagation. Furthermore, after the completion of 
virion assembly, the progression of apoptosis may disseminate the infection further. 
Indeed, phagocytosis of apoptotic cells or cell bodies containing intact viruses may 
propagate infection via cell-cell-contacts. This mode of action is particularly relevant 
during the late stages of infection, e.g., being employed by human immunodeficiency 
virus. It was noticed that macrophages carrying intact human immunodeficiency viruses 
disseminated viruses to other CD4+-cells throughout the body (Ghorpade et al., 1998). 
Another example is given by reconstructed pandemic influenza A virus of the year 1918. 






genes in macaques, and this has been speculated to have contributed to the severity and 
lethality of the 1918 virus (Cilloniz et al., 2009). Thus, the pathogenic nature of the virus 
may correlate with the extent of apoptosis. Furthermore, this can be partly explained by 
host responses causing tissue damage, such as the intense secretion of inflammatory 
cytokines and lymphocyte-mediated destruction of infected cells. Against all these 
backgrounds, the importance of appropriate regulation of apoptosis for host survival 
during the course of infection becomes obvious. Moreover, there must exist a fairly 
precise threshold for execution of apoptosis since there is no possibility of return once that 
threshold has been crossed. 
2.3.1. Induction of cell death 
Both internal (e.g., changes in metabolism, growth, and cell cycle progression) and 
external cues (e.g., presence or absence of certain hormones, growth factors, and 
cytokines, or agents released by cytotoxic lymphocytes) may initiate apoptosis. For long it 
has been known that dsRNA and IFNs sensitize cells, depending on their type, for 
programmed cell death (Tanaka et al. 1998; Kaiser et al., 2004). This is exemplified e.g., 
by the action of IFN-inducible genes like tumour suppressor p53, PKR, and 2'5'-OAS-
RNaseL system (Balachandran et al., 1998; Li et al., 2004; Takaoka et al., 2003). In terms 
of executors of apoptosis, the discovery of caspase-1 led onto the trail of other caspases 
that initiate or execute apoptosis. These are the so called initiator caspases: caspase-2, -8, -
9, -10, and -12, as well as the effector caspases: caspases-3, -6, -7, and -14 (Fernandes-
Alnemri et al., 1994; Nicholson et al., 1995; Pop and Salvesen, 2009; Yuan et al., 1993). 
One should recall that the rest of the characterized caspases are inflammatory, i.e., 
caspase-1, -4, -5 in humans, as well as caspase-11 in mice, a homologue of human 
caspase-4. It seems that inflammatory caspases are not directly involved in apoptosis, but 
rather may function in pyroptosis, in the inflammation-promoting mode of cell death. 
Since viral replication engages multiple parts of the host's metabolic processes, a variety 
of signals may trigger apoptosis, pyroptosis, as well as necroptosis. However, whereas the 
first two mentioned pathways converge in the activation of apoptotic and inflammatory 
caspases, respectively, necroptosis progresses independently of these proteases 
(Vandenabeele et al., 2010). 
Initiation and progression of cell death is intimately linked to functions of 
mitochondria which seem to be sensors of well-being of cells (Ott et al., 2007; Zhou et al., 
2010, Castanier et al., 2010). For example, not only are they important for the innate 
immunity, but they also are vital for key metabolic pathways in cells, such as the citric 
acid cycle, β-oxidation, and electron transport chain. These pathways convert fats, 
carbohydrates, and proteins to water and carbon dioxide and supply of metabolic energy in 
the form of ATP and NADPH (nicotinamide adenine dinucleotide phosphate). 
Furthermore, the biosynthesis of haem, some phospholipids, and iron-sulfur clusters for 
enzymes take place in mitochondria, and these organelles also participate in the regulation 
of calcium homeostasis and ROS production (Westermann, 2010; Ott et al., 2007). 






membrane potential, altering negatively its function, and causing its damage, undoubtedly 
evoke cell death. 
Both extrinsic and intrinsic apoptotic pathways converge at the level of mitochondria 
(Garrido et al., 2006; Nakahira et al., 2011; Zhou et al., 2010). In addition, pyroptosis, and 
necroptosis may also involve mitochondria (Vandenabeele et al., 2010). The intrinsic, 
apoptotic cascade, also known as the mitochondrial pathway, includes proteolytic 
processing of the pro-apoptotic protein, Bid (BH3 interacting domain death agonist) into 
its truncated variant (t-Bid) and its subsequent translocation with Bax (Bcl-2–associated X 
protein) from cytoplasm to the mitochondrial outer membrane. These proteins ultimately 
destabilize mitochondrial membranes, resulting in release of cytochrome c from the 
mitochondrial inner membrane space to the cytoplasm (Luo et al., 1998; Shimizu et al., 
1999; Strasser, 2005). Then, in the presence of cytoplasmic ATP or dATP, an 
apoptosome, a high molecular weight complex containing Apaf1 (Apoptotic protease 
activating factor 1), cytochrome c, and pro-caspase-9 is oligomerized leading to 
subsequent caspase-9 activation (Li et al., 1997). Caspase-9 recruits pro-caspase-3 and 
mediates its processing into its active form. Finally, caspase-3, the terminal member of 
apoptotic caspase cascade, executes apoptosis (Bao and Shi, 2007; Nicholson et al., 1995). 
The extrinsic apoptotic pathway, in turn, is often activated when specific cell surface 
receptors bind to pro-apoptotic ligands, such as TNF, FasLigand (TNF ligand superfamily 
member 6), or TRAIL (TNF-related apoptosis-inducing ligand). Subsequently, the death-
inducing signalling complex (DISC), comprising e.g., of FADD/TRADD, is formed (Hsu 
et al., 1996; Kischkel et al., 1995). In response to a cytoplasmic dsRNA trigger, DISC also 
recruits two initiator caspases, caspase-8 and -10 (Iordanov et al., 2005; Takahashi et al., 
2006). Upon activation, caspase-8 may proteolyse Bid into t-Bid, resulting in the 
activation of caspase-3 and commitment to apoptosis, as described above (Luo et al., 
1998; Strasser, 2005). Importantly, cytoplasmic dsRNA-induced apoptosis has also been 
reported to be independent of the extrinsic pathway, suggesting that there may well be an 
alternative pathway for DISC assembly and activation of the caspase cascade during viral 
infection (Iordanov et al., 2005). It is also worth mentioning that other caspases than 
caspase-8, as well as lysosomal proteases, cathepsins, may cleave Bid, providing further 
evidence that mitochondria are linked to the intrinsic and extrinsic apoptotic pathways 
through actions of Bid (Yin, 2006). 
The mitochondrial connection for initiation of caspase-1-mediated pyroptosis is related 
to NLRP3, ATP, and/or ROS production (Elliott et al., 2009; Zhou et al., 2010). However, 
NLRP3, ATP, and ROS are also believed to be involved in necrosis and apoptosis 
(Chekeni et al., 2010; Ghiringhelli et al., 2009; Iyer et al., 2009; Willingham et al., 2009; 
Willingham et al., 2007). Furthermore, several viruses can induce cell death with necrotic 
features which are also shared by pyroptosis. Thus, as mentioned already before, the 
predominant cell death mechanism may be difficult to pinpoint during infection. 
Necroptosis is an only recently characterized cell death mechanism, which may 
become active if caspase-mediated cell death mechanisms are blocked by the infecting 
virus (Degterev et al., 2005; Ray et al., 1992; Ray and Pickup, 1996). Necroptosis 
involves the active disintegration of mitochondrial, lysosomal, and plasma membranes, 






et al., 2010). The intracellular signalling complex involved in necroptosis is similar to 
DISC presented above, but requires RIP1 and -3 for its full activity. The importance of 
necroptosis during virus-host responses is also highlighted by the fact that there are 
viruses which block RIP-signalling (Mack et al., 2008). 
2.3.2. Nucleic acid-sensing TLRs, RLRs, and inflammasomes in cell death 
The molecular pathways that cause activated PRRs to trigger caspase-3 during viral 
infection are not well known. At least all RNA-sensing TLRs have been reported to induce 
apoptosis via both intrinsic and extrinsic mechanisms (Salaun et al., 2006; Schon et al., 
2004). It has been also observed that virus-induced TLR3 activation and the subsequent 
vigorous cytokine response have often detrimental outcomes to the host by disrupting the 
normal functions of tissues or by causing disproportionate tissue damage, suggesting that 
also other cell death mechanism than apoptosis may occur after TLR activation (Le Goffic 
et al., 2006; Wang et al., 2004). 
The mitochondrial localization of MAVS and the involvement of mitochondria in 
apoptotic pathways suggest that RLRs may be directly linked to apoptosis. Several viruses 
cleave MAVS and/or MDA-5 and RIG-I to counteract the functions of RLR pathway 
(Barral et al., 2007; Barral et al., 2009; Lin et al., 2006). MAVS also contains specific 
cleavage sites for caspases and is proteolysed by them during apoptosis (Rebsamen et al., 
2008; Scott and Norris, 2008; Yu et al., 2010). Furthermore, the cleavage of MAVS can 
be blocked by overexpression of the anti-apoptotic protein, Bcl-XL (B-cell lymphoma-
extra large) (Scott and Norris, 2008). Moreover, the association of MAVS with FADD and 
RIP-1 may also imply that RLRs are tied to activation of the extrinsic apoptotic pathway 
and possibly also to necroptosis, respectively (Lad et al., 2008). In fact, the molecular 
pathways for virus-induced apoptosis are in many ways still poorly characterized. 
Although, the large protein family of NLRs were initially identified through a 
homology search of the apoptosome regulator of human Apaf-1, and its equivalents in 
Caenorhabditis elegans, Drosophila, and plant cells (Manji et al., 2002), so far there is no 
direct molecular evidence for cross-talk between components of apoptosome and NLRP3-
inflammasomes. However, activation of inflammasomes and apoptosomes display many 
similarities that might be interconnected. For example, increased extracellular ATP-
concentrations trigger ATP-sensitive P2X7 receptor and a pannexin-1 hemichannel 
resulting in reduced cytoplasmic ATP- and K+-concentrations which are both features 
found in the inflammasome and apoptosome activation (Cain et al., 2001; Chekeni et al., 
2010; Cruz et al., 2007; Pelegrin and Surprenant, 2006; Perregaux and Gabel, 1994; 
Petrilli et al., 2007). Furthermore, pannexin-1 is cleaved and subsequenly activated by 
caspase-3 and -7 during apoptosis, and the pancaspase inhibitor, z-VAD-FMK, suppresses 
ATP release through pannexin-1 from cells that otherwise might potentially amplify the 
apoptotic and inflammatory responses (Chekeni et al., 2010). 
With respect to the other NLRs, it has been reported that anti-apoptotic proteins of the 
B-cell lymphoma 2 (Bcl-2) family, namely Bcl-2 and Bcl-XL, transiently bind to and 






NLRP1-inflammasome activity is likely linked to the mitochondrial pathway. 
Furthermore, a NLR member, NLRX1, is constitutively localized within the mitochondria 
and has been suggested to induce formation of ROS in response to recognition of 
cytoplasmic dsRNA (Tattoli et al., 2008). ROS, in turn, may lower the apoptotic threshold 
by destabilizing mitochondrial membranes, resulting in cytochrome c leakage and 
triggering apoptosome assembly (Ott et al., 2007). 
Albeit early works ascribed apoptotic functions to caspase-1, later NLRP3, ASC, and 
caspase-1 were linked to necrosis and pyroptosis in response to inflammatory signals 
(Fernandes-Alnemri et al., 2007; Li et al., 2009; Willingham et al., 2009; Willingham et 
al., 2007). In a human macrophage cell line, THP-1, LPS and a TLR7/8 agonist, R837, 
induced ASC dimerization, ASC-dimer oligomerization, and subsequent recruitment and 
activation of caspase-1 (Fernandes-Alnemri et al., 2007). This large (2 µmM in diameter) 
supramolecular assembly of ASC oligomers and caspase-1 was reported to be structurally 
distinct from inflammasomes and was called pyroptosome. Interestingly, only one 
pyroptosome per cell is formed within minutes in response to inflammatory signals 
resulting in an abrupt rupture of the plasma membrane and subsequent cell death 
(Fernandes-Alnemri et al., 2007). Similarly to the situation for inflammasome and 
apoptosome assembly, this involves depletion of intracellular concentration of K+. Thus, 
also pyroptosome activation resembles those encountered in the activation of 
inflammasomes and apoptosome. The exact inflammatory signals regulating the 
assembling of pyroptosomes and inflammasomes, (as well as of apoptosomes) during 
microbial infections are gradually emerging (Martinon et al., 2009). 
3. Influenza A virus infection and structure of the virus 
Influenza viruses are enveloped RNA viruses belonging to the Orthomyxoviruses. They 
are further classified into influenza A, -B and -C viruses according to antigenic differences 
in their nucleocapsid protein (NP) and matrix proteins (M) (Murphy and Webster, 1996) 
(see Fig. 10). Influenza A virus infects birds and mammals, and it is the most pathogenic 
virus of the Orthomyxoviruses to humans (Hale et al., 2010). The name influenza was 
introduced by Italians during an outbreak in 1354 for which they blamed the influence 
"influentia" of the stars (http://www.naturalnews.com/017503.html). 
Influenza A virus spread from person to person via aerosols, droplets, or by contact 
transmission (Weber and Stilianakis, 2008). The virus causes acute respiratory infections 
which can range from mild disease to fatal but rare viral pneumonia. Approximately 5-
15% of the population living in the northern hemisphere will be infected with influenza 
viruses every year (Sanders et al., 2011). The productive replication of influenza A virus 
may result in severe acute respiratory illnesses, serious enough to require hospitalization 
or cause death. There were between 3-5 millions of these cases worldwide in 2010. The 
infection can be life-threatening, especially to people at the risk of developing secondary 
bacterial pneumonia, e.g., immuno-compromised and pregnant women, or people 
suffering chronic illnesses, such as congestive heart failure or chronic obstructive 
pulmonary disease. However, usually most deaths occur in very young children or 
individuals over 65 years, albeit elderly individuals in good health may also be protected 
from seasonal infections since they possess high-avidity antibodies generated against 
influenza viruses that they have experienced previously in their lifetime (Monsalvo et al., 
2011). 
The highly pathogenic nature of influenza A viruses is due to the extensive intra- and 
interspecies re-assortments and variation of their genomes (Holmes, 2008). Consequently, 
different influenza A virus strains are serologically categorized according to their two 
surface glycoproteins: hemagglutinin (HA) and neuraminidase (NA), against which the 
antibody responses are mainly targeted. The distinct antigenic subtypes of influenza A 
viruses are different configurations of H1 to H16 and N1 to N9. Seasonal epidemics are 
caused by influenza A virus H1N1, H2N2, and H3N2. The influenza A virus strain most 
extensively used in this study, A/Udorn/72, belongs to influenza A virus subtype H3N2. 
 
Figure 9 Influenza A viruses are pleiomorphic. Tomogram sections of frozen-hydrated 
A/Udorn/72(H3N2) influenza A virions recorded in a single tomogram field. The 
picture is used with the permission of the authors (Calder et al., 2010) 
The primary cellular targets of influenza A viruses are epithelial cells of the upper 
respiratory tract, alveolar macrophages, and DCs. The virus binds to the terminal sialic 
acid moieties of oligosaccharide chains on the cell surface glycolipids or -proteins (in 
humans to sialic acid attached to galactose with an (2,6)-linkage) via its virion envelope 
protein, HA (Skehel and Wiley, 2000). Interestingly, the structure of the HA tip of H1N1 
"swine flu" from the year 2009, achieved 95% similarity with the pandemic strain of the 
year 1918 influenza A virus, which killed more than 50 million people during the winter 
of 1919 (Wei et al., 2010). Fortunately and in contrast to the aforementioned pandemic 
strains, this HA subregion is glycosylated in seasonal viruses and elicits an effective 
antibody response. In addition to qualities of incoming viruses, genetic background, age, 








Figure 10 Schematic view of structure of influenza A virus. The viral envelope has three types 
of membrane proteins: HA, NA, and M2. M1 protein forms the underlying 
nucleocapsid where vRNPs, consisting of eight negative sense ssRNAs, viral 
polymerase, and NPs are enclosed. The eight ssRNAs encode for the proteins 
necessary for viral replication. From each ssRNA segment, mRNAs are produced for 
the synthesis of the viral proteins indicated in the figure. The virion has 
approximately 500 trimers of HA and 100 tetrameres of NA on its surface, important 
for entry and egress of influenza A virus. Adapted from Kääriäinen and Ahola (2007). 
3.1. Replication of influenza A virus 
Influenza viruses are unusual among the RNA viruses since their RNA synthesis takes 
place in the cell nucleus instead of the cytoplasm, meaning that its genome must be 
transported from the cell surface to the nuclear periphery and released from the virion's 
protein shell, called the nucleocapsid, and from RNA-bound proteins (Flint et al., 2004d; 
Nayak et al., 2004). The viral replication events begin when HA binds to terminal sialic 
acid moieties of the oligosaccharide chains on the host cell surface. This triggers 
internalization of the virus via receptor-mediated endocytosis resulting in the formation of 
endocytic vesicles. When these endocytic vesicles become acidified during their transport 
toward the nucleus, HA undergoes an acid-catalyzed membrane fusion (Flint et al., 2004b; 
Skehel and Wiley, 2000). In addition to the fact that the low pH induces conformational 
changes on HA, it triggers proton transport inside the virus particle through the virion's 
surface ion-channel M2. Acidification of the interior of the virion is the key for 
dissociation of the viral genome-protein complexes, called viral ribonucleoproteins 
(vRNPs), from the nucleocapsid wall, where they have been anchored via M1. A low pH 
is also required for loosening of the virion coat, and subsequent release of eight genomic 











signals present in NPs target vRNPs into nucleus (Flint et al., 2004d) (Fig. 11). In addition 
to NPs, vRNPs consist of trimeric viral RNA polymerase (which holds for polymerase 
basic protein (PB)-1 and -2 and polymerase acidic protein (PA)). PA, PB1, and PB2 are 
responsible for transcription and efficient initiation of translation of viral nucleic acids and 
mRNAs, respectively. Importantly, the viral polymerase is highly error-prone and partly 
responsible for the huge viral variation observed among influenza A viruses. It is worth 
mentioning that all the negative-sense ssRNA segments of influenza A virus contain 5'-
ppp-ends, produced by viral RNA-dependent RNA-polymerase (Pichlmair et al., 2006). 
Influenza A viruses have unusual replication strategies, such as cap-snatching, RNA 
splicing, use of overlapping reading frames or reinitiation of translation, and leaky 
scanning that all ensure that there are high amounts of distinct mRNAs produced for viral 
protein synthesis from a limited number of genomic sequences (Flint et al., 2004f). 
Furthermore, these strategies maximize the use of cellular protein synthetic machineries. 
Viral mRNA synthesis is initiated by viral polymerase that uses host-made 5'-capped RNA 
fragments, cleaved from host mRNAs, as primers (the 5'-cap snatching mechanism). The 
5'-cap structure is necessary for the stability of mRNAs and the initiation of translation, 
and because influenza A virus does not encode any enzymes that synthesize 5'-cap-
structures or otherwise manipulate the host's 5'-cap-synthesizing system, it cleaves the 5'-
cap from host's mRNA molecules utilizing it for the production of its own mRNAs (Flint 
et al., 2004e). Subsequently, the translation of cellular mRNAs is hindered in the absence 
of 5'-cap-structures. This is an example of how the virus gains a competition advantage 
over the host in the use of the host's protein synthesis machinery. The de novo positive-
sense RNAs (viral mRNAs) produced are transported, with or without splicing, from the 
nucleus to the cytoplasm, and used as "template" for viral protein synthesis. 
Most of the influenza A virus proteins are translated by free ribosomes in the 
cytoplasm. However, mRNAs specifying HA, NA, and M2 are translated by ER-bound 
ribosomes and simultaneously inserted into the ER-Golgi pathway, and once there, they 
are post-translationally processed, glycosylated (HA and NA), and then transported 
through this classical secretion pathway to the plasma membrane. Part of the de novo-
synthesized polymerase subunits (PB1, PB2, PA), and NPs, in turn, are imported back 
from cytoplasm into the nucleus, where they serve to support exponential replication of 
full length positive sense viral mRNAs and then of negative sense genomic ssRNAs of 
influenza A virus. During the late stages of infection, the vRNPs are assembled and 
transported to the cytoplasm in a M1- and nuclear export protein (NEP)-aided manner. 
The progeny vRNPs, HA, NA, and nucleocapsid proteins gather together for assembly and 
budding to the plasma membrane. The recently assembled virions obtain their envelope 
from the sites of host's plasma membrane which are rich of cholesterols and 
glycosphingolipids (Simpson-Holley et al., 2002). NA releases virions from the sialic acid 
residues of cell surface and prevents self-aggregation of the virus particles. The released 
virion seeks a new target. 
The genome of influenza A virus also encodes an important multifunctional 
nonstructural protein 1 (NS1) which is synthesized in infected cells but is not incorporated 
into virions (Krug et al., 2003). Instead, it disturbs normal cellular functions to promote 






production. Firstly, NS1 binds ss- and dsRNAs, thus sequesters substrates e.g., from PRRs 
and IFN-inducible antiviral effector proteins, such as PKR and 2'5'-OAS/RNase L, 
resulting in suppression of IFN-/ synthesis and inhibition of other antiviral innate 
immune responses (Gack et al., 2009; Hatada et al., 1999; Mibayashi et al., 2007; Min and 
Krug, 2006; Wang and Krug, 1996). Secondly, NS1 also blocks IFN-/ production in 
infected cells by interacting with RIG-I and E3 ubiquitin ligase TRIM25. NS1 prevents 
TRIM25-mediated K63-ubiquitination of a CARD of RIG-I and subsequent interaction of 
RIG-I with MAVS (Gack et al., 2009; Mibayashi et al., 2007). Thirdly, the viral protein 
inhibits transactivation of IFN- promoter by IRF3, NF-κB, and AP-1 transcription 
factors, subsequently impairing the efficient expression of IFN- (Ludwig et al., 2002; 
Talon et al., 2000; Wang et al., 2000). Interestingly, IFN-inducible genes display different 
sensitivities to NS1-mediated inhibition of their expression (Geiss et al., 2002). This may 
partly be due to NS1-mediated cleavage of the polyadenylation specificity factor, 30 kDa 
(CPSF30) (Nemeroff et al., 1998; Noah et al., 2003). CPSF30 processes the 3'-ends of 
cellular pre-mRNAs, which is necessary for efficient translation, splicing, and capping of 
host mRNAs. Subsequently, when these functions are compromised, translation of viral 
mRNAs is enhanced at the expense of translation of the host mRNAs. Moreover, more 
resources for 5'-cap snatching become available. 
It is uncertain whether the binding of NS1 to RIG-I also affects the pro-inflammatory 
cytokine response through inhibition of RIG-I/ASC-inflammasome. However, certain NS1 
variants can interact with caspase-1 and enhance secretion of IL-1 and IL-18, as well as 
promote apoptosis, suggesting that NS1 may play a role in activation of inflammasome-
mediated events (Stasakova et al., 2005). To conclude, NS1 has a variety of effects on the 
progression of infection. This capacity varies between distinct influenza A virus strains, 
and subsequently poses a challenge to immunization programs and to the development of 
effective antiviral therapies against this virus. 
Replication of influenza A virus is destructive to the host cell and the cell eventually 
dies because of the infection. It seems that the death of cells is attributable to the activities 
of caspases and the extensive inflammation response. Indeed, activation of caspase-3 is 
necessary for efficient propagation of influenza A viruses (Wurzer et al., 2003), and the 
presence of caspase cleavage motifs in influenza virus proteins has been shown to 
determine their immunopathogenicity (Zhirnov and Syrtzev, 2009). Furthermore, the 
extent of inflammation is an important determinator of life and death of host (Cilloniz et 
al., 2009; Le Goffic et al., 2006) 
 
Figure 11 Key events during influenza A virus replication. (A) Attachment. (B) Receptor-
mediated endocytosis, (C) Fusion of the endocytic vesicle with acidic endosomes and 
subsequent breakdown of the virion capsid. (D) Release of vRNPs into the cytoplasm 
and their import into the nucleus. (E) Transcription of viral mRNAs and genome 
segments in the form of nucleocapsids. (F) The 5'-cap-snatching from recently 
transcripted host mRNAs to be attached to viral mRNAs. (G) NEP-assisted 
nucleocapsid export to cytoplasm. (H) Translation of NP, PA, PB1, and PB2 by the 
host's ribosomes in cytoplasm. (I) Nuclear import of viral polymerase for exponential 
viral RNA synthesis. (J) Viral mRNAs encoding HA, NA, and M2 are translated by 
ER-bound ribosomes, and (K) subsequently shunted into the ER-Golgi pathway for 
post-translational modifications, such as glycosylation. (L) HA, NA, and M2 are 
transported to the plasma membrane where (M) all the rest of the virion constituents 
have already gathered for virion assembly and budding. (N) NA detaches mature 











Aims of the Study 
Macrophages play central roles in the innate immunity and microbial defence. They have a 
high expression level of PRRs and are markedly activated by PAMPs and DAMPs. The 
main goal of this study was to characterize the host response to influenza A virus infection 
in human primary macrophages. The molecular pathways involved in the activation of 
innate immune during virus infection were examined with the following aims; 
 
 To characterize the cytoplasmic RNA-induced antiviral- and pro-inflammatory 
cytokine response, inflammasome activation, and apoptosis in human primary 
macrophages (I, III). 
 
 To explore influenza A virus-induced subcellular changes by two-dimensional 
electrophoresis (2DE) -coupled with mass spectrometric (MS) analyses (II). 
 
 To delineate quantitatively influenza A virus-induced subcellular changes and 
secretomes in a global manner by high-throughput proteomics, and to elucidate 
host-virus-interactions and inflammasome activation in influenza A virus-infected 






Summary of Materials and Methods 
The materials and methods of this study are described in more detail in the original 
publications I-IV. 
1. Cells 
1.1. Human primary macrophages 
Human primary macrophages were obtained from leukocyte-rich buffy-coats from healthy 
blood donors. Peripheral blood mononuclear cells (PBMCs) were extracted by density 
gradient centrifugation. Monocytes were differentiated into macrophages by maintenance 
in Macrophage serum-free media supplemented with Granulocyte-macrophage colony-
stimulating factor (GM-CSF) at 10 ng/ml and antibiotics, as described more detail in I-IV 
and by Sareneva et al., (1998). After five days of culturing, the cells were used in the 
experiments. Each macrophage sample represents a pool of separately stimulated cells 
from three different blood donors. All results are representatives of three independently 
but similarly performed experiments. 
1.2. Other cell types 
Table 1. Use of other cell types for indicated purposes during the study. 
Other Cell Types             Description                             Reference 
 
HaCaT (from American   In vitro spontaneously transformed         I 
Type Culture,                   keratinocytes from histologically normal 
Collection, ATCC)          skin used for transfection experiments 
 
Primary T-cells                Purified and activated from non-                               I 
                                         adherent PBMCs, maintained in 
                                         10% Fetal Calf Serum and IL-2 to study 
 
 
             IL-18-induced responses 
293T (ATCC)                  Embryonic kidney cell line used for         I 
                                         propagation of genetically engineered 
                                         retroviruses 
 
Embryonated eggs           Utilized for influenza A virus growth             I, II, IV, 
                       (Pirhonen et al., 1999) 
L929 (ATCC)                  Mouse fibroblast cells for                                        III, 







2.1. Influenza A virus 
Influenza A virus (A/Udorn/72(H3N2)) is an enveloped and morphologically filamentous-
shaped virus (Fig. 9). In addition to Udorn, also another influenza A virus strain 
(A/Beijing/353/89(H3N2)) was utilized in this study (IV). Viruses were cultured in 11-
day-old embryonated eggs, as described by Pirhonen et al., (1999). The cells were 
stimulated with 2,56 hemagglutination U/ml and as depicted in I, II, and IV. Influenza A 
viruses were kindly provided by Professor Ilkka Julkunen. 
2.2. Other RNA viruses 
Table 2. Other RNA viruses used in this study. More details are found from mini-glossary 
and from the indicated references. 
Virus                  Description                                                          Reference 
 
EMCV                Picornavirus, a positive sense ssRNA virus                     III 
 
VSV                   Rhabdovirus, a negative sense ssRNA virus                         III 
 
Both virus stocks were a kind gift from Dr. Jesper Melchjorsen, and used 
at 1 multiplicity of infection (MOI), as described in III. 
3. Synthetic RNA polymers 
3.1. Double-stranded RNA mimetic poly(I:C) 
Poly(I:C) is a long synthetic analog of dsRNA (Fig. 12). It is a polymer of polyinosinic: 
polycytidylic acids and has been used for decades to mimic RNA virus infections. It 
contains 5'-mono- or diphosphate ends (Grunberg-Manago et al., 1955). The commercially 
available product is heterogenous in nature and lot-to-lot variations commonly occur. The 
molecular weight range is 100,000-200,000 which corresponds roughly to 125-250 base 
pairs. Cells can be stimulated with either extracellular or intracellular poly(I:C) (Ablasser 
et al., 2009b; Alexopoulou et al., 2001; Yoneyama et al., 2004). Transfection of poly(I:C) 
with lipofectamine 2000 was used for intracellular delivery of poly(I:C) into the cell 
cytoplasm. Poly(I:C) was used at 10 μg/ml unless otherwise mentioned (I-III), and was 
introduced into the cell cytoplasm according to instructions of the manufacturer (Sigma-
Aldrich, St. Louis, Mo).  
 
 
Figure 12 Chemial structure of (A) poly(I:C) and (B) base-pairing of RNA strands. (B) Uracil 
and adenine and cytidine and guanine are most often base-paired between ssRNA 
molecules. The ribose-sugars of RNA are not shown in B. 
3.2. Single-stranded RNA mimetic R848 
Resiquimod (R848) is a low molecular weight compound of the 
imidazoquinoline family. R848 has potent antiviral and antitumour-
properties in animal models and it is being evaluated e.g., for treatment of 
genital warts and superficial basal cell carcinoma in humans (Gupta et al., 
2004). R848 signals through TLR7/8 (Hemmi et al., 2002; Jurk et al., 
2002). The compound was purchased from Invovogen (San Diego, CA). 
Figure 13 Chemical structure of R848. 
4. Exogenous cytokines 
To study effects of exogenous IFN-/, IFN- (Betaferon) was provided to cells at 100 
international unit (IU)/ml as described in I. GM-CSF was given to PBMC-derived 
monocytes at 10 ng/ml to in vitro differentiate them into macrophages and to maintain the 
obtained pool of cells. IFN- and GM-CSF were purchased from Schering Plough (Espoo, 












Several inhibitors were utilized to delineate the roles of their known targets during innate 
immune response to viruses. 
 
Table 3. Chemical inhibitors, their targets, and manufacturers. More detailed information 
of their use is presented in the references (I-IV). 
Inhibitor              Description                              Company          Reference 
 
Ca-074 Me          Cathepsin B inhibitor                 Calbiochem             III, IV 
 
Cytochalasin D    Promotes conditions for            Sigma-Aldric                II 
  actin depolarization and may 
 
 
 block endocytotic trafficking 
Cathepsin Selectively inhibits        Calbiochem                  III 
inhibitor III cathepsin B, L, S, and papain 
 
EST (E-64d) Irreversible inhibitor of        Calbiochem                  III 
  cysteine proteases 
 
z-VAD-FMK Pancaspase inhibitor                  Santa Cruz                    II 
  of caspase-1, -3, -4, and -7        Biotechnology 
 
z-FA-FMK Inhibitor of cathepsin B and L  Calbiochem                  IV 
 
AZ11645375 P2X7 receptor inhibitor        Sigma-Aldric               IV  






6. Antibodies (Abs) 
Table 4. Abs used in this study. More information is found in the indicated references 
Abs against                       Manufacturer                              Reference 
 
Actin                                Santa Cruz Biotechnology                         II 
Annexin A1                     Santa Cruz Biotechnology                         IV 
ApoE                                Santa Cruz Biotechnology                        IV 
ASC                                 Millipore                                                    III 
-Amyloid (APP) (20.1) Santa Cruz Biotechnology                         IV 
BID                                  Cell Signaling Technology                        III 
Caspase-1p10                   Calbiochem                                               I-III 
Caspase-1p10                   Santa Cruz Biotechnology                        IV 
Caspase-                           Sigma-Aldrich                                          I-III 
Caspase-3p17/19              Cell Signaling Technology                      I-IV 
Cathepsin B                     Calbiochem                                             III, IV 
Cathepsin D (C-20)         Santa Cruz Biotechnology                      III, IV 
Cathepsin Z                     Santa Cruz Biotechnology                         IV 
Cytochrome c                  Santa Cruz Biotehcnology                         IV 
Galectin-3                        Santa Cruz Biotechnology                        IV 
GAPDH                           Santa Cruz Biotechnology                        IV 
Histone H1                      Santa Cruz Biotechnology                         IV 
HMGB1                           Santa Cruz Biotechnology                        IV 
         HSP90                             Cell signaling Technology                         IV 
H3N2                              kindly provided by Prof. Ilkka Julkunen   II, IV 
IFIT3                              BB Transduction Laboratories                   IV 
IKKε (Q-15)                 Santa Cruz Biotechnology                          II 
IL-1                               kindly provided by Prof. Ilkka Julkunen     I 
IL-18                               MBL                                                             I 
IL-18                               (Pirhonen et al., 1999)                              I-IV 
         LAMP-1                          Santa Cruz Biotechnology                         IV 
MAVS                             kindly provided by Prof. Ilkka Julkunen    II 
MDA-5                            kindly provided by Dr. Paul B. Fisher       II 
P2X7 (H-265)                  Santa Cruz Biotechnology                         IV 
RIG-I                               kindly provided by Prof. Ilkka Julkunen   I, II 
TRADD (A5)                  Santa Cruz Biotechnology                          II 
TRIM25                          BD Transduction Laboratories                    II 
VDAC-1 (D-16)              Santa Cruz Biotechnology                         IV 







Only a brief description of central methods is provided. See also Table 5 for summary of 
all methods utilized in the original publications. 
7.1. RNA isolation and complementary DNA (cDNA) synthesis (I-III) 
Total cellular RNA was isolated by RNeasy kit (Qiagen, Valencia, CA) according to the 
manufacturer’s instructions. A total of 0.5 µg of RNA was reverse transcribed into cDNA 
by a high capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA) 
in a 25 μl reaction mixture containing optimized reverse transcription buffer, random 
primers, deoxyNTP mixture, and MultiScribe reverse transcriptase. The conditions for 
cDNA synthesis were: annealing at 25° C for 20 min. and synthesis at 37º C for 120 min. 
The reverse transcription reaction was performed in an Applied Biosystems' Thermal 
cycler version 2720. 
7. 2. Quantitative real-time polymerase chain reaction (real-time PCR) and data 
analysis (I-III) 
For quantitative real- time PCR, TaqMan analysis was done in a 96-well optical reaction 
plate in ABI PRISM 7500 Fast Sequence Detector (Applied Biosystems). The cDNA was 
amplified in 11 μl of 1 x TaqMan Fast universal PCR master mix with pre-developed 
TaqMan® assay primers and probes sets which were designed and optimized according to 
Applied Biosystems' guidelines. For each sample, PCR amplification of the endogenous 
18S rRNA was determined to control for the amount of cDNA added according to the 
manufacturer's instructions (Applied Biosystems) and to allow for normalization between 
the samples. The thermocycling conditions consisted of an initial step of 95ºC for 20 s, 40 
cycles of denaturation at 95ºC for 3 s, and annealing and extension steps at 60ºC for 30 s. 
Real time-PCR was performed at least in duplicate for each cDNA product. No template 
control (NTC), in which molecular grade water was used instead of the template, was 
included in each assay. 
The real- time PCR data was developed by using Sequence detector system version 1.4 
software (Applied Biosystems). The cycle threshold value (CT) of a sample, that is the 
cycle number at which measured fluorescence was greater than the manually fixed 
threshold fluorescence in the amplification plot, was selected according to the 
manufacturer's guidelines. Relative units (RU) were calculated by a comparative CT 
method. First, CT, the difference between the CT value of the target amplicon and 18S 
rRNA, was determined for each sample. Second, a calibrator CT value of 40, obtained 
from NTC, was subtracted from average CTs of 18S rRNAs to obtain CT. Finally, the 
amount of target normalized to an endogenous control which was relative to the NTC-
calibrator, was calculated from equation 2-CT. Standard curve and statistics were 






7. 3. Protein extraction for Western blot analysis (I-IV) 
Cells were suspended into a buffer containing 10 mM Tris (pH 7.4), 150 mM NaCl, and 
25% ethylene glycol supplemented with Complete mini protease inhibitor mixture (Roche 
Diagnostics, Mannheim, Germany) and homogenized by ultrasound sonication. Total of 
10 g of proteins were separated on 15% SDS-PAGE (Sodium dodecyl sulfate 
polyAcrylamide gel electrophoresis) at 200 V, and transferred on Immobilon-P transfer 
membranes (Millipore, Bedford, MA). Blots were stained with Ponceau red to confirm 
equal loading and transfer of the protein samples. Membranes were blocked in PBS 
containing 5% non-fat milk and stained with Abs of interest at +4 ºC for 18 h. 
Subsequently, membranes were washed with PBS-Tween (0.05%) and incubated at Room 
Temperature (RT) for 1 h with appropriate Horseradish peroxidase-conjugated secondary 
Abs (Dako A/S, Glostrup, Denmark.) Proteins were visualized by an enhanced 
chemiluminescence system (PerkinElmer™ Life Sciences, Zaventem, Belgium). 
7. 4. Enzyme-linked immunosorbet assay (ELISA) (I-IV) 
Cytokine concentrations of IL-1 and IL-18 were determined with ELISA according to the 
manufacturer's instructions. Human IL-1 Eli-pair and IL-18 ELISA were purchased from 
Diaclone (Besançor Cedex, France) and Medical & Biological Laboratories Co (Naka-ku 
Nagoya, Japan), respectively. 
7. 5. Immunofluorescence staining and confocal microscopy (II) 
For indirect immunofluorescence staining, human macrophages were grown on coverslips. 
After 12 h infection, cells were incubated with 1 μM MitoTracker Red580 (Molecular 
Probes, Eugene, OR) for 30 min at 37ºC cell incubator at 5% CO2. The cells were fixed 
with 4% paraformaldehyde in PBS and permeabilized with ice-cold acetone for 5 min. The 
aldehyde groups were quenched with 50 mM NH4Cl for 20 min. Cells were treated with
 
specific Abs for 1 h at RT followed by treatment with secondary, species-specific Abs 
conjugated with Alexa488 (Molecular Probes) for 1 h. The samples were mounted in 
Mowiol and viewed under a Leica TCS SP5 confocal microscopy. A HCX APO 63x/1,30 
(glycerol) objective was used and images were processed using the LAS AF program 
(Leica application Suite advanced Fluorescence) and Adobe Photoshop. 
7. 6. Co-immunoprecipitation (II) 
Macrophages were infected with influenza A virus for 18 h or left untreated. Cells were 
lysed with 500 μl lysis buffer containing 50 mM Hepes, pH 7.4, 150 mM NaCl, 1% NP-
40, 1 mM EDTA and protease inhibitor cocktail (Roche Diagnostics). Lysates were 






incubated with the RIG-I Ab overnight. Immune complexes were captured on protein A 
beads and the immunoprecipitates were washed three times with lysis buffer and once 
with PBS. The bound proteins were eluted with Laemmli sample buffer and subjected to 
SDS-PAGE. Separated proteins were blotted onto PVDF-membrane and analyzed with 
TRIM25-Ab. 
7.7. Transient transfection of RIG-I and TLR3 constructs into HaCaT cells (I) 
HaCaT cells, obtained from ATCC (Boras, Sweden), were cultured in DMEM 
supplemented with 10% FCS, 2 mM L-glutamate, and antibiotics (all from GIBCO, 
Carslbad, CA). TLR3 expression plasmid was purchased from InVivoGen (Toulouse, 
France). The RIG-I and ΔRIG-I plasmids have been presented previously (Imaizumi et al., 
2002; Matikainen et al., 2006). The RIG-I expression vectors were transfected into HaCaT 
cells using FuGENE 6 transfection reagent, as specified by the manufacturer (Roche 
Diagnostics). 
7.8. Retroviral infection of HaCaT cells by MAVS cDNA (I) 
MAVS cDNA was amplified (5'-prime: CCG TTT GCT GAA GAC AAG ACC TAT 
AAG TAT and 3'-prime: CTA GTG CAG ACG CCG GTA CAG CAC CA) using Pfu 
polymerase (Stratagene, Cedar Creek, TX), and cloned into modified retroviral 
pMSCVpuro vector (Invitrogen) where the puromycin gene had been replaced by human 
CD8 cDNA. N-terminal HA-epitope tag sequence was inserted into the MAVS cDNA. 
The parental and MAVS-encoding vectors were simultaneously transfected with pCL 
retroviral packaging vector and pVSVG-envelope protein into human embryonic kidney 
293T cells using standard calcium phosphate precipitation method to produce retroviruses 
(Naviaux et al., 1996). After 48 h of transfection, growing HaCaT cells were combined 
with culture supernatant containing retrovirus and polybrene (8 g/ml), and centrifuged at 
2500 rpm at RT for 45 min. A second infection was conducted 24 h later after which the 
cells were used for experiments. The infection level was verified by flow cytometry and 
with R-Phycoerythrin-conjugated anti-CD8-Ab (Becton Dickinson, Frankling Lakes, NJ). 
The average infectivity was 78 % for parental vector and 40 % for vector encoding 
MAVS. 
7.9. Small interfering RNA (siRNA) experiments (III, IV) 
After five days of cell culture in 12-well plates, macrophages were transfected with 100 
nM (III) or 200 nM (IV) non-targeting control siRNA (AllStars Negative Control siRNA) 
and with 50 nM (III) or 100 nM (IV) of each of the two different siRNAs (Hs_CTSD_1 
and Hs_CTSD_3 (III), or Hs_P2RX7_1 and Hs_P2RX7_2 (IV)) by using HiPerFect 






4 h of siRNA treatment, fresh macrophage medium was supplied to the cells. On the 
following day, macrophages were left unstimulated or stimulated with transfected 
poly(I:C) (poly(I:C)-t) (III) or infected with influenza A virus (IV) for 8 and 9 h, 
respectively. Cell culture supernatants were collected and total proteins extracted for 
ELISA and western blot analyses, respectively. 
7.10. APOPercentage apoptosis assay (III, IV) 
The percentage of apoptotic cells was assayed with APOPercentage Apoptosis Assay 
according to manufacturer´s instructions (Biocolor Life Science Assays, Carrickfergus, 
UK). Photographs were taken with an Olympus DP70 digital microscope camera 
connected to an Olympus IX71 light microscope using DP Controller (version 2.2.1.227) 
and DP Manager (version 2.2.1.195) software (Espoo, Finland). The stained (apoptotic) 
and unstained cells were manually counted, and the percentage of apoptotic cells was 
calculated. 
7.11. Subcellular fractionation of infected cells and concentration of cell culture 
media for secretome analyses (II-IV) 
Macrophages were infected with influenza A virus, strain A/Udorn/72 (H3N2) in complete 
Macrophage-SFM medium. The studied cells were lysed or fractionated into 
mitochondrial, cytoplasmic, and/or nuclear fractions. Mitochondrial and cytoplasmic 
fractions were isolated by QproteomeTM Mitochondria Isolation Kit (Qiagen) and the 
cytoplasmic fractions were further purified with 2-D Clean-Up Kit (GE Healthcare, 
Helsinki, Finland) (II, IV). Nuclear fractions were isolated by QproteomeTM Nuclear 
Protein Isolation Kit (Qiagen) and the insoluble and soluble nuclear protein fractions were 
combined before analysis (IV). About 1 x 107 cells were used for all isolations (II, IV). In 
the secretome analyses, the cells grown in complete Macrophage-SFM medium were 
washed three times with PBS, after which the cells were stimulated in RPMI growth 
media supplemented with 1mM HEPES, L-Glutamine, and antibiotics (GIBCO) (III-IV). 
The growth media were collected and concentrated in Amicon Ultra centrifugal filter 
devices (Millipore), and analysed further by Western blotting or MS-based proteomics 
(III-IV). 
7.12. Two-dimensional (2DE) electrophoresis and protein identification (II) 
The first dimension of 2DE was performed with 11 cm pH 4-7 immobilized pH gradient-
strips (Bio-Rad, Helsinki, Finland) and the second dimension with Criterion Tris-HCl 8-
16% gradient precast gels (Bio-Rad). Isolated mitochondrial and cytoplasmic fractions 
from influenza A virus infected and untreated macrophages were dissolved in 200 l 






buffer 4-7) and the proteins were absorbed onto immobilized pH gradient-strips for 24 h at 
RT. Isoelectric focusing to a total of 55 kVh was done at 20°C, and the focused strips were 
equilibrated two times at RT for 15 min with SDS-equilibration buffer containing 6M 
urea, 50 mM Tris-HCl, pH 6.8, 2 % SDS, 20 % glycerol, and 10 mg/ml dithiothreitol for 
the first equilibration, and 25 mg/ml iodoacetamide for the second equilibration. SDS-
PAGE was run at 200V using a Criterion-electrophoresis unit (Bio-Rad) at +4°C. Proteins 
were detected with MS-compatible silver staining(O'Connell and Stults, 1997). Only those 
protein spots that were reproducibly clearly up- or downregulated in at least three 
independent experiments were chosen for identification. 
For identification, the proteins were in-gel digested with trypsin and the resulting 
peptides were analyzed by peptide-mass fingerprinting (PMF) as previously described 
(Nyman et al., 2001; Shevchenko et al., 1996). The mass spectra were acquired using an 
Ultraflex TOF/TOF instrument (Bruker Daltonik, Bremen, Germany) in the positive ion 
reflector mode. Database searches were done with publicly available Mascot search engine 
against NCBInr database (http://www.matrixscience.com). The search criteria were: 
human-specific taxonomy; trypsin digestion with one missed cleavage allowed; 
carbamidomethyl modification of cysteine as a fixed modification and oxidation of 
methionine as a variable modification; peptide tolerance maximum ±50 ppm. All of the 
protein identification scores were significant (p<0.05). 
7.13. Secretome characterization by gel-based mass spectrometry (MS) (III) 
Cell culture supernatants were collected and concentrated as described in 7.7., followed by 
protein purification using the 2D Clean-Up Kit (GE Healthcare). Next, proteins were 
separated using SDS-PAGE and visualized with silver-staining. For protein identification, 
whole gel lanes were cut into 30 pieces of equal size, proteins were in-gel digested with 
trypsin and the resulting peptides were analyzed by nanoLC-MS/MS (nano-liquid 
chromatography-tandem mass spectrometry) as described previously (Ohman et al., 2010). 
The LC-MS/MS data was searched with in-house Mascot version 2.2 through a 
ProteinPilot 3.0 interface against the SwissProt database (version 56.12). The search 
criteria for Mascot searches were as presented above in 7.12. 
7.14. Isobaric tag for relative and absolute quantification (iTRAQ)-labeling and MS 
(IV) 
Mitochondrial, cytoplasmic or nuclear fractions or secretomes of uninfected control cells 
and influenza A virus infected cells at given time-points were labeled with 4plex iTRAQ. 
The samples were first dissolved into 43 µl of iTRAQ dissolution buffer and 2 µl of each 
sample was run into an SDS-PAGE gel. When evaluating the intracellular fractions, equal 
protein amounts of each sample were taken for the iTRAQ analyses based on the silver 
stained gels. In the secretome analyses, the whole samples were labeled. Protein 
alkylation, trypsin digestion, and labeling of the resulting peptides were done according to 






samples were pooled, dried and dissolved into 20 mM KH2PO4 (pH 3). Labeled peptides 
were fractionated by strong cation exchange chromatography (SCX) on an Ettan HPLC 
(high-performance liquid chromatography) system (Amersham Biosciences, Uppsala, 
Sweden). Each SCX fraction containing labeled peptides was analysed twice with nano-
LC-ESI-MS/MS (nano-liquid chromatography-electrospray ionization-tandem mass 
spectrometry) analysis (using Ultimate 3000 nano-LC (Dionex, Amsterdam, Netherlands) 
and QSTAR Elite hybrid quadrupole time-of-flight mass spectrometer (AB Sciex) with 
nano-ESI (approximately 22 SCX fractions for intracellular samples and 13 fractions for 
secretome). MS data were acquired automatically using Analyst QS 2.0 software. 
Information-dependent acquisition method consisted of a 0.5 s TOF-(time-of-flight)-MS 
survey scan of m/z (mass-to-charge ratio) 400-1400. From every survey scan, the two 
most abundant ions with charge states +2 to +4 were selected for product ion scans. Once 
an ion was selected for MS/MS fragmentation, it was placed on an exclusion list for 60 s. 
7.15. Data analysis (IV) 
Protein identification and relative quantitation were performed using ProteinPilot 2.0.1 
software (AB Sciex). Data files from both technical replicates of an iTRAQ sample set 
were processed together. The search database was a self-built combination of Uniprot 
human protein sequences and Uniprot ssRNA negative-strand viruses sequences (both 
from the release 55.0, 02/08). The search criteria were: cysteine alkylation with MMTS 
(methyl methanethiolsulfonate), trypsin digestion, biological modifications allowed, 
thorough search, and detected protein threshold of 95% confidence (Unused ProtScore > 
1,3). Additionally, automatic bias correction was used for intracellular fractions to correct 
for uneven protein loading. ProteinPilot identification and quantitation results were also 
manually checked: for each identified protein with at least two unique peptides with good 
quality MS/MS data were required, and MS/MS spectra with all reporter ion peak heights 
below 10 counts were manually removed from quantitation results. False discovery rates 
were calculated using a concatenated normal and reversed sequence database and a 
previously reported method (Yanai et al., 2009). 
Proteins identified from each subcellular fraction were classified based on their Gene 
Ontology annotations using GeneTrail (Sato et al., 2009). Additionally, k-means 
clustering analysis was performed for the differentially regulated proteins in each 
subcellular fraction using Chipster, an open source data analysis tool 
(http://chipster.sourceforge.net). Clustering was done based on the relative quantitation 
results from the iTRAQ experiments, and a suitable number of clusters for each 
subcellular fraction was determined by studying the cluster profiles. Protein-protein 







Table 5. Methods of this study. More details are found from the references (I-IV) 
Method                                       Reference 
 
Cell culturing: 
Monocyte isolation and differentiation into macrophages                     I-IV 
T-cell purification and culture                         I 
H
 
aCat cell culture                         I  
Transfections: 
Retroviral infection for gene transfection                        I 
Transient gene transfection (with FuGene 6; Roche Diagnostics)             I 
Poly(I:C) transfection (with Lipofectamine; Invitrogen)                      I-III 
siRNA transfection experiments (with HighPerfect; Qiagen)                 III, IV 
  
Basic Techniques of molecular biology and of protein analysis: 
RNA extraction, cDNA synthesis and real-time PCR (TaqMan)           I-III 
Protein extraction, SDS-PAGE, Western blotting, and                           I-IV 
Enhanced Chemiluminicence 
Co-immunoprecipitation                        II 
IL-1 ELISA                                                                                             I, IV 
I
 
L-18 ELISA                         I-IV 
Techniques used in proteomic experiments: 
Subcellular fractionation                      II, IV 
Cell culture media concentration                    III, IV 
2DE and MS                                                                                               II 
Protein in gel digestion, silver staining and MS                                     II, III 
Protein digestion, iTRAQ labeling and MS                                              IV 
D
 
ata analyses of proteomes and secretomes                     II-IV 
Stainings and microscopy: 
Mitochondrial staining (MitoTracker)                       II 
Immunofluoresence staining for confocal microscopy                      II 






Results and Discussion 
1. Human primary macrophages as a model to study innate immune 
responses 
Macrophages are an important cell population which are responsible for eliciting innate 
immune responses during microbial encounter. Once they gain access to tissues, 
circulating blood monocytes differentiate into specific, morphologically and somewhat 
functionally distinct, macrophage cell populations. PBMC-derived CD14+-monocytic cells 
differentiated with GM-CSF adopt classical phenotype, such as high surface expression of 
macrophage marker 25F9+ (data not shown), and are potent producers of e.g., IL-1 and IL-
12 (Mosser and Edwards, 2008). Furthermore, GM-CSF-derived primary macrophages 
has been reported to resemble that of human alveolar macrophages (Akagawa et al., 2006), 
thus providing an excellent and relatively cost-effective cell model with which to study 
innate immune responses against respiratory viruses, like influenza A virus. 
2. Recognition of extracellular and cytoplasmic RNA (I) 
Nucleic acid-sensing TLRs reside primarily in endolysosomal compartment where 
endocytosed virus particles and phagocytosed extracellular nucleic acids e.g., from 
damaged cells, end up by poorly known mechanisms. In order to study extracellular RNA-
elicitated innate immune responses, synthetic dsRNA and ssRNA mimetics, poly(I:C) and 
imidatsoquinole R848, respectively, were extracellularly administered to human 
macrophages to engage TLR3 and -8, respectively (Alexopoulou et al., 2001; Jurk et al., 
2002). During the virus replication cycle, virus-derived RNAs also become often exposed 
to recognition via cytoplasmic PRRs. Since dsRNA is an obligatory replication 
intermediate of many viruses, often generated at some point during the infection (Jacobs 
and Langland, 1996; Kumar and Carmichael, 1998; Weber et al., 2006), poly(I:C)-
polymer was tranfected into cell cytoplasm, denoted as poly(I:C)-t, to trigger the RLR 
pathway i.e., to mimic virus replication in the cell.  
2. 1. Extracellular and cytoplasmic dsRNA activate differentially synthesis of 
antiviral cytokines 
2.1.1. Cytoplasmic dsRNA is a strong inducer of antiviral cytokines 
Extracellular and cytoplasmic dsRNAs are known to activate an antiviral cytokine 
response (Alexopoulou et al., 2001; Diebold et al., 2003; Yoneyama et al., 2004). In 






moderate synthesis of type I and III IFNs: IFN- and IL-29, respectively. This 
transcriptional elicitation occurred early, at the 3 h time point, but was not sustained for a 
long period. However, a cytoplasmic dsRNA stimulus triggered forceful IFN- and IL-29 
mRNA expression which remained elevated up to 24 h. The results suggested that 
recognition of viral RNA in cytoplasms via RLRs is primarily responsible for the intense 
expression of IFNs during virus infection. Hence, entry or replication of viruses in 
cytoplasm, but not their presense in endolysosomes, seems to be the sign of active virus 
infection in an infected cell, and this consequently establishes an effective IFN response to 
protect the host. 
2.2. Extracellular and cytoplasmic dsRNA regulate differentially transcription of 
pro-inflammatory cytokines IL-1 and IL-18 
2.2.1. Extracellular dsRNA induces expression of pro-inflammatory cytokine IL-1 
Both extracellular and cytoplasmic RNA recognition pathways have been connected to 
NF-κB activation and production of pro-inflammatory cytokines (Alexopoulou et al., 
2001; Yoneyama et al., 2005; Yoneyama et al., 2004). In human macrophages, 
extracellular dsRNA activated robust expression of IL-1 both at the mRNA and protein 
level. The transcriptional activation of IL-1 in response to extracellular dsRNA was 
dose-dependent, and the kinetics resembled those of cytoplasmic dsRNA-induced IFN- 
production: pro-IL-1 mRNA levels were most pronounced at 3 h, and remained elevated 
still at the 24 h time point. The highest concentration of extracellular dsRNA also 
amplified constitutive expression of pro-IL-18 in human primary macrophages. However, 
in contrast to extracellular dsRNA, cytoplasmic dsRNA elicited only modest expression of 
IL-1 mRNA and protein without any effect on continuously expressed IL-18, suggesting 
that recognition of cytoplasmic RNA was not sufficient to promote efficient 
transcriptional activation of IL-1-engoding gene. The results implied that TLR signalling 
is superior to RLRs in the initiation of transcription of the IL-1 precursor, and that the 
recognition of extracellular pathogens via TLRs competently prime cells for a vigorous 
IL-1 pro-inflammatory cytokine response. 
2.3. Extracellular and cytoplasmic dsRNA regulate differentially processing and 
secretion of IL-1 and IL-18 
2.3.1. Cytoplasmic dsRNA evokes efficient processing and secretion of IL-18 
Caspase-1 is responsible for processing of pro-IL-1 and pro-IL-18 into their biologically 
active equivalents before they can be secreted by unconventional protein secretion 






inactive 45 kDa (p45) precursor which undergoes autoproteolysis in inflammasomes to 
become enzymatically active heterodimer composed of p10 and p20 subunits (Cerretti et 
al., 1992; Thornberry et al., 1992). Albeit extracellular dsRNA induced transcription of 
pro-inflammatory cytokine IL-1 in human primary macrophages, extracellular dsRNA 
did not clearly activate caspase-1, assessed as formation of caspase-1p10 and p20 subunits 
and via the secretion of IL-1 and IL-18. The result indicated that recognition of 
endolysosomal RNAs were not directly connected to assembly and activation of 
inflammasomes in human primary macrophages. 
In contrast to extracellular dsRNA and also other well-known ligands of TLRs (R848 
and LPS), cytoplasmic dsRNA and influenza A virus-infection promoted clear and 
efficient caspase-1 activation which resulted in robust processing and secretion of IL-18. 
The result suggested that only viral RNA in cytoplasm may directly or indirecly trigger 
inflammasome in infected cells. Since cytoplasmic dsRNA- and influenza A virus-induced 
expression of pro-IL-1 was weak, the measured secretion of IL-1 was low. The reasons 
why cytoplasmic dsRNA and influenza A virus infection-induced only modest production 
of pro-IL-1 were not elucidated, but may be related to functional specialization of RLRs 
and TLRs in promotion of antiviral and pro-inflammatory cytokine expressions, 
respectively. 
In order to verify that recognition of cytoplasmic dsRNA and influenza A virus-
infection, resulted in secretion of biologically active IL-18 from human primary 
macrophages, media from poly(I:C)-t -stimulated or influenza A virus-infected cells were 
transferred to primary T-cells, and expression of IFN- mRNA was analysed by real- time 
PCR. In accordance with the knowledge that T-cells produce IFN- in response to IL-18 
and IFN- (Sareneva et al., 1998), IFN- was markedly induced and its expression could 
be blocked by neutralizing Abs against IL-18. Not only did the result exclude the 
possibility of influenza A virus to promote processing of IL-18 to a form that could not 
engage IL-18 receptors, namely IL-18R and IL-18R, but it also elegantly demonstrated 
the functional relevance of macrophages in the interface between innate and acquired 
immune responses. 
2.3.2. Effect of TLRs on virus infection-induced pro-inflammatory cytokine response 
In contrast to IL-18 secretion, IL-1 was significantly secreted from cytoplasmic dsRNA-
stimulated and influenza A virus infected human primary macrophages, only if the cells 
had been stimulated first with TLR-agonists. Concurrent exposure of macrophages with 
TLR agonists and cytoplasmic dsRNA-stimulus or influenza A virus-infection also 
elevated IL-18 secretion. The extent of the synergistic action varied depending on the TLR 
in question. The results clearly showed that TLRs augmented the initially weak 
cytoplasmic RNA-induced expression of pro-IL-1 and were necessary for significant 
virus-induced IL-1 secretion. In other words, it seemed that TLRs ensured the initiation 
of transcription of IL-1-encoding gene (signal one), whereas recognition of cytoplasmic 
RNA contributed to the inflammasome assembly, caspase-1 activation, and secretion of 






Firstly, the results indicated that without simultaneous recognition of extracellular and 
intracellular PAMPs (or DAMPs), pro-IL-1, is not expressed and processed into mature 
protein and externalized in cells stimulated with poly(I:C)-t or infected with influenza A 
virus. The requirement for two signals presumably prevents the unintentional initiation of 
an intense pro-inflammatory cytokine response unless the host is severely infected. An 
interesting example of the cooperation of TLRs with cytoplasmic PRRs during virus-
infection is given by Ichionahe et al.,: commensal microbiota in the intestine provide 
constitutive expression of pro-IL-1 and NLRP3, that is necessary for inflammatory 
responses in the lung during influenza A virus infection. Conversely, certain antibiotics 
alter the composition of intestinal microbes, resulting in weakened immune responses 
against influenza A virus (Ichinohe et al., 2011). 
In the context of an ongoing infection, the results obtained firstly suggested that the 
pro-inflammatory cytokine response of the virus-infected cell may be amplified by 
phagocytosis of extracellular RNAs from injured or apoptotic neighbouring cells 
containing viral RNAs. This would be rather likely especially during late phases of 
infection when macrophages phagocytose damaged or apoptotic cells in order to clear the 
site of infection. This is also supported e.g., by the concept of Nishiya et al.,: TLR3 and 
TLR7/8 preferentially localize near phagosomes containing apoptotic cell particles 
(Nishiya et al., 2005). 
Secondly, since stimulation of human primary macrophages with the prototypic TLR4-
ligand LPS amplified tremendously influenza A virus-induced IL-1 and IL-18 secretion, 
it can be speculated that concomitant inhalation of LPS, bacterial coinfection, or formation 
of TLR4-stimulating DAMPs, may contribute to the "cytokine storm", hypercytokinemia, 
in the infected host. Indeed, secondary bacterial infections are known to associate with 
severe illnesses and mortalities of influenza A virus-infected individuals (Morens et al., 
2008). Moreover, oxidized phospholipids produced during acute lung injury with H5N1 
avian influenza virus trigger TLR4 and are intimately involved in the pathogenesis of 
virus-induced severe acute respiratory distress syndrome (Imai et al., 2008). Thus, one 
might hypothesize that simultaneous engagement of TLRs by these kinds of DAMPs 
during influenza A virus infection, may maintain a major pro-inflammatory cytokine 
response in human primary macrophages. 
 
At the level of infected individuals, pathogens have been reported to use TLR-mediated 
inflammation as a route of dissemination i.e., to establish an infection in other parts of the 
body. Intense production of cytokines via TLRs may damage tissues, resulting in the 
spread of the virus (Cilloniz et al., 2009; Kash et al., 2006; Kurt-Jones et al., 2004). 
Consistent with this concept, TLR3 has been shown to play a pathological, rather than a 
protective, role during influenza A virus infections: TLR3-knockout mice infected with 
influenza A virus display lower levels of pro-inflammatory cytokines and diminished 
numbers of CD8+T-cells in the bronchoalveolar airspace of lung than their wild-type 
counterparts (Le Goffic et al., 2006). The peripheral inflammatory responses against 
encephalitogenic and positive sense ssRNA virus, such as West Nile virus, are also 
initiated by TLR3-induced cytokines resulting in increased permeability of blood-brain 






there also is one reported case in which loss-of-function mutation in TLR3 caused severe 
influenza A virus-associated encephalopathy (Hidaka et al., 2006). 
3. Inflammasome activation in response to cytoplasmic RNA (III) 
Both cytoplasmic dsRNA-stimulus and influenza A virus-infection promoted robust IL-18 
secretion, without any necessary assistance from TLRs in human primary macrophages. 
For this reason, IL-18 secretion was utilized as a direct marker of inflammasome 
activation. In an attempt to characterize further the mechanism for engagement of 
inflammasomes during virus infection, macrophages were stimulated with the mimetic of 
cytoplasmic signature of viral infection, poly(I:C)-t, as above. 
3.1. Cytoplasmic dsRNA induces secretion of inflammasome components caspase-1 
and ASC 
Time-course analysis of cytoplasmic dsRNA-induced secretion of IL-18 was performed in 
human primary macrophages. IL-18 was secreted at 3 h and increasingly thereafter, 
detected by ELISA from cell media and by western bloting from intracellular protein 
lysates of cytoplasmic dsRNA-stimulated cells. Accordingly, also the subunit of activated 
caspase-1 was observed from western blots of intracellular protein lysates starting at the 
same time point and at later times. At 6 h, IL-18 was significantly secreted, and the 
biologically active equivalent of the cytokine was observable also in western blots of 
extracellular, secreted, proteins. Furthermore, two core components of inflammasomes, 
caspase-1 and ASC, were also found in the extracellular protein lysates of cytoplasmic 
dsRNA-stimulated cells, indicating that the inflammasome had indeed been activated. 
Unfortunately, due to unavailability of specific Abs against NLRP3 and MDA-5, 
externalization of NLRP3 and MDA-5 could not be analysed. The most likely explanation 
for the secretion of core components of inflammasomes is to limit inflammatory response 
and cell death during infection. In addition to poly(I:C)-t, also a positive sense ssRNA 
virus, EMCV, and negative sense ssRNA virus VSV, induced IL-18 secretion, meaning 
that this phenomenon may well occur among viruses from different RNA-virus families. 
3.2. Secretome characterization of cytoplasmic dsRNA-stimulated human 
macrophages 
In addition to the fact that prolonged activation of caspase-1 results in secretion of 
inflammasome components, caspase-1 activation is known to trigger unconventional 
protein secretion (Keller et al., 2008). In an attempt to obtain more information about 
protein secretion in the response to cytoplasmic dsRNA, global secretion pattern of 
proteins, secretomes, from control and cytoplasmic dsRNA-stimulated cells were 






left unstimulated or were stimulated with cytoplasmic dsRNA for 6 h and 18 h, after 
which the proteins from cell culture media were collected, concentrated, precipitated, and 
subjected to SDS-PAGE. The SDS-PAGE gels were cut into lanes and then into smaller 
equal-size pieces to identifiy the SDS-PAGE-separated proteins, and the fragments were 
in-gel digested with trypsin, and the resulting peptides were analysed with nanoLC-
MS/MS. 
This method revealed almost 300 proteins from cell culture supernatants of 
cytoplasmic dsRNA-stimulated cells at 6 h and more than 400 proteins at the 18 h time 
point, whereas the corresponding numbers in the control cells remained at approximately 
200. Thus, recognition of dsRNA induced strong and early protein secretion, which was 
augmented as time progressed. This phenomenon is probably related to both active and 
passive processes mediated by prolonged caspase-1 activation and cell death. The elevated 
protein secretion might serve as a mechanism to regulate inflammation and acquired 
immune responses in the host during virus infection, as already mentioned in the review of 
the literature in 2.2.3.3., and will be discussed in more detail in 5.4. 
Identification of proteins from cytoplasmic dsRNA-treated cells revealed many 
unconventionally secreted proteins and proteins associated with exosomes, transport, and 
secretion, suggesting that both conventional and caspase-1-mediated unconventional 
protein secretion pathways were in operation. In particular, there was significant secretion 
of Ras-related proteins, rabs. Since these small GTPases are involved in the regulation of 
vesicular transport in and between distinct organelles as well as in the endocytic apparatus 
(Zerial and McBride, 2001), their secretion implied that marked alterations had occurred 
in secretory routes in response to recognition of cytoplasmic dsRNA. 
Importantly, several lysosomal proteins, like cathepsins and endogenous inhibitors of 
cysteine-specific proteases, cystatins (Turk and Stoka, 2007; Turk and Bode, 1991), were 
detected, indicating that recognition of cytoplasmic dsRNA destabilized also lysosomal 
membranes and subsequently resulted in the leakage of lysosomal proteins into cytoplasm. 
This, in turn, might potentiate inflammasome activation in infected cells, and it was 
studied in further detail. 
3.3. Cathepsins are vital for cytoplasmic RNA-triggered inflammasome activation 
3.3.1. Cathepsin D secretion precedes secretion of cathepsin B in response to cytoplasmic 
dsRNA 
Secretome analysis suggested substantial changes in secretion of cathepsins and their 
endogenous regulators in response to cytoplasmic dsRNA-stimulus. To delineate further 
cytoplasmic dsRNA-induced effects on cathepsin regulation, secretion of individual 
cysteine- and aspartate-specific proteases, cathepsin B and cathepsin D, respectively, were 
analysed by western blotting. Interestingly, secretion of mature cathepsin B followed 
release of activated caspase-1 and ASC, suggesting that the inflammasome had been 






dsRNA-induced secretion of cathepsin D preceded that of cathepsin B, implying that also 
cathepsin D may take part in inflammasome activation, or alternatively, was localized in 
the same secretory vesicles than caspase-1, ASC, and IL-18, as postulated by Andrei et al., 
(Andrei et al., 2004). To delineate this further, cells were prestimulated with the most 
commonly used cathepsin B inhibitor, Ca-074 Me, before they were treated with 
cytoplasmic dsRNA. Ca-074 Me almost totally blocked secretion of IL-18 and ASC in 
response to cytoplasmic dsRNA-stimulus. Moreover, it suppressed also EMCV- and VSV-
induced IL-18 secretion, suggesting that cathepsin B is essential for inflammasome 
activation in response to cytoplasmic dsRNA, EMCV, and VSV, and conceivably in 
general during RNA-virus infections. Two other pharmacologically distinct cathepsin 
inhibitors, Est and CatIII, also abolished cytoplasmic dsRNA-elicited IL-18 secretion, 
supporting the results obtained with Ca-074 Me. 
To elucidate further the role of cathepsin D in cytoplasmic dsRNA-induced 
inflammasome activation, expression of cathepsin D was silenced with cathepsin D-
specific siRNAs. After silencing, human primary macrophages were stimulated with 
cytoplasmic dsRNA mimetic for 8 h, and then samples for western blotting and ELISA 
were prepared. Cathepsin D-specific siRNAs effectively reduced cytoplasmic dsRNA-
induced protein expression of cathepsin D and secretion of IL-18. These were not 
observed with cells treated with non-targetting control siRNAs. The results indicated that 
cathepsin D is likely involved in cytoplasmic dsRNA-induced inflammasome activation. 
Similarly to the obtained results, -amyloid- and cholesterol crystal-induced NLRP3-
inflammasome-activation have also been reported to require lysosomal proteases other 
than cathepsin B for their activation (Duewell et al., 2010; Halle et al., 2008; Hornung et 
al., 2008). 
 
What mechanism then might be involved in cytoplasmic dsRNA-induced inflammasome 
activation which is associated to direct or indirect activation of cathepsins? It has been 
hypothesized that cathepsins may convert inflammasome component(s) into their active 
conformation(s), or process unknown cytoplasmic factor(s) that subsequently promote 
inflammasome assembly and activation (Martinon et al., 2009). It is noteworthy that 
NLRP3 contains cleavage sites for caspase-1, cathepsin B, and cathepsin L (E. Latz, 
unpublished observation). Further work will be definitely needed to delineate the roles of 
the individual cathepsins in inflammasome activation. However, this is a challenging task 
because numerous cathepsins (i.e., cathepsin B, C, H, F, K, L, O, S, V, W, and X/Z), and 
species-specific differences between mice and men exist that complicate knock-out studies 
(Turk and Stoka, 2007). 
 
The high-throughput secretome data of cytoplasmic dsRNA-stimulated human 
macrophages revealed also secretion of cystatins, endogenous inhibitors of cysteine-
specific proteases, like cathepsin B and caspase-1 (Turk and Stoka, 2007; Turk and Bode, 
1991). In particular, cystatins-A and -B were detected, implying that the actions of 
cysteine specific proteases are tightly controlled during cellular stress and this might bring 
additional level of regulation for inflammasome activation during virus infection. 






(Lenarcic et al., 1988; Lenarcic et al., 1991). Thus, cathepsin D might antagonise the 
inhibitory functions of cystatins on cysteine specific proteases, and in this way may 
promote indirectly cathepsin B-dependent inflammasome activation, or alternatively 
activities of caspase-1. Furthermore, in contrast to plant cells which also defend 
themselves by LRR-containing disease resistance proteins, mammalian cells do not 
encode proteases that would negatively regulate the actions of aspartate-specific proteases, 
like cathepsin D (Lison et al., 2006). It is not known why the extra-lysosomal actions of 
cathepsin D are not inhibited in mammals. Nonetheless, complex proteolytic cascades 
evidently regulate the activities of inflammasomes during viral infection. 
4. Apoptosis in response to virus infection (I, III) 
4.1. Extracellular and cytoplasmic dsRNA regulate differentially apoptosis (I, III) 
Recognition of cytoplasmic RNA, but not that of extracellular dsRNA, evoked the 
appearance of apoptotic morphology in human primary macrophages, including cell 
shrinkage and rounding, and subsequent detachment of cells from their growth site. In 
contrast to stimulation of TLR3 with extracellular dsRNA (or activation of other TLRs 
together or alone with their respective agonists i.e., LPS and/or R848), only cytoplasmic 
dsRNA and influenza A virus-infection activated caspase-3. This was evident as the 
appearance of caspase-3 p17/19 subunit of the activated heterodimeric enzyme (the other 
subunit being caspase-3 p12) (Fernandes-Alnemri et al., 1994; Nicholson et al., 1995). 
Furthermore, the biologically inactive fragment of IL-18, formed by caspase-3 from pro-
IL-18 and of IL-18 (Akita et al., 1997; Pirhonen et al., 1999), was detected by western 
blotting from cytoplasmic dsRNA-treated cells, suggesting that caspase-3 was functionally 
active. 
In addition to cytoplasmic dsRNA-stimulus and influenza A virus-infection, also 
EMCV and VSV induced caspase-3 activation in human primary macrophages, showing 
that infection with these RNA-viruses included activation of programmed cell death. 
4.2. Cytoplasmic dsRNA elicits inflammasome activation before apoptosis (III) 
Apoptosis was also assessed with a unidirectional dye-uptake bioassay which is based on 
membrane alterations during apoptosis (APOPercentage; III, IV). After overnight 
exposure with cytoplasmic dsRNA, approximately 50% of the live cells, still attached to 
the bottom of cell growth plates, had progressed to apoptosis. (Influenza A virus had 
slower kinetics: no apoptotic cells were detected after 6 h post-infection, and 19% of the 
cells infected with the virus had progressed to apoptosis at 12 h and 73% were apoptotic at 
18 h (IV)). Importantly, a clear activation of caspase-3 occurred at 6 h in cytoplasmic 






inflammasome activation were detected, suggesting that pro-inflammatory cytokine 
response was initiated before apoptosis in virus infected cells. The inflammatory response 
prior to apoptosis is an effective mechanism to signal the presence of danger and to 
activate the cellular arm of the innate and acquired immunity, as well as resident cells at 
the site of infection. 
4.3. Mechanism for cytoplasmic dsRNA-induced apoptosis (I, III) 
In an attempt to clarify the molecular mechanism of cytoplasmic dsRNA-induced 
apoptosis, an actively dividing cell line, human keratinocytes, HaCaTs, were examined. 
RIG-I and MAVS-encoding genes were transiently overexpressed or stably transfected 
through retroviral gene transfer into the nuclei of HaCaTs, respectively. With both of these 
constructs and methods, the end-result was the same: caspase-3 was significantly activated 
and the cells died, clear evidence that RIG-I and MAVS are capable of triggering 
apoptosis (I). 
It has been known for a long time that exogenous IFN-/ can potentiate apoptosis 
(Tanaka et al., 1998; Kaiser et al., 2004), possibly via increased expression of IFN-
inducible genes that are involved in apoptotic responses (Balachandran et al., 1998; Li et 
al., 2004). However, in HaCaTs, exogenous administration of IFN- itself did not enhance 
apoptosis, suggesting that the production of IFN-/ was not primary reason for the RIG-
I/MAVS-induced apoptotic effects in these cells. 
Similarly, Chattopadhyay et al., subsequently reported that RIG-I elicited apoptosis 
through MAVS-TRAF3-TBK1 and via adapter molecules TRAF2 and TRAF6 without 
concomitant transcriptional activation of ISRE-containing genes by IRF3 (Chattopadhyay 
et al., 2010). In contrast, this pathway culminated in direct interaction of IRF3 with pro-
apoptotic protein Bax and subsequent permeabilization of mitochondrial membranes. 
However, MAVS has also been tightly connected to signal transduction cascades that lead 
to IRF3-mediated trancriptional activation of pro-apoptotic genes, like Noxa and Puma 
(Besch et al., 2009; Lallemand et al., 2007). Furthermore, others have reported that the 
cytoplasmic dsRNA pathway involves death-ligand and death-receptor-independent DISC 
assembly and subsequent activation of the caspase cascade via interaction of MAVS with 
FADD, TRADD, and the apoptotic initiator caspases, caspase-8 and -10 (Iordanov et al., 
2005; Takahashi et al., 2006). In addition, reovirus-induced activation of MAVS and IRF3 
is connected to caspase-3 activation (Holm et al., 2007). It is also worth mentioning that 
previous studies described apoptotic functions to MDA-5 (Kang et al., 2004; Kang et al., 
2002; Kovacsovics et al., 2002). Further evidence of involvement of RLRs in apoptotic 
responses is illustrated by the fact that there are viruses which cleave and subsequently 
inactivate RIG-I, MDA-5, and MAVS during infection (Barral et al., 2007; Barral et al., 
2009; Lei et al., 2009; Rebsamen et al., 2008; Yu et al., 2010). This processing, mediated 
either by viral proteins or host caspases activated by the infecting virus, suggests that 
viruses do attempt to attenuate innate immune responses, including the initiation of 
apoptosis, in infected cells. Furthermore, the actions of anti-apoptotic proteins of host may 






For example, cleavage of MAVS during infection can be blocked by overexpression of 
Bcl-XL, and certain primary cells can be rescued from RIG-I/MDA-5-mediated apoptosis 
by Bcl-XL (Besch et al., 2009; Scott and Norris, 2008). Overal, these reports from other 
laboratories strongly support the results obtained here: RLR pathway integrates apoptotic 
signals during virus infection. The knowledge of the capacity of RIG-I/MAVS signalling 
pathway to promote apoptosis may have therapeutic significance in medicine. 
 
Importantly, in addition to the fact that cathepsin B inhibitor Ca-074 Me significantly 
suppressed inflammasome activation in response to recognition of cytoplasmic dsRNA in 
human primary macrophages, it also abolished cytoplasmic dsRNA-, EMCV-, and VSV-
triggered caspase-3 activation (III). Furthermore, the agent inhibited cytoplasmic dsRNA-
induced proteolysis of Bid into t-Bid and the number of apoptotic cells. Thus, the obtained 
results with human primary macrophages implied that in addition to MAVS and RIG-I, 
also cathepsins are involved in the induction of apoptosis in response to the recognition of 
cytoplasmic RNA. Importantly, Blomgran et al., and Kagedal et al., have reported that 
cathepsins are important activators of oxidative stress-induced apoptosis in neutrophils 
and fibroblasts (Blomgran et al., 2007; Kagedal et al., 2001). Thus, it can be speculated 
that recognition of cytoplasmic RNA in human primary macrophages might trigger ROS 
production resulting in destabilization of lysosomal membranes, leakage of cathepsins into 
cytoplasm, proteolysis of Bid, and subsequent activation of pro-apoptotic proteins like 
Bax, breakdown of mitochondrial membrane integrity, cytochrome c release, and 
apoptosis (Garrido et al., 2006; Li et al., 1998; Luo et al., 1998; Strasser, 2005).  
 
Overall, one might hypothesize that recognition of cytoplasmic RNA induces formation of 
multiprotein complexes, including RIG-I/MDA-5, MAVS, ASC/NLRP3, and/or t-Bid/Bax 
in the vicinity of mitochondria, from where the signals for antiviral and pro-inflammatory 
cytokine responses, and apoptosis are successively initiated or regulated. This concept is 
supported at least by three recent reports showing that MAVS regulates mitochondrial 
dynamics to facilitate the mitochondria-ER association required for antiviral signal 
transduction; NLRP3 and ASC localize to ER-membranes near to mitochondria after a 
stimulus; and NLRP3 is essential sensor of membrane permeability of mitochondria and 
subsequent release of cytochrome c in response to the appearance of danger signals 
(Castanier et al., 2010; Nakahira et al., 2011; Zhou et al., 2010). A hypothetical model for 
cytoplasmic RNA recognition pathway-induced inflammasome activation and apoptosis in 
human primary macrophages is presented in figure 14. 
 
Figure 14 Hypothetical pathways for inflammasome activation and apoptosis in virus-infected 
cells. Inflammasome activation preceded apoptosis in cytoplasmic dsRNA-stimulated 
cells. Host response to virus may destabilize membrane integrity of mitochondria and 
lysosomes. Lysosomal enzymes, such as cathepsins, leak into cytoplasm. There, (B) 
they may proteolyse an unknown host-factor(s) (or e.g., NLRP3), resulting in (C) 
inflammasome activation as well as apoptosis. (D) Indirect or direct cleavage of Bid 
by cathepsins promotes (E) mitochondrial membrane destabilization and subsequent 
release of cytochrome c into cytoplasm. (F) Caspase-3 is activated and apoptosis 
ensues. In addition to NLRP3-inflammasome, also other inflammasomes may be 







Figure 15 Methodological differences between 2DE-based- and quantitative high-throughput-
iTRAQ-based proteomics. In 2DE-based proteomics, differentially expressed 
proteins are cut out of the gels, in-gel digested into peptides, and identified by MS 
and database searches. Through this method, high-abundance proteins with clear 
differences in their expression compared to controls are best characterized. In 
quantitative high-throughput MS-based proteomics, proteins in solution are digested, 
labelled, pooled, and fractionated with liquid chromatography (LC). The resulting 
peptide fractions are analysed twice with MS to improve quality of protein 
identifications and quantifications. The MS data is further handled with 
bioinformatics. The quantitative MS-based proteomics is able to detect minimal 
changes on protein expression and post-translational modifications from a very 
limited amount of starting material. 
5. Subcellular proteome and secretome profiling of influenza A virus-
infected human primary macrophages (II, IV) 
Proteomics addresses the level of gene products in cells at certain time points, and may 
provide information about changes of protein abundances, locations, and modifications. In 
an attempt to characterize influenza A virus-induced effects at the proteome level, the 
infected cells were fractionated into different subcellular compartments and the fractions 
were individually analysed. First, cytoplasmic and mitochondrial proteomes were analysed 
by 2DE-based proteomics (II) (Fig. 15). Next, fast methodological development of 
proteomics enabled quantitative high-throughput subcellular and secretome profiling of 
influenza A virus-infected human primary macrophages, and consequently provided a 











infection. The quantitative proteomic data from nuclear, cytoplasmic, and mitochondrial 
proteomes of influenza A virus-infected macrophages at 6 h, 12 h, and 18 h post-infection 
were generated by MS-based proteomics, namely the iTRAQ-technique (Fig. 15). To 
complete characterization of influenza A virus-mediated events in human primary 
macrophages, also the secretomes at 6 h, 9 h, and 12 h post-infection were analysed with 
the same method. 
5.1. Marked alterations in cytoplasmic and mitochondrial proteomes of influenza A 
virus-infected cells (II) 
2DE coupled to MS revealed marked changes in cytoplasmic and mitochondrial protein 
fractions between infected and non-infected cells at 18 h after the onset of the influenza A 
virus infection. Several proteins were upregulated in both fractions in response to the 
infection. These included IFN-inducible MxA, and several stress- and apoptosis-
associated proteins, such as heat-shock proteins (HSPs) and protein fragments produced 
by caspase-3, respectively. The result indicated that antiviral-, apoptosis- and stress-
related processes were predominant in the cells during early phases of influenza A virus 
infection. Indeed, in terms of the antiviral cytokine response, the time-course analysis of 
influenza A virus infected cells revealed that mRNA and protein expressions of RIG-I 
were rapidly induced at 3 h and 6 h post-infection, respectively, before significant mRNA 
expression of IFN- and IL-29 occurred, suggesting that high RIG-I expression preceded a 
vigorous IFN-response, and that cells adopted rapidly an antiviral cytokine status after 
influenza A virus infection. 
The virus elicited also translocation and fragmentation of various cytoskeletal 
components, such as actins, - and -tubulins, vimentins, and gelsolins, pointing to the 
interaction of influenza A virus with its host resulted in marked cytoskeletal 
rearrangement. In particular, intact and fragmented actin molecules accumulated 
significantly in the mitochondrial protein fraction at 18 h post-infection. The extensive 
redistribution of the actin network in response to influenza A virus infection was 
confirmed also by examination with confocal microscopy. 
Caspase-3 proteolyses cytoskeletal proteins like actin, gelsolin, and vimentin (Fischer 
et al., 2003; Gourlay and Ayscough, 2005). In line with this knowledge, caspase-3 
activation was followed by the appearance of actin fragments and their translocation into 
mitochondria at 16 h post-infection. In accordance, inhibition of caspase-3 with the 
pancaspase inhibitor, z-VAD-FMK, but not with the caspase-1 and -4 inhibitor, z-YVAD 
(data not shown), blocked caspase-3 activation and clearly decreased actin fragmentation 
and its mitochondrial translocation. The result suggested that influenza A virus-activated 
caspase-3 is involved in the breakdown of the actin cytoskeleton, and the actin fragments 
produced were subsequently translocated to mitochondria during the infection. 
 
The proteomic analysis of Liu et al., also detected significant changes in actin network 
with avian influenza virus (H9N2) infection in a human cell line (Liu et al., 2008). 






remodelling of the actin network for entering and budding in polarized epithelial cells 
(Simpson-Holley et al., 2002; Sun and Whittaker, 2007). Moreover, egress of filamentous 
influenza A viruses, e.g., influenza A virus strain Udorn, can be reduced by actin 
depolymerizing agents cytochalasin D or jasplakinoline in this cell type (Roberts and 
Compans, 1998; Simpson-Holley et al., 2002), suggesting that the actin cytoskeleton 
organizes viral proteins at the site of viral exit. However, in the present experiments, 
cytochalasin D did not have any effect on the production of influenza A virus proteins, 
indicating that disruption of actin filaments did not disturb replication of the virus in 
human primary macrophages. 
The significance in fragmentation and relocalization of actins may also be related to 
the utilization of actin for transport and sorting of viral RNAs and proteins (Simpson-
Holley et al., 2002; Sundell and Singer, 1991). At least NP and M1 of influenza A virus 
are known to interact with cytoskeletal elements and apparently facilitate vRNP transport 
to the budding sites (Avalos et al., 1997). Interestingly, retroviruses and several negative 
strand RNA viruses also incorporate cellular actins into their virion particles, and other 
viruses use actin to propel themselves out of cells (Roper et al., 1998; Sagara et al., 1995). 
However, influenza A virus is not known to utilize actins in such properties. 
Alternatively, the observed breakdown of the cytoskeleton by caspase-3 could also 
reflect cell's intrinsic defence mechanisms: efficient transcription, protein synthesis, 
movement of organelles, transport of proteins, vesicular cargoes, and individual proteins 
are dependent on an intact actin network (Miralles and Visa, 2006; Wickramarachchi et 
al., 2010), and without a cytoskeleton, the cell interior will collapse, shrink, and apoptosis 
will ensue. Furthermore, without proper cell-functions, cell replication is halted. 
5.2. Translocation of RIG-I/MAVS signalling components from cytoplasms to 
mitochondria (II) 
Cytoplasmic RNA recognition gathers several signalling components of the RLR pathway 
to close proximity of mitochondria (Gack et al., 2007; Lin et al., 2006; Michallet et al., 
2008a). In accordance, it was found that influenza A virus infection, recognized by RIG-I, 
promoted translocation of TRIM25, IKKε, RIG-I, and TRADD into the mitochondrial 
protein fraction, whereas cytoplasmic dsRNA, triggering mainly MDA-5, induced hardly 
any or even no mitochondrial translocation at all of these above signalling components. 
This data is also in line with other reports which show that influenza A virus and the long 
cytoplasmic dsRNA polymer are mainly recognized by RIG-I and MDA-5, respectively 
(Kato et al., 2006; Pichlmair et al., 2006). 
Interestingly, mitochondrial translocation of TRIM25 and TRADD followed 
translocation of intact actins from cytoplasm to mitochondria in response to influenza A 
virus infection. These events, in turn, preceded simultaneous translocation of RIG-I and 
fragmented actins into the mitochondrial fraction, suggesting that the actin cytoskeleton is 
intimately involved in the regulation of virus recognition and subsequent signalling, and 
could serve as a platform for immune-associated molecules. However, inhibition of 






mitochondria did not hinder translocation of RLR-signaling molecules, RIG-I, TRIM25, 
or TRADD into the mitochondrial protein fraction. Thus, this suggested that RIG-I is 
translocated to mitochondria without the requirement for caspase-3-mediated actin 
fragmentation. To delineate this further, the cells were stimulated with cytochalasin D 
before the virus was inoculated, and the expression of antiviral cytokines was analysed 
with real- time PCR at 6 h post-infection. The pharmacological agent diminished mRNA 
expression levels of type I and III IFNs, as well as that of TNF- suggesting that intact 
actins are involved in efficient expression of antiviral and pro-inflammatory cytokines. 
However, cytochalasin D had no effect on influenza A virus protein production or 
apoptosis, as determined with the Abs recognizing subunits of H3N2 influenza A virus 
and activated caspase-3, respectively. Although the importance of intact actins for 
transport of viral proteins was not elucidated, it was found that they accumulated in excess 
in mitochondria during the progression of infection. This observation highlighted the 
importance of mitochondrial location for viral proteins during infection in human primary 
macrophages. Indeed, PB2 of influenza A virus contains a mitochondrial localization 
signal, and PB2 has been recently found to accumulate in mitochondria and interact there 
with MAVS and to suppress IFN-signalling (Carr et al., 2006; Graef et al., 2010). 
Collectively, the result suggested that an intact actin network supports efficient 
signalling for transcriptional activation of certain cytokines, such as IFNs. Furthermore, 
the close interaction between mitochondria and actin filaments might be involved in 
regulating the progression of influenza A virus infection. 
 
Interestingly, Mukherjee et al., have reported that RIG-I binds via its CARD to actin and 
facilitates actin polymerization, and overexpression of RIG-I induces cellular migration 
and wound healing of nonpolarized epithelial cell (Mukherjee et al., 2009). Kong et al., 
also demonstrated that RIG-I binds to and co-localizes with actin, and IL-1, LPS, and 
poly(I:C) enhance further this interaction (Kong et al., 2009). Furthermore, loss of RIG-I 
was found to impair phagocytosis of bacteria. In another study, genetic deletion of RIG-I 
led to a colitis-like phenotype, and similarly to the study of Kong et al., increased the 
susceptibility to bacterial infections in mice (Wang et al., 2007). These examples suggest 
that the functions of RIG-I are linked to the cytoskeleton, and cytoskeletal changes which 
negatively impact on RIG-I may have profound effects on the clearance of infective agents 
from the surroundings, preventing the recovery from microbial infection, as well as 
interfering with normal mucosal signaling of the intestine. Thus, it seems that RIG-I has 
other roles beyond the elicitation of cytokines and apoptosis during complex host-virus-
interactions, and these might include restoration of homeostasis after infection. To 
summarize, the early induction of RIG-I observed during influenza A virus infection both 
in human primary macrophages, as well as in HaCaTs (I), may be more than simply a 






5.3 Quantitative analyses of subcellular proteomes of influenza A virus-infected cells 
(IV) 
The quantitative and more global proteomic analysis of influenza A virus-infected 
macrophages identified 3477 distinct proteins, of which 2466 were reliably quantified, and 
from these, 1321 were differentially regulated in the intracellular fractions of influenza A 
virus-infected human primary macrophages. Proteins with known cytoplasmic, 
mitochondrial, or nuclear location were detected mainly in their respective fractions. 
However, in addition to mitochondrial proteins, most lysosome- and ER-associated 
proteins identified were also found in the mitochondrial proteomes, impying that these 
subcellular organelles were enriched in mitochondrial protein fractions. Interestingly, 
large numbers of mainly nuclear proteins were found in the cytoplasmic fractions, 
pointing to heavy traffic of proteins between these cellular compartments during influenza 
A virus infection. 
Indeed, the largest number of differentially regulated proteins was detected in the 
nuclear fractions, the nucleus being the main replication site of the virus. Over 300 
proteins were up- and downregulated while approximately 200 proteins retained their 
nuclear abundance at 12 h and 18 h post-infection. Based on gene ontology annotations, 
the upregulated proteins originated from mitochondria, ER, Golgi, and cytoplams, and 
were functionally classified into proteins involved in gene expression, metabolism, Ca2+-
ion binding, transport, and signalling. The downregulated proteins, in turn, were mainly of 
nuclear origin, and functioned in gene expression, particularly in nucleotide metabolism 
and mRNA processing. Furthermore, approximately 5% of them were related to mRNA 
splicing, the process utilized by influenza A virus during its replication cycle (e.g., NEP 
and M2 are generated via splicing from NS1- and M1-encoding mRNAs, respectively 
(Flint et al., 2004c), suggesting that the host response to influenza A virus might include 
downregulation of activities of e.g., spliceosomes. Since several nuclear histones and other 
nuclear proteins were upregulated in the cytoplasmic protein fraction at 12 h and 18 h 
post-infection, influenza A virus infection likely promoted marked changes in the 
architecture of nuclei. 
In addition to several nuclear proteins, lysosomal proteins including cathepsins, and 
mitochondrial inner membrane proteins, like components of electron transport chain, 
oxidative phosphorylation, and cytochrome c, were upregulated in the cytoplasmic 
proteomes of influenza A virus-infected cells. The results suggested that substantial 
subcellular alterations/damage had occured in these organelles likely impairing their 
functions during infection. For example, lysosomes are indispensable for destruction of 
phagocytosed pathogens and autophagy-mediated recycling of cellular components and 
malfunctioning organelles, while mitochondria are vital for innate immunity, apoptosis, 
energy production, and many other metabolic processes described earlier in the review of 
the literature (2.3.1.). If damaged, mitochondria in particular produce ROS and this is 
linked to the development and amplification of pro-inflammatory cytokine response and 
apoptosis of cell (Ott et al., 2007; Skulachev, 2000; Zhou et al., 2009). Indeed, classical 
signs of apoptosis were detected from influenza A virus-infected human primary 






increased and that of Bax decreased in the cytoplasmic protein fraction during the course 
of the infection, and vice versa in the mitochondrial protein fraction. Western blot analysis 
of caspase-3 activation, as well as apoptotic staining of influenza A virus-infected cells 
(the APOPercentage assay), also confirmed induction of apoptosis in human primary 
macrophages. 
In addition, the antiviral cytokine response prevailed. Increased levels of IFN-
inducible proteins, such as ubiquitin-like-protein-ISG15 (ISG15) and IFN-induced protein 
with tetratricopeptide repeats (IFIT)-1 and -3 were detected in cytoplasmic protein 
fractions at 6 h post-infection and increasingly thereafter, suggesting that IFN-response 
was started immediately after recognition of the virus. (This concept was also in 
accordance with the time kinetic studies performed with real-time PCR presented in 
original publication II, and here in 5.1.). Furthermore, their increased expression is 
essential for host response to viruses: ISG15 stabilizes and activates various host proteins 
important for antiviral responses, such as RIG-I, and inhibits nuclear entrance of NS1 
preventing replication of influenza A virus (Zhao et al., 2005; Zhao et al., 2010). The 
antagonistic actions of IFITs on influenza A virus are less clear at present: IFITs suppress 
the translation of viral RNAs lacking 2'-Ο-methylation in their 5'-cap that the influenza A 
virus is able to subtly subvert by acquiring 2'-Ο-methylated 5'-caps from host mRNAs 
(Daffis et al., 2011; Zust et al., 2011). 
Although multiple antiviral effector proteins are involved in the initiation of 
translational block during infection, several influenza A virus proteins, such as HA, NA, 
and NP were significantly upregulated in the cytoplasmic and mitochondrial protein 
fractions at 12 h and 18 h post-infection, respectively, suggesting that the virus strongly 
counteracted the host responses, possibly via actions of NS1. The increased expression of 
viral proteins in those subcellular compartments was also observed by the western blotting 
technique in the previously described 2DE work (II). 
5.4 Quantitative secretome analyses of influenza A virus-infected cells uncover 
secretion of important mediators of innate immunity (IV) 
With regards to secretomes, influenza A virus induced substantial protein secretion 
already at 6 h post-infection which increased with the progression of time. Proteins with 
and without signal-peptides were secreted, indicating that both conventional protein 
secretion pathways, consisting of ER-trans-Golgi-network, as well as poorly characterized 
unconventionally secretion pathway(s) were functioning (Keller et al., 2008). 
Furthermore, influenza A virus infection elicited secretion of several proteins that were 
also identified from cytoplasmic dsRNA-stimulated cells (III), suggesting that virus 
infections may induce a common pattern of protein secretion. These proteins induced 
lysosomal cathepsins, their endogenous inhibitors, cystatins, as well as subunits of 
vacuolar-(v)-type proton ATPases and Ras-related proteins. 
Vacuolar-type proton ATPases and Ras-related proteins, Rabs, regulate endosomal 
acidification or trafficking and recycling, respectively (Savina and Amigorena, 2007; 






in Drosophila and in human lung epitlelial cells have also identified v-type proton 
ATPases as important host factors for influenza A virus infection (Hao et al., 2008; Karlas 
et al., 2010; Konig et al., 2010). Consistently with the knowledge that v-type proton 
ATPases are required for endosomal acidification, Hao et al., and Guinea et al., reported 
that the activity of v-type proton ATPases was essential for influenza A virus entry and 
replication (Hao et al., 2008; Guinea and Carrasco, 1995). With regards to Ras-related 
proteins, Bruce et al., found regulator of actin dynamics, Rab11, to be essential for 
morphogenesis of filamentous influenza A virus particles, and Sieczkarski et al., 
demonstrated that Rab5 and -7 were required for early and late endosomal trafficking of 
the virus and the subsequent establishment of influenza A virus infection (Bruce et al., 
2010; Sieczkarski and Whittaker, 2003). Thus, secretion of v-type ATPases and Rabs may 
serve as an early attempt of the host to prevent replication of viruses: without functional v-
type proton ATPases endosomal acidification, being required for membrane fusion 
between viral and host membranes and uncoating of the virus genome from its capsid is 
impaired, while without Rabs, no correct assembly or endosomal trafficking of virus 
occurred in infected cells. Since Rabs are involved in exosome biogenesis and traffic, their 
secretion may also be an indication of release of different kinds of membrane vesicles, 
including also apoptotic vesicles, from infected cells in order to mount pro-inflammatory 
cytokine response and material for antigen presentation. 
In addition, soluble mediators of innate immune responses, including chemokines, 
such as CCL8 and CCL24 (chemokine (C-C motif) ligand 8 and -24, respectively), and 
proteases and proteinases, such as matrix metalloproteinase-9, metalloelastase, and 
plasminogen activator inhibitor, were secreted. Their annotated functions demonstrate the 
importance of macrophages in mediating innate immune responses in vivo, such as the 
attraction of leukocytes, stimulation of resident cells, and the regulation of extracellular 
matrix turnover at the site of infection or tissue damage, respectively (Coelho et al., 2005; 
Westermann et al., 2010). Furthermore, secretomes of influenza A virus (and of 
cytoplasmic dsRNA) contained also proteins that have previously been detected from 
secretory vesicles of apoptotic DCs (Thery et al., 2001; Thery et al., 2009). The protein 
composition of DCs' secretory vesicles was unique with both immunostimulatory and/or 
cell-protecting properties. This implies that also influenza A virus-infected human primary 
macrophages may regulate immune responses through increased protein secretion. 
Human primary macrophages infected with influenza A virus secreted also several 
nuclear components such as histones, which might serve as antigens for self-reacting 
lymphocytes. For example, autoantibodies targetted against histones are found in systemic 
lupus erythematosus patients (Banchereau and Pascual, 2006). Although the mechanisms 
involved in the pathogenesis of autoimmune diseases in response to viruses are poorly 
known, the extracellular presence of these kinds of proteins might contribute to the 
development and/or progression of autoimmune diseases especially in individuals with 
autoimmune disease-prone genetic background. 
 
One of the most intriguing findings of the secretome data was the identification of 
potential DAMPs, such as S100 proteins, HSPs, HMGBs, and galectin-3, from cell culture 






verified by western blotting. According to the literature, these DAMPs were mainly 
unconventionally secreted, suggesting that their release from cells could be associated 
with caspase-1 and inflammasome activation (Keller et al., 2008; Mambula et al., 2007). 
Furthermore, since most of the aforementioned proteins have dual functions both 
intracellularly and extracellularly (Arnoys and Wang, 2007), to be discussed below, their 
secretion might critically regulate host-virus interactions, inflammation, and immune 
responses. Indeed, it has been shown that ASC/caspase-1 activation determines the 
development of acquired immune responses in influenza A virus-infected mice (Ichinohe 
et al., 2009; Ichinohe at al., 2011). 
With respect to the identified DAMPs from secretomes of influenza A virus-infected 
macrophages S100A8 and S100A9 proteins were well represented. S100A8 and S100A9 
are Ca2+-binding proteins that undergo various post-translational modifications and form 
homo- and hetero-oligomers with specific functions (Lim et al., 2009). Intracellularly, 
they may be involved in the regulation of cytoskeletal rearrangements and redox balance, 
whereas extracellularly they have multiple anti-inflammatory and pro-inflammatory roles, 
and are released in abundance also during rheumatoid arthritis, inflammatory bowel 
disease, and cancer (Halayko and Ghavami, 2009). Furthermore, since S100A8/A9 induce 
cell proliferation, apoptosis, inflammation, collagen synthesis, and/or cell migration in 
resident and infiltrating airway cells, S100A8/A9 could promote airway remodelling and 
perhaps chronic airway inflammation during virus infection. Indeed, respiratory virus 
infections have been linked to the development of asthma and idiopathic pulmonary 
fibrosis (Hakonarson et al., 1999; Pulkkinen et al., 2009), to diseases in which all the 
aforementioned symptoms are common. 
Another interesting protein group found in the influenza A virus secretome was HSP 
chaperones. HSPs assist in proper folding, function, and stability of their protein-binding 
partners, and their expression is elevated in response to cellular stress (Richter et al., 
2010). HSPs were also observed during influenza A virus infection in the 2DE work (II). 
Many HSPs are intracellularly anti-apoptotic, and HSP90- and HSP90 have been 
implicated in positive regulation of RIG-I's stability and activation of NLRP3, respectively 
(Matsumiya et al., 2009; Mayor et al., 2007), suggesting that their externalization may 
negatively impact on antiviral-, inflammatory, and/or apoptotic responses. Moreover, 
HSP70 is a guardian of lysosomal and mitochondrial membrane integrity (Kirkegaard et 
al., 2010; Stankiewicz et al., 2005). Interestingly, Hsc70 is known to interact with M1 of 
influenza A virus and without Hsc70, M1 and vRNPs are not exported from the nucleus 
resulting in incomplete replication of the virus (Watanabe et al., 2006). In addition, HSP90 
binds to influenza A virus proteins (Momose et al., 2002). Its binding to PB2 stimulates 
viral RNA synthesis possibly by hindering self-aggregation of newly-produced PB2s or by 
otherwise stimulating the functions of PB2. 
As described, HMGB1 and -2 are universal sentinels for nucleic acid-mediated innate 
immune responses and they operate upstream of RLRs and TLRs (Yanai et al., 2009). 
Cytoplasmic HMGB1 is also a crucial regulator of autophagy, being released from cells in 
response to apoptosis (Tang et al., 2010). Interestingly, extracellular HMGB1s have been 
associated with cancer and autoimmune diseases, like systemic lupus erythematosus and 






Galectin-3 is a -galactoside-binding lectin which also has dual functions inside and 
outside cells, and is highly expressed and secreted, especially by macrophages (Liu et al., 
1995). Intracellular galectin-3 seems to be vital for efficient phagocytosis, whereas 
extracellular galectin-3 attracts monocytes and macrophages, and induces superoxide 
production (Sano et al., 2003; Sano et al., 2000). Furthermore, since galectin-3 has a 
unique ability to associate with macrophages, it may facilitate the recognition of 
carbohydrate-containing PAMPs and promote the removal of pathogens via phagocytosis. 
The role of galectin-3 in direct binding and neutralization of influenza A virus 
glycoproteins (HA, and NA) is worthy of further characterization. In summary, secretion 
of DAMPs may have a major impact on the host response and subsequent prograssion and 
outcome of influenza A virus infection. 
 
Importantly, IL-1, IL-18, and all the aforesaid proteins are secreted unconventionally. 
This might be particularly important if the infecting agent disturbs mechanisms or the 
ultrastructure of organelles involved in conventional protein secretion. Many viruses 
encode proteins that block classical transport routes or induce dramatic reorganization of 
ER-trans-Golgi-network (Flint et al., 2004g). However, unconventional secretion of the 
aforementioned DAMPs (as well as IL-1 and IL-18) ensures that they are released 
without any constraints from cells upon caspase-1 activation, more or less independently 
of the structure and function of the conventional secretion pathway. Hence, 
unconventional protein secretion may also be considered as a cell's intrinsic defence 
mechanism. It is noteworthy that intracellular bacteria are expelled from infected cells as a 
result of prolonged caspase-1 activity (Miao et al., 2010). 
5.5. Cathepsins, P2X7 receptors, and Src kinases are involved in influenza A virus-
induced inflammasome activation (IV) 
Due to the cytoplasmic increase of cathepsins, as well as their secretion in influenza A 
virus infected human primary macrophages, it was decided to characterize their 
involvement in inflammasome activation. Similarly to cytoplasmic dsRNA-stimulated 
cells, it was found that significant secretion of cathepsin D preceded that of cathepsin B in 
influenza A virus-infected human primary macrophages. Moreover, treatment with the 
cathepsin B inhibitor Ca-074 Me, almost completely abolished influenza A viruses Udorn- 
and Beijing-elicited IL-18 secretion, as well as caspase-3 activation. The result suggested 
that cathepsins were important also for influenza A virus-induced inflammasome 
activation and apoptosis, equally well as they were for cytoplasmic dsRNA-, EMCV-, and 
VSV-triggered inflammasome activation and apoptosis. Interestingly, Ngamurulert et al., 
reported the interaction of NS1 of influenza A virus (H5N1) with cathepsin B in a yeast 
two-hybrid system (Ngamurulert et al., 2009), suggesting that influenza A viruses may 
manipulate activities of cathepsin B for their own benefit, e.g., by hindering cathepsin B-
mediated host responses or by utilizing its proteolytic abilities to mature viral proteins. 
In an attempt to delineate host-virus interactions further and potential regulatory 






inflammation-related proteins, was generated from proteins identified in the intracellular 
protein fractions of influenza A virus-infected human primary macrophages. NLRP3 was 
added to the protein interaction network since it has been reported to be important for 
activation of inflammatory response during influenza A virus infection (Allen et al., 2009; 
Thomas et al., 2009). The network showed that there was a direct link between ASC 
(illustrated as PYCARD in original publication IV; Fig. 5A), NLRP3, and P2X7 receptor. 
Functional studies were conducted, and it was found that inhibition of ATP-sensing 
protein P2X7 receptor with AZ11645373 suppressed influenza A viruses Udorn- and 
Beijing-induced IL-18 secretion. Treatment with the inhibitor reduced also IL-1 secretion 
in LPS-primed and influenza A virus-infected human primary macrophages. Furthermore, 
silencing the expression of P2X7 receptor with siRNAs reduced inflammasome activation 
in response to virus infection. Importantly, also Ichinoce et al., reported the partial 
involvement of P2X7 receptor in inflammasome activation during influenza A virus 
infection in mice (Ichinohe et al., 2010). 
It is known that binding of extracellular ATP to purinergic P2X7 receptor at 
concentrations known to be present at sites of injury and inflammation, triggers a rapid 
and massive ATP- and K+-effluxes from cells (Mariathasan et al., 2006; Mackenzie et al., 
2001; Perregaux and Gabel, 1994; Perregaux et al., 2000; Petrilli et al., 2007) and 
promotes gradual formation of pannexin-1 membrane-hemichannel and inflammasome 
activation in response to different kinds of stimuli (Pelegrin and Surprenant, 2006; 
Pelegrin and Surprenant, 2007). K+-efflux (and increased intracellular concentrations of 
Ca2+) trigger secretion of the IL-1-family of pro-inflammatory cytokines, but may also 
result in cathepsin B and cathepsin D secretion (Andrei et al., 2004; Qu et al. 2007; Qu et 
al. 2009). Furthermore, the activation of P2X7 receptor promotes a rapid rearrangement of 
actin resulting in membrane blebbing and exosome release and the creation of secretory 
routes available not only for IL-1 and IL-18, but also for other unconventionally secreted 
proteins (MacKenzie et al., 2001; Qu et al., 2007; Qu et al., 2009). Thus, in human 
primary macrophages, ATP released in response to influenza A virus-infection, and 
subsequently sensed by P2X7 receptor might be a likely mechanism for inflammasome 
activation, secretion of IL-1 and IL-18, and of all the unconventionally secreted proteins. 
Furthermore, ATP-dependent opening of pannexin-1 allows the passage of small-sized 
ions and DAMPs across the plasma membrane into both directions (Chekeni et al., 2010; 
Marina-Garcia et al., 2008; Pelegrin and Surprenant, 2007), which might further 
contribute and intensify inflammasome activation in an infected cell, as well as in its 
neighbour. Moreover, the apoptotic response during influenza A virus infection may also 
be initiated by extracellular ATP acting via the P2X7 receptor and pannexin-1 opening: 
reduced cytoplasmic concentrations of ATP and K+ are required for apoptosome formation 
(Cain et al., 2001). In addition, elevated extracellular levels of ATP sensed by P2X7 
receptor on DCs are known to be able to activate the inflammasome in DCs, which is a 
necessary prerequisite for activation of cytotoxic CD8+T cells (Ghiringhelli et al., 2009). 
Thus, sensing of extracellular ATP through the P2X7 receptor may drive inflammasome 
activation and/or apoptosis in resident cells, as well as in APCs recruited to the site of 








Macrophages are professional phagocytes which kill microbes through increased ROS 
production (see review of the literature 1.1.1.). The enzymes responsible for ROS 
generation in the extracellular or luminal space are NADPH oxidases. NADPH oxidases 
are transmembrane proteins composed of several subunits that transport electrons across 
biological membranes in order to reduce oxygen to superoxide which is then converted to 
ROS (Bedard and Krause, 2007). The protein-protein interaction network, constructed 
from intracellular proteins of influenza A virus-infected macrophages, linked NLRP3 and 
ASC closely with NADPH oxidase subunits p22phox and gp91phox (illustrated as CYBA 
and CYBB, respectively, in the original publication IV; Fig. 5A). These proteins have 
been demonstrated to be involved in inflammasome activation through ROS production in 
response to various stimuli (Cruz et al., 2007; Dostert et al., 2009; Gross et al., 2009). The 
network analysis linked p22phox and gp91phox also to tyrosine kinase Src, a prototypic 
member of the nonreceptor membrane-associated tyrosine kinases. Src is involved in the 
regulation of oxidative signalling and it responds to ROS (Giannoni et al., 2010). 
Interestingly, Src has been shown to upregulate the expression of subunits of NADPH 
oxidases and to interact with these components (Giannoni et al., 2010; Touyz et al., 2003). 
It was found here that in influenza A virus-infected human primary macrophages, the Src 
inhibitor, PP2, almost completely abrogated the secretion of IL-18 and LPS-primed 
secretion of IL-1. In addition, the influenza A virus strain Beijing was sensitive to PP2-
mediated blockage of inflammasome activation, showing that this phenomenon may by a 
general feature of influenza A viruses. The results emphasized the significant role for Src 
(and possibly to that of ROS) in the regulation of the pro-inflammatory cytokine response 
in influenza A virus-infected human primary macrophages. In line with this result, Raung 
et al., reported that IL-1 secretion and viral propagation in response to neurotropic 
Japanese encephalitis virus, recognized also by RIG-I, was sensitive to Src inhibition 
(Raung et al., 2007). Moreover Dostert et al., and Shio et al., demonstrated that malarial 
hemozoin-induced inflammasome activation and secretion of IL-1 were partly dependent 
on ROS, as well as required the contribution of Lyn, another member of the Src tyrosine 
kinase family (Dostert et al., 2009; Shio et al., 2009). Importantly, in addition to 
inflammasome signalling, efficient RIG-I signalling involves gp91phox and Src, and 
under certain circumstances, increased ROS (Johnsen et al., 2009; Soucy-Faulkner et al., 
2010; Tal et al., 2009). One should not forget that Src is also vital for TLR3 signalling 
(Johnsen et al., 2006). Moreover, other members of Src kinases have been suspected of 
playing physiologically important roles during hepatitis C virus replication or 
pathogenesis (Macdonald et al., 2004). The precise role of Src in host response to 
influenza A virus infection is worthy of more detailed characterization. 
 
Interestingly, patients suffering from chronic granulomatous disease lack the core 
component of all NADPH oxidases, namely p22phox, but are still capable of secreting 
normal amounts of IL-1 in response to the inflammasome trigger (van Bruggen et al., 
2010). However, primary cells extracted from these patients, treated with ROS scavengers 
or general flavoprotein inhibitors, and then stimulated with inflammasome agonists, 






ROS are involved in inflammasome activation, but their source is unclear. Indeed, ROS 
are known to be involved in different forms of inflammasome activation e.g., in response 
to ATP, particulate matter, and many microbes (Cruz et al., 2007; Dostert et al., 2008; 
Eisenbarth et al., 2008; Gross et al., 2009; Kankkunen et al., 2010; Nakahira et al., 2011; 
Shio et al., 2009; Zhou et al., 2009; Zhou et al., 2010). 
Mitochondria are a possible origin of intracellular ROS in the response of the organelle 
to stress (Ott et al., 2007; Zhou et al., 2010). The high-throughput proteomic data of 
influenza A virus-infected macrophages revealed marked mitochondrial (and lysosomal) 
alterations and/or damage, as described in 5.3. Thus, mitochondrial ROS might contribute 
to the inflammasome activation seen in influenza A virus-infected macrophages. In line 
with this hypothesis, Allen et al., reported that influenza A virus-induced inflammasome 
activation was sensitive to inhibitors blocking ROS production (Allen et al., 2009). The 
mechanism for influenza A virus-induced ROS production has also been recently 
associated to the function of proton-selective ion channel M2 of the influenza A virus 
(Ichinohe et al., 2010; Lazrak et al., 2009). Particularly, Ichinohe et al., linked the 
expression of M2 to increased ROS production, K+-efflux, and inflammasome activation 
(Ichinohe at al., 2010). Although the mechanisms for M2-induced inflammasome 
triggering and elevated intracellular concentrations of ROS and reduced K+ levels were 
not elucidated, the localization of M2 in acidified Golgi-compartment was essential for the 
process to occur. 
Not only do ROS detrimentally affect on mitochondria, they may also destabilize the 
lysosomal membranes and this would subsequently result in cathepsin leakage into 
cytoplasm and cathepsin-dependent inflammasome activation and apoptosis. Furthermore, 
increased ROS levels may trigger the inflammasome during virus infection by directly 
modifying crusial cellular components that then are recognized as DAMPs. Indeed, 
minimally oxidized LDLs and oxidized phospholipids produced during the progression of 
infection or cellular stress, might be sensed as danger signals (Duewell et al., 2010; Imai et 
al., 2008; Masters et al., 2010; Miller et al., 2005). These kinds of DAMPs could also be 
responsible for the influenza A virus-induced inflammasome activation and/amplification 
of pro-inflammatory responses observed in human primary macrophages. Figure 16 
presents the current model for inflammasome activation in response to microbial infection 
and physical damage. 
 
Figure 16 Prevailing model for inflammasome activation in response to numerous stimuli. (A) 
Extracellular ATP released in response to danger or cell lysis binds to P2X7 receptor. 
This results in K+-efflux and activation of pore-forming pannexin-1 hemichannel. (B) 
The opening of pannexin-1 promotes entry of extracellular activators of the 
inflammasome inside the cell, as well as ATP- and K+-efflux. (C) The phagocytosis of 
large particles, or other physical forces in cells during infection, or in the presence of 
damage, induces ROS production and lysosomal rupture followed by cathepsin 
leakage into cytoplasm. ER-stress releases also Ca2+-cations into cytoplasm which 
might contribute to the creation of the conditions for inflammasome assembly. (D) 
Alterations in the equilibrium of general denominators for inflammasome activation, 
shown in the box, likely promote inflammasome activation. (E) Recognition of nucleic 
acids in the cytoplasm may trigger direcly NLRP3-independent or -dependent 
inflammasomes into action. (F) Caspase-1 launches a vigorous pro-inflammatory 
cytokine response and unconventional protein secretion. Potential DAMPs are 
released, which may provide conditions for inflammasome activation in neighbouring 
cells. The inflammation response becomes extended. Cell death may ensue and/or 












The presence of the molecular signature of viral infection, cytoplasmic RNA, triggers 
multiple cellular signalling pathways within the host. The immune response of the host, 
which viruses try to subvert and counteract in many ways, ultimately determines the 
outcome of infection. The main goal of this thesis was to elucidate the innate immune 
responses and complex host-virus interactions occurring during influenza A virus 
infection in an crucial effector cell type of innate immunity, human primary macrophages. 
 
The involvement of membrane-bound TLRs and cytoplasmic PRRs in the elicitation of 
antiviral- and pro-inflammatory cytokines and the activation of apoptosis was 
characterized first. Recognition of extracellular dsRNA by TLR3 induced only a modest 
antiviral cytokine response, but resulted in intense expression of pro-IL-1. The 
executioner of apoptosis, caspase-3, was not activated. This implied that phagocytosis of 
extracellular RNAs, originating from virus-infected cells, prepared uninfected cells for 
possible incoming danger without eliciting vigorous antiviral or pro-inflammatory 
cytokine responses or programmed cell death. In contrast, the hallmark of ongoing viral 
replication, the presence of viral RNA in the cytoplasm, efficiently induced type I and III 
IFNs, caspase-1 activation, and subsequent secretion of processed IL-18. Furthermore, 
caspase-3 and apoptosis were rapidly induced in response to recognition of cytoplasmic 
RNA, and these effects were linked to functions of RIG-I/MAVS at the molecular level. 
Thus, recognition of cytoplasmic RNA served as a marker of actual infection and it 
seemed to be a prerequisite for induction of efficient antiviral cytokine response, 
inflammasome activation, and apoptosis. Interestingly, IL-1 was not significantly 
secreted in response to cytoplasmic dsRNA stimulation or influenza A virus infection. Its 
abundant secretion occurred only if the TLR stimulus complemented the initially weak 
cytoplasmic RNA-induced pro-IL-1 expression first. The results suggested that an 
intense inflammatory response, which is potentially damaging to tissues, was engaged 
only after definite perception of severe infection, activating both endosomal as well as 
cytoplasmic PRRs in human primary macrophages. Overall, the results higlighted key 
roles for cytoplasmic PRRs during innate immune responses against viruses. 
 
Inflammasome activation results often in secretion of its core components and of 
unconventionally secreted proteins that likely fine tune the inflammatory responses. In an 
attempt to characterize how the inflammasome responds to cytoplasmic dsRNA, a 
complete set of secreted proteins, secretomes, were analysed with high-throughput MS-
based methods. Cytoplasmic dsRNA triggered robust protein secretion. Several lysosomal 
proteins, such as cathepsins, were identified, suggesting that lysosomal integrity had been 
impaired. Further characterization revealed that inflammasome activation preceded 
apoptosis, and that pharmacological inhibition of cathepsin B could abolish the secretion 
of IL-18 and halt the progression of apoptosis. Interestingly, cathepsin D was secreted 
simultanously with inflammasome components, and silencing of cathepsin D expression 
suppressed cytoplasmic dsRNA-induced inflammasome activation. These results implied 






components, and that both cathepsin B and cathepsin D participated in this response. 
Importantly, EMCV- and VSV-induced inflammasome activation and apoptosis were also 
abolished by cathepsin B inhibition. As a whole, the results highlighted the importance of 
lysosomal proteases in orchestration of innate immune responses against RNA-viruses. 
 
2DE-based proteomic analysis was performed to characterize alterations in subcellular 
proteomes of human primary macrophages during influenza A virus-infection. The virus 
induced marked changes in cytoplasmic and mitochondrial proteomes: IFN-inducible 
proteins and stress- and apoptosis-related ones were upregulated, and striking cytoskeletal 
rearrangements were observed. The constituents of cytoskeleton were caspase-3-
dependently fragmented, and translocated from cytoplasm to mitochondria. Moreover, 
sequential translocation of intact and fragmented actin molecules from cytoplasm 
coincided with the ordered translocation of RLR signalling pathway members from 
cytoplasm into mitochondria. In addition, viral proteins accumulated to mitochondria 
during progression of infection, an evidence of their importance for their presence in 
mitochondria during infection. Interestingly, pharmacological breakdown of the actin 
network with cytochalasin D resulted in decreased IFNs expression, without any effect on 
the progression of caspase-3 activation or viral protein synthesis, suggesting that the 
antiviral cytokine response was dependent on intact actin cytoskeleton. The results implied 
close interaction of actin network with mitochondria in the regulation of antiviral 
responses during influenza A virus infection. 
 
The host-virus-interactions were examined in more detail during influenza A virus-
infection by conducting quantitative subcellular high-throughput proteome and secretome 
profiling. More than one thousand host proteins were differentially expressed and/or 
localized during infection in human primary macrophages. Several nuclear, lysosomal, 
and mitochondrial proteins were leaked or translocated into cytoplasm, and potential 
DAMPs were significantly secreted. In order to obtain a more comprehensive view on this 
robust host-virus interaction and on potential regulatory proteins for inflammasome 
activation, a protein-protein interaction network was constructed via bioinformatics from 
the identified intracellular and inflammation-related proteins of influenza A virus-infected 
cells. Functional studies were carried out, and the results suggested that cathepsins, P2X7 
receptor, and Src kinases participated in influenza A virus-induced inflammasome 
activation. Overall, the results demonstrated that multiple cellular pathways ensure 
activation of inflammasomes during influenza A virus infection. 
 
The outcome of virus infection depends primarily on host-virus interactions. The functions 
of several PRRs and of individual influenza A virus proteins are rather well characterized. 
Furthermore, cellular responses to influenza A virus and other RNA viruses have been 
elucidated by genome-wide screening techniques, as well as 2DE- and more sophisticated 
MS-based proteomic methods in cell lines. However, few studies have globally adressed 
host-virus responses in human primary cells with modern high-throughput proteomic 
techniques, albeit these are an excellent way to understand the progression of viral 






meet these needs, and provides an interesting insight into inflammatory and antiviral 
innate immune responses during influenza A virus infection in human primary 
macrophages. In addition, the work presented here highlights the importance of 
macrophages in the development of immune responses of the host: infected cells secrete 
many proteins that undoubtedly contribute to antigen presentation, local inflammatory 
responses, as well as signalling the presence of danger to other parts of the body. 
Moreover, antigen presentation and cytokine secretion enhance the development of 
acquired immune responses, resulting in the clearance of pathogen and recovery from the 
infection. Future studies conducted in human primary cells will be necessary to delineate 
whether a common or rather specific protein secretion pattern is launched in response to 
distinct pathogens, virus families, and viruses within a virus species. Furthermore, an 
understanding of differences in proteomes and secretomes between infected individuals 
and possible identification of reliable biomarkers which can be associated with severe 
infection may be of significant clinical value. Perhaps in the future, secretome- and 
proteome profiling will become cost-effective techniques in diagnostics to be used to 
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